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Burn injuries result in loss of skin covering, and can result in substantial morbidity 
and mortality despite major advances over the past three decades. Grafting of 
autologous skin cells is the ideal for restoration of large burn surfaces, but requires a 
long tissue culture period, during which patients are vulnerable to infections and 
fluid-electrolyte imbalances. The availability of an unrestricted non-immunogenic 
allogeneic epidermal cell source may overcome this problem. It is hypothesized that 
foetal skin may be able to act as a universal donor source for skin grafts, as it may be 
less immunogenic and its cells are predicted to have a great proliferative potential.  
Second trimester human foetal dorsal skin was characterized for possible use 
in allogeneic transplantation applications. Histological and immunohistochemical 
assessments were conducted on foetal and adult skin biopsies to determine 
embryological changes, the expression patterns of epidermal keratins, basement 
membrane proteins, extracellular matrix proteins, stem cell-associated markers, and 
other biomarkers for tracking changes in skin development. The collagen composition 
as well as the expression profiles of several proteins including K18, K19 and K17 
were observed to be different in the foetal skin as compared to adult skin.  
Isolation techniques were established for foetal keratinocytes. The cells were 
grown in an optimized serum-free culture regime, and shown to be stably and 
successfully cultured in vitro whilst maintaining their normal phenotype and 
karyotype. It was shown that several keratins including K18 and K7 can be used to 
identify foetal keratinocytes. Examination of their proliferative potential revealed that 
foetal keratinocytes have higher proliferative index, shorter doubling times and faster 
expansion times in vitro, and had greater clonogenic capacity at low cell density than 
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adult keratinocytes. They also show longer average telomere length (by Southern blot 
hybridization against telomere repeats), suggesting that they are indeed further from 
cell senescence. Foetal keratinocytes were also shown to be able to stratify in vitro in 
organotypic co-cultures. 
Characterization of the major histocompatibility complex (MHC) profile of 
foetal keratinocytes revealed a low expression of MHC I and no expression of MHC 
II. Foetal keratinocytes did not induce proliferation of T cells when they were co-
cultured, and in high numbers they appeared to suppress the proliferation of 
stimulated T cells.  
Experimental transplantation of human foetal keratinocytes, seeded on an 
optimized fibrin gel scaffold, yielded excellent epidermal architecture and phenotype, 
and showed successful engraftment and stable skin regeneration in vivo. The 
successful development of humanized skin mouse model using foetal cells has 
demonstrated that they can be used for the construction of bioengineered skin. 
Collectively, these results support the feasibility of using second trimester 
foetal skin for grafting, with the possibility of using such cells as a universal donor 
skin graft source. This study expands our understanding of skin development and 
opens new avenues for novel approaches in cell-based therapy for serious burns. In 
addition, investigations into the composition of foetal skin may contribute to the 
understanding of foetal scar-less wound healing and the creation of an ideal skin graft 
with appendageal development. 
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Skin is a vital organ, in the sense that loss of a substantial fraction of its mass 
immediately threatens the life of the individual. The loss of skin can occur for many 
reasons such as genetic disorders (bullous conditions) or result suddenly, either from 
fire or from a mechanical accident. Loss of skin can also occur in a chronic manner, 
as in skin ulcers. The resulting deficit is considered life threatening, primarily because 
skin is a barrier to loss of water and electrolytes from the body, and it is a barrier to 
infection from airborne organisms. A substantial deficit in the integrity of skin leaves 
the individual unprotected either from shock or from sepsis, the result of a massive 
systemic infection. Burns and scalds can result in extensive deep wounds which 
cannot be successfully treated with common techniques, and can lead to death.  
It has been reported that fire-related burns account for 322,000 deaths in the 
world in 2002 (WHO-International Society for Burn Injuries Fact Sheet) with more 
than half of all fire-related burn deaths occurring in South-East Asia. According to the 
American Burn Association, there are currently over 350 cases annually in the US 
involving full and partial-thickness burns covering over 50% of the patient’s total 
body surface area (TBSA) with a mortality rate as high as 80% (American Burn 
Association National Burn Repository). Other causes of skin loss such as chronic 
wounds associated with ageing and diabetes have become very significant in the 
developed world (Falanga, 1993). The estimated prevalence of diabetes in the US 





population is 8.3% or 26 million individuals (Centers for Disease Control and 
Prevention, 2011) and 11.3% in Singapore (http://www.diabetes.org.sg/). Of these, 
more than 60% eventually necessitate amputation due to chronic diabetic ulcers 
(Centers for Disease Control and Prevention, 2011). 
1.1.1  The Clinical Unmet Need of Skin Grafting 
Any loss of full-thickness skin of more than 4 cm in diameter will not heal well 
without a graft (Herndon et al., 1989). Currently, the clinical ‘gold standard’ in full 
thickness injuries treatment is split-thickness autologous skin graft that contains all of 
the epidermis but only part of the dermis (Supp & Boyce, 2005). These are removed 
from healthy areas of the body to treat damaged areas. In the case of more extensive 
injury, donor sites are extremely limited and in such cases wounds are covered with 
temporary dressings or cadaver skin to form a mechanical barrier. However, 
availability is limited and the tissue is often rejected by the host. Only delayed serial 
autologous split skin grafting can be used to heal these injuries (Papini, 2004). 
Alternative life-saving approaches in the treatment of extensive wounds include the 
use of cultured autologous keratinocytes. In this therapy, the patient's own skin cells 
are taken, grown in the laboratory, and used to replace the damaged skin. Chronic 
wounds represent a different kind of challenge as autografts may lead to slow healing 
at the donor site and may be unsuccessful because of the underlying deficiencies in 
wound healing. 
Significant progress has been made in the development of bioengineered skin 
substitutes using cultured cells (Pham et al., 2007). Despite the development of recent 
biotechnologies, the problem of permanent wound coverage for the patient with 
massive wound injuries remains unsolved (Balasubramani et al., 2001). The major 





disadvantage is that there is at least a three week period needed to grow enough cells. 
The failure to close burn wound puts the patients at risk of developing infection, 
sepsis, multiple organ failure, and death in severely injured burn patients. There has 
been active search and development for inert synthetic and biosynthetic matrices. 
Presently however, these substitutes have not replaced skin in large burns since they 
increase the risks of subsequent graft rejection and disease transmission. This is due to 
the fact that they contain bovine collagen and allogeneic skin cells. Furthermore, no 
currently available tissue-engineered skin replacement can fully replace the functional 
and anatomical properties of the native skin, and appendageal development are absent 
in the healed area of full-thickness wounds.  
There is an overwhelming need for readily available, transplantable skin grafts 
worldwide to meet the ever increasing demand. Clinical barriers to effectively treat 
patient with massive burns and chronic wounds have spawned the search for 
alternative sources for treatments and wound care innovations. Hopefully, these will 
facilitate faster healing, better aesthetics, and promote the development of a new 
tissue that bears a close resemblance to the uninjured skin. 
 
1.2 THE PRESENT STUDY 
1.2.1 Hypothesis and Objectives 
The hypothesis underlying this thesis work is that foetal skin might provide an 
alternative source of cells for overcoming these clinical barriers. An important 
advantage for the use of foetal cells for therapeutic reasons is that the foetus has not 
yet developed a fully functioning immune system and foetal tissues are associated 





with a reduced capacity to produce an immunological response. The decreased ability 
to evoke an immunological response might be associated with the lack of post-thymic 
T-lymphocytes prior to 14 weeks of gestation within foetal tissues (Gabbianelli et al., 
1990). Foetal cells have also long been known to exist in microchimerism, whereby a 
small number of foetal cells establish and multiply within the mother during 
pregnancy, and it appears that microchimerism persists until decades later 
(O'Donoghue et al., 2004). Foetal mesenchymal stem cells (MSCs) do not express 
human leukocyte antigen (HLA) class II antigens and may not express HLA class I 
antigens as well. Since these early foetal stem cells appear to have pre-immune status, 
this may be ideal for allogeneic transplantation situations, as both undifferentiated and 
differentiated foetal MSCs do not elicit alloreactive lymphocyte proliferation 
(Götherström et al., 2004). In fact, foetal tissue as a source of cells for regenerative 
medicine have already been in clinical use since the first allogeneic umbilical cord 
blood transplant in 1989 (Gluckman et al., 1989). Umbilical cord blood cells are now 
widely used to treat hematological disorders (Kurtzberg, 2009). Several sources of 
cells derived from foetal tissues have also been investigated. In skin tissue 
engineering, Hohlfeld and associates developed foetal skin constructs using foetal 
fibroblasts without keratinocytes to improve healing of such severe burns (Hohlfeld et 
al., 2005). Their simple techniques provided complete treatment without autografting, 
but it worked as a “biological Band-Aid” to promote spontaneous healing, rather than 
a permanent cover. Nevertheless, this shows that foetal skin cells might have great 
potential to treat burns and eventually acute and chronic wounds of other types.  
To this end, the current project aims to study foetal skin cells, particularly 
focusing on foetal keratinocytes. Foetal skin is hypothesized to have the potential to 
act as a universal donor source for skin grafts, as it may be less immunogenic and is 





predicted to have a great proliferative potential. Based on this hypothesis, the specific 
objectives were identified as below: 
1. Understanding foetal skin and establishing techniques to obtain human foetal 
keratinocytes and fibroblasts from foetal skin, as well as characterizing these cells. 
2. Evaluate the proliferation and differentiation capabilities of foetal keratinocytes, 
as compared to adult keratinocytes. 
3. Evaluate the immunogenic potential of foetal keratinocytes. 
4. Develop a suitable skin equivalent and evaluate the quality of foetal tissue 
engineered skin equivalent in vitro and in vivo. 
1.2.2 Research Rationale and Strategy 
 
  
Figure 1.1   Research Rationale and Strategy  
 





1.2.3 Organization of the Thesis 
Chapter 1 introduces the background and brief overview of the problem of massive 
burn wounds, the current clinical unmet need of skin grafting, and defines the 
hypothesis and objectives of this research. 
Chapter 2 provides a detailed literature review of relevant topics, leading to the 
motivation of using foetal skin cells as a strategy to address the problem. 
Chapter 3 describes the materials and methods for all the techniques adopted 
throughout the course of this research, as well as some novel and improved methods 
for isolating and transplanting foetal cells. 
Chapters 4 to 8 of the thesis report the results, discussion and summarize novel 
findings of each research themes. Chapter 4 attempts to characterize and understand 
foetal skin tissue by immunohistochemistry. This is followed by establishing 
techniques to isolate and culture foetal skin cells in chapter 5, as well as 
characterizing the isolated cells. Chapter 6 studies the proliferation and 
differentiation capabilities of foetal keratinocytes using established methods, while 
chapter 7 evaluates the immunogenic potential of foetal keratinocytes. Chapter 8 
evaluates the possibility of foetal skin constructs to be transplanted onto full thickness 
wounds and assessing their histological profile. 
Chapter 9 summarizes the significance and implications of this research, drawing 





















2.1 THE FUNCTIONAL GEOGRAPHY OF POSTNATAL SKIN 
Skin (the epidermis and dermis and associated structures) forms the body’s first line 
of defense and protection against dehydration, injury, infection and UV irradiation, 
and is important for excretion (through sweat) and temperature regulation. Thus the 
skin needs to be physically tough, disposable and able to rapidly repair itself, and 
must be able to continue to function throughout life. The outermost layer of the skin, 
the epidermis, can be seen to meet these challenges in its prodigious capacity for cell 
proliferation during wound healing and tissue maintenance. The ultimate functional 
state of the epidermis is to form a sealed layer of dead cells covering the living body 
from terminal differentiation of its post-mitotic cells. Epidermal differentiation 
follows an ordered sequence through spatially fixed compartments of cells, where 
each stage can be marked by well-mapped indicator proteins. Far from being a passive 
membrane that keeps the internal organs in shape, skin is a complex organ. 
The postnatal skin is made up of two different tissue compartments, the 
epidermis and the dermis, which are both interdependent. The outer epidermis is 
relatively thin, but tough stratified squamous epithelium about 0.1 mm thick. In most 
places it is composed of about 6 cell layers of differentiating keratinocytes moving 
progressively outwards. The basal layer which consists of a single underlying layer of 
proliferative keratinocytes at the interface with the dermis is responsible for cell 
production in the epidermis. The regeneration of the epidermis after wounding and the 





homeostatic maintenance of the epidermis arise from this layer of keratinocytes, thus 
parts of this basal layer must contain epidermal stem cells. Other cell types such as 
Merkel cells, melanocytes, Langerhans cells and infiltrating lymphocytes in varying 
numbers are also seen in the epidermis, but do not contribute directly to the 
generation of new keratinocytes.  
The basement membrane consists of a thin sheet of extracellular matrix which 
separates the epidermis from the dermis, and is a critical signaling interface that 
presents cytokines and growth factors to the keratinocytes. The underlying dermis is 
much thicker (1–2 mm) than the epidermis (about 0.1 mm), and functions as an 
impact-absorbing collagenous matrix. Fibroblasts are scattered through the dermis, 
synthesizing a range of collagens that impart insulation and tensile strength to the skin, 
while some fibroblasts of the “adventitious dermis” follow the contours of the dermo-
epidermal interface. The dermal matrix is vascularized, and is traversed by small 
blood vessels, lymph vessels and nerve fibres. Also present are glands and their ducts 
which empty onto the skin surface and occasional smooth muscle which are attached 
to hair follicles. A thin layer of smooth muscle, the panniculus carnosus, as well as a 
layer of subcutaneous fat mark the inner limit of the skin.  
The epidermis is not a flat sheet but is developed into variable projections into 
the dermis. Rete ridges or rete pegs are smaller projections while the larger ones form 
specialized appendages such as hair follicles, sebaceous glands, and other ectodermal 
glands including sweat glands. These appendages and projections provide many 
physically protected sites that may harbour stem cell niches. During development, 
epidermal appendages form as invasive downgrowths into the connective tissue 
dermis, flanking by mesenchymal fibroblast populations of cells in the dermis at all 





times (see section 2.2). The epidermis and the outer root sheath of the hair follicle are 
contiguous and biochemically similar. The pilosebaceous units of hair follicle consist 
of sebaceous glands, which bud out from the outer root sheath of the hair follicle 
during development. Sweat glands bud down from the epidermis slightly after the hair 
follicles develop, remaining discrete from them. 
Hair follicles undergo cycles of growth (anagen phase), degeneration (catagen), 
and rest (telogen) throughout human life. A hair follicle consists of an external funnel-
like ingrowth of the epidermis (the permanent infundibulum), plus a deeper section 
which grows and regresses cyclically. Cells in mitosis can readily be seen at the 
lowest point of the transient follicle, the hair bulb, where the hair fibre grows out. As 
the growing hair move up, the epithelial cylinder of the hair follicle becomes flattened 
and thinner (the isthmus) until the sebaceous gland duct opens into the hair canal. At 
this point the inner root sheath has degenerated, and the hair canal widens into the 
infundibulum and opens at the skin surface, exposing the hair fibre. There are many 
differentiation lineages that contribute to the cyclical formation of this complex 
structure, with 8 distinct differentiation lineages all originating in the proliferative but 
transient zone of the hair bulb (Moll et al., 2008).  
Keratin filaments are the hallmark of basal keratinocytes. Keratins can be 
divided into acidic subclass (type I), K9-20, and basic subclass (type II), K1-8. 
Keratins form heterodimers of type I and type II keratin, which in turn form tetramers. 
The basic keratin is usually 5 kDa heavier than their acid partner and hence longer 
than their natural partners (Moll et al., 1982b). In normal interfollicular epidermis, 
cells divide exclusively in the basal layer (i.e. in contact with the basal lamina), to 
supply a renewing source of cells to populate the epidermis. Basal keratinocytes at 





steady state are marked by the expression major keratin intermediate filament proteins 
K5 and K14, and have hemidesmosomes, which connect the cell to the basement 
membrane. Hemidesmosomes contain plectin, integrins α6 and β4, and bullous 
pemphigoid antigens, BP230 and BP180.  
Differentiation in the epidermis follows a well-ordered sequence, where post-
mitotic cells committed to terminal differentiation move out from the basal layer and 
upward toward the skin surface, gradually flattening out while they undergo a 
progressive programme of differentiation. In the suprabasal layers (the spinous layers 
or stratum spinosum), keratinocytes switch to synthesizing large amounts of 
suprabasal keratins (K1 and K10), strengthening their cytoskeleton as well as 
intercellular connections to provide better resistance to mechanical stress (Figure 2.1). 
As cells transit into the granular layer (stratum granulosum), they synthesize 
eponymous keratohyalin granules visible by light microscopy. These granules contain 
essential components for the final differentiation step. Finally, as cells lose their 
nucleus and organelles, they flatten into compacted squames and fuse to the underside 
of the forming stratum corneum, or cornified layer. In this process they extrude 
specialized lipids of the intercellular glue that makes the cornified layer watertight, 
thus forming the functional barrier layer of the skin. Failure to form this barrier in the 
stratum corneum has serious pathological consequences. In the cycle of differentiation 
the squames are continuously sloughed from the stratum corneum or being rubbed off 
at the skin surface as cells are constantly regenerated from the basal layer.  
At certain body sites specific variations on this theme are informative on 
structure-function relationships. For example, in the particularly thick skin of the 
palms and soles of the feet, the dermo-epidermal interface is extended by the presence 





of very deep rete ridges and folds, so that the proliferative compartment is much 
greater relative to the area of skin surface. Palmoplantar epidermis is 2-3 times thicker 
than ordinary thin skin, consisting more living cell layers, and the stratum corneum is 
very much thicker, reflecting the larger proliferative compartment.  Although this 
body site has no hair follicles, it has plentiful sweat glands. In addition, there are some 
site-specific keratins expressed in the keratinocytes at these locations only. 
Presumably these differences combine to give higher resilience to the tissue 
(Swensson et al., 1998), but few attempts have been made to analyze the physiology 
underlying these tissue properties. 
The epidermal appendages and the interfollicular epidermis undergo 
continuous growth and renewal, and it takes only 3 to 4 weeks in humans and mice to 
replace all the cells of the interfollicular epidermis (Potten & Booth, 2002). The 
epidermis can also regenerate large areas to cover wounds very fast, covering a 5 mm2 
wound within 4 days by extension, migration and proliferation of the keratinocytes. 
All these processes must continue for a lifetime in humans, as they are clearly 
essential for the skin to maintain an intact life-supporting barrier. 






Figure 2.1   Schematic diagram of the organization of the epidermis. 
 





2.2 EMBRYOGENESIS OF THE SKIN 
In order to interpret the structural and functional properties of foetal skin and to 
manipulate them, an understanding of how the skin develops in the embryo and foetus 
is needed. The embryo and the foetus are two major stages of development of an 
organism, where the embryo becomes a foetus at the end of the second month of 
gestation, coincident with the onset of bone marrow function. During embryonic and 
foetal stages of skin development, morphologic characteristics of the epidermis and 
biochemical markers can be used to determine maturity and stage of development. 
The human skin has three major components: a stratified epidermis, dermis composed 
of fibroblasts, and neural-crest derived melanocytes. The germ layers that give rise to 
these components organize very early in development. The ectoderm develops into 
epidermis, while mesenchymal and neural crest cells develop into the dermis. The 
epidermis then stratifies and epidermal appendages differentiate. The dermis and 
hypodermis become demarcated as well.  
2.2.1 Emergence of the Ectoderm 
The epidermis originates from the ectoderm which covers the embryo after 
neurulation. The ectoderm is formed at 10 to 12 days estimated gestational age (EGA) 
(Holbrook KA, 1991) and is induced to form the epidermis by the actions of bone 
morphogenetic proteins (BMPs), which promote epidermal specification and induce 
transcription factors that blocks neural development (Bakkers et al., 2002). BMPs 
help initiate epidermal production by inducing p63 transcription factor in the basal 
layer. The p63 protein has different splicing isoforms, which contribute differentially 
to the multiple roles of the protein. The p63 protein is required for keratinocyte 





proliferation and differentiation in the epidermis (Truong & Khavari, 2007; Koster & 
Roop, 2004; Pellegrini et al., 2001).  
The epidermis is originally one cell layer thick but soon becomes a multi-
layered structure. As in the adults, the foetal epidermis is organized into layers which 
correlate with stages of keratinocyte differentiation, where cells become more 
specialized structurally, synthesize new gene products, and perform new functions, 
culminating in the formation of the cornified layer (stratum corneum). The foetal 
epidermis takes about 22 to 24 weeks to acquire the capacity to show cornifying 
differentiation, such that in post-natal epidermis a cell leaving the basal layer takes 
about 2 weeks to reach the cornified layer. While epidermal differentiation occurs in a 
dry environment in post-natal skin, the epidermis of the foetus is exposed to amniotic 
fluid as it differentiates. In the developing skin, the outer layer gives rise to the 
periderm, a transient covering found only on embryonic and foetal epidermis. 
2.2.2 The Periderm 
The periderm is a feature found only in the skin of the developing embryo, and is shed 
once the inner layer differentiates to form a true epidermis. The periderm originates 
from the ectoderm, and contains a single population of cells, but whether it is the first 
layer of the skin, or derived secondarily from cells in the basal layer is still unknown. 
Regardless, the periderm persists on the surface of the developing skin until the 
cornification of the underlying epidermal layers is complete at around 19-20 weeks 
(Holbrook & Odland, 1975). During the first trimester, the periderm stops dividing, 
but continue to expand in surface area and project superficial blebs (Holbrook & 
Odland, 1975). At later stages about 18 weeks, the periderm cells flatten and the blebs 
regress to small, buttonlike protrusions. The characteristic blebbing as well as 





expression of apoptotic markers such as transglutaminases, DNA fragmentation 
suggest that the periderm undergoes programmed cell death, as loss of a periderm 
cells occurs throughout the second trimester (Polakowska et al., 1994).  
 As observed with the electron microscope, the shape and surface morphology 
of the periderm are so consistent for different gestational ages that they can be used to 
define the stage of epidermal development (Holbrook & Odland, 1975). The periderm 
is thought to play a role in early stages of development to protect the epidermal layer. 
The extensive microvilli and blebbing of the periderm cell may also suggest that the 
periderm plays a role in exchange of substances between the foetus and the amniotic 
fluid (Mears & Van Petten, 1977; Parmley & Seeds, 1970; Riddle, 1985). As 
monoclonal antibodies have been made to recognize periderm cells (Schofield et al., 
1990) (Lane et al., 1987), these antibodies may be of use in isolating this population 
of cells, establishing them in cultures, and to study their origin and function in 
association with the developing keratinocytes. 
2.2.3 Development of the Skin 
The skin in the first trimester consists of an epidermis, dermal-epidermal junction, 
dermis, and subcutaneous tissue. The epidermis includes the basal and periderm 
layers, both contain large amounts of glycogen where it may serve as an energy 
source. Keratins that are characteristic of simple and glandular epithelium K18, K19 
and K8 are expressed in both periderm and basal cells (Moll et al., 1982a; Dale et al., 
1985), whereas the basal cells contain keratin markers of the stratified epithelia K5 
and K14 (Tseng et al., 1982; Dale et al., 1985; Moll et al., 1982c). At around second 
month of gestation when the embryo becomes a foetus at the onset of bone marrow 
function, the stratification of the epidermis occurs. The intermediate cell layers 





express higher molecular weight, differentiation-specific keratins K1 and K10 (Dale 
et al., 1985; Moll et al., 1982c), as well as other markers of differentiation (involucrin, 
loricrin). Although glycogen occupies a significant volume in the basal keratinocytes 
initially, they start losing some of their glycogen content once the intermediate layer 
is formed and continue to diminish in later stages of development. The cells in the 
foetal epidermis including periderm cells can divide during this time but by the end of 
the first trimester this ability appears to be restricted to basal keratinocytes 
(Bickenbach & Holbrook, 1986; Bickenbach & Holbrook, 1987). 
Between 22 and 24 weeks EGA the interfollicular epidermis begins to cornify, 
and filaggrin is expressed which correlate with the appearance of lamellar granules 
and keratohyalin granules in the upper intermediate layers (Dale et al., 1985). The 
numbers of layers of cornified cells continue to increase as well as the size of 
keratohyalin granules. At the third trimester, foetal skin corresponds to the skin of a 
premature infant, but the cells still retain a substantial amount of glycogen. The 
periderm is sloughed from most of the skin surface revealing the underlying cornified 
epidermis.  
Non-ectodermal cells in the epidermis such as Langerhans cells can be 
detected as early as 49 days EGA. They react positively to HLA-DR and express 
CD1a at around 80 days EGA (Foster & Holbrook, 1989; Foster et al., 1986). They 
are dendritic and the density of these cells is low (65 cells/mm2) during this period of 
development and does not increase significantly until the third trimester. Melanocytes 
can be detected at 50 days EGA using HMB-45 monoclonal antibody that recognizes 
an antigen in melanoma cells and foetal melanocytes (Holbrook et al., 1989). At this 
early age, they are high in density (1050 cells/mm2) but do not contain melanosomes 





(Holbrook et al., 1989). They continue to increase in density to approximately 2300 
cells/mm2 during the late first trimester, and melanosomes start to appear around 65 
day EGA depending on the race and body site of the foetus. Their density decreases 
toward birth within the values of newborn epidermis, probably reflecting the growth 
of the foetus. Merkel cells can be detected in foetal epidermis using antibodies against 
K20 as early as 56 days EGA in foetal palmar and plantar skin, as their characteristic 
neuropeptides are only apparent in adult Merkel cells (Moll & Moll, 1992; Kim & 
Holbrook, 1995).  
The epidermis is associated with a basement membrane at the dermal-
epidermal junction at all foetal ages. Early stages of hemidesmosome formation are 
evident morphologically but these structures are incomplete and sparse (McMillan & 
Eady, 1996). At the onset of epidermal stratification, basal keratinocytes synthesize 
components of the hemidesmosomes, anchoring filaments, and anchoring fibrils, 
completing the structure of hemidesmosomes. The dermal-epidermal junction is 
relatively flat initially but as the age increases, rete ridges and dermal papillae become 
more prominent. 
The dermis in the first trimester is a loose network of mesenchymal cells with 
little fibrous connective tissue matrix, and hyaluronic acid rich environment which 
promotes cell migration. Collagen types I, III, V, and VI are present but contain few 
fibrils (Smith et al., 1986; Smith, 1994). As gestation age progresses, the 
mesenchymal cells differentiate into fibroblasts and the dermis becomes less watery 
as more fibrous connective tissue accumulates, and there is a decrease in hyaluronic 
acid (Smith et al., 1986). Elastic fibres do not appear to be expressed until 
approximately 15 weeks EGA, and elastic fibre networks are seen in the foetal skin by 





immunohistological methods around 20 weeks EGA albeit immature in structure 
(Deutsch & Esterly, 1975; Smith et al., 1982). Foetal skin has fine collagen fibrils and 
small-sized collagen fibre bundles, giving the dermis a highly cellular and delicate 
appearance. Adipose tissue is synthesized considerably later in development, so that 
the hypodermis, which consists of fine connective tissue, is difficult to distinguish 
until 15 weeks EGA. By 18 weeks EGA there is a small accumulation of fat. 
2.2.4 Initiation of Cutaneous Appendages 
Epidermal appendages form between 12-16 weeks EGA depending on the body site. 
The pilosebaceous structure begins to form as groups of basal cells known as placodes 
that bulge into the dermis. Follicle formation begins on the head and proceeds in a 
cephalocaudal direction. The epidermal cells which form the placodes secrete Wnt 
proteins, which are critical for initiation of follicular development (Andl et al., 2002; 
Reddy et al., 2001). This signals the underlying fibroblasts to aggregate beneath it 
into a dermal papilla that will influence the formation of hair fibre. A series of 
reciprocal inductive messages between the ectodermal epithelium and dermal 
mesenchyme induce and promote follicular morphogenesis. 
 Wnt signaling is crucial in placode formation as forced expression of Wnt 
inhibitor Dickkopf (Dkk) or deletion of β-catenin prevents placode formation. On the 
other hand, constitutive active form of β-catenin results in induction of hairlike fate 
(Närhi et al., 2008; Gat et al., 1998). The patterning of placode thus rely on the 
competition between Wnts and secreted inhibitors including the Dkk family and 
several BMP family (Sick et al., 2006; Mou et al., 2006; Bazzi et al., 2007). Wnt 
regulates its own activity by activating expression of its own inhibitor, Dkk4 in 
placodes, and may suppress placode cell fate in adjacent cells, thus contributing to 





patterning. Once placodes are established, further proliferation of these cells result in 
the formation of inner root sheath and hair shaft. Sebaceous gland and bulge develop 
on the periphery of the hair germ around 12 to 14 weeks EGA. The bulge marks the 
site for the attachment of the arrector pili muscle and also the presumptive location of 
follicular stem cells (see below) (Cotsarelis et al., 1990). The lanugo hairs in the 
human embryo are thin and usually shed before birth, replaced by short and silky 
vellus hairs. The bulge is a prominent structure in the developing lanugo follicle and 
thus potentially useful for analysis of the cells in vitro.  
 
  







Figure 2.2   Ontogeny of developing human epidermis. (A) One cell-layered epithelium 
(<5 weeks). (B) Two-layered epidermis (6-9 weeks). (C) Three-layered, stratified 
epidermis (10-14 weeks). (D) Four-layered or more stratified epidermis (14-22 weeks). 
(E) Epidermis showing cornification (>22 weeks). Arrow, periderm. Modified from 
Akiyama et al., 1999. 
 





2.3 SKIN REGENERATION IN VIVO 
In response to injury of the skin, multicellular organisms tend to restore homeostasis 
by either of two different mechanisms and processes towards wound closure – 
regeneration or repair. Skin regeneration is the recapitulation of the developmental 
process of the skin by restoring the architecture of the skin with normal structure and 
function. On the other hand, skin repair is a substitution of cellular matrix as a patch 
to immediately reestablish the interrupted continuity to the skin. This is usually by 
scar formation without reconstituting normal skin architecture. The ability to 
regenerate body parts exists in certain lower species, such as the salamander and crab. 
In contrast, adult humans have lost this capacity and can only replace a limited 
amount of damaged skin tissues by the process of regeneration. The cellular and 
molecular mechanism of epidermal renewal is reviewed as below. 
2.3.1 Epidermal Stem Cells 
Identifying the source of epidermal renewal has been the focus of many years of 
research. The concept of cell turnover and stem cells in tissues was first proposed by 
Leblond, based on autoradiography and calculations of cell numbers and kinetics 
(Clermont & Leblond, 1953). Definitions of stem cells have been continually 
proposed and redefined, but must be based on observed function -  a given population 
of stem cells must be “capable of renewing a tissue for the lifetime of an organism” 
(Lajtha, 1979). During successive rounds of cell division, stem cells must be able to 
renew both stem cells and differentiating cells, and this can be done in different ways. 
Each cell can undergo asymmetric divisions giving one stem cell and one 
differentiating cell, or it can fluctuate stochastically between symmetric or 
asymmetric divisions. Asymmetric divisions in the epidermis have certainly been 





observed, as asymmetric distribution of polarity proteins between daughter cells 
(Lechler & Fuchs, 2005), and as fluctuations in the plane of cleavage (Smart, 1970). 
Due to the accessibility of the tissue, definitions of epidermal stem cells have 
often been very functional. Morphologically, epidermal stem cells are generally 
agreed to be slow-cycling in vivo or relatively quiescent when the tissue is at steady 
state. They are also undifferentiated, relatively small in size (Barrandon & Green, 
1985), and are typically confined to a spatially protected niche (Potten & Loeffler, 
1990). All these characteristics have been variously used to define, enrich and 
characterize stem cells in the epidermis. 
The Epidermal Proliferation Unit 
The earliest description of stem cell activity in epidermis perhaps came from in vivo 
studies of skin regeneration from a single epithelial cell surviving irradiation in mouse, 
and the formation of epidermal microcolonies, providing the first functional definition 
of “stemness” in the epidermis (Withers, 1967). In 1969 an ordered structure was 
described in mouse dorsal epidermis (Mackenzie, 1969). Subsequently, the 
organization of proliferating and differentiating cells was described as an “epidermal 
proliferative unit” (Potten, 1974), as observed by the outline of large hexagonal-
shaped cornified cells in the surface view of epidermal sheets, supported by vertical 
columns of upward-moving cells. Studies suggested that each epidermal proliferative 
unit (EPU) contained a single centrally placed stem cell in its basal layer, surrounded 
by transit amplifying cells (see below) (Allen & Potten, 1974). However, the 
epidermal proliferative unit was only ever clearly demonstrable in mouse ear skin, 
and the possibility of uneven or faster local growth rates elsewhere could mean that 





cell clones did not retain their structural integrity in a histologically recognizable way 
(Mackenzie et al., 1981).  
Transit Amplifying Cells  
One mechanism to regulate cell numbers whilst protecting the stem cells is to 
establish a proliferative hierarchy, where stem cells undergo asymmetric division to 
give transit amplifying cells, a secondary proliferative population of lineage-
committed cells to bulk up the tissue between the stem cells and the differentiating 
cells. This idea was first suggested by Lajtha for the haematopoetic system (Lajtha, 
1979) and predicts that transit amplifying cells divide a limited number of times with 
a high probability of withdrawing from the cell cycle, where they are destined to be 
lost by terminal differentiation (Watt, 1998). This hypothesis is supported by 
measurements of cell cycle times and cell numbers in a tissue, and means that the 
majority of cell divisions will be borne by transit amplifying cells whilst the stem 
cells are exposed sparingly and only rarely subjected to mitotic stress, providing 
protection against accumulating cancer-causing damage to a tissue.  
Recent studies have however questioned the existence in the epidermis of a 
transit amplifying cell compartment and the discrete size-limited epidermal 
proliferative unit (Clayton et al., 2007; Doupé et al., 2010). Lineage tracing and 
clonal analysis in mouse epidermis failed to find supporting evidence for the existence 
of stem cells and transit amplifying cells with different kinetics. Instead, these studies 
suggested that progenitor populations in the mouse skin sites tested were either all 
stem cells, or no stem cells (i.e. stem cells totally inactive at body sites and time 
periods tested). Tracking the fate of cells in mouse tail epidermis in vivo showed that 
a committed progenitor cell population could maintain interfollicular epidermis 





without contribution from a population of typically long-lived, self-renewing stem 
cells (Clayton et al., 2007). Lineage tracing using an inducible YFP reporter revealed 
that the number of labeled basal cells increased with time and cells differentiated as 
they migrated laterally as well as vertically through the suprabasal cell layers, which 
is inconsistent with a classic EPU model (Ro & Rannala, 2005). Similar results have 
now been reported for mouse back skin (Doupé et al., 2010). These results indicate 
that amplifying tissue progenitor cells do not need to be “transient”, and they imply 
that such cells are probably quiescent or dormant during normal epidermal 
maintenance. 
Differential Clonogenicity  
High proliferative capacity is a fundamental stem cell property that can be observed in 
tissue culture clonogenicity assays. This is measured by estimating a cell’s growth 
potential from the sizes of colonies resulting from single cell plating. Epidermal 
keratinocytes show variable proliferative potential when placed into culture and the 
resulting clones have been described in three classes (Barrandon & Green, 1987). 
“Holoclones” have the greatest growth potential, are likely to contain the most stem 
cells, and when replated, nearly all cells form growing colonies. “Paraclones” contain 
cells with a short replicative lifespan (i.e. forming small colonies) or aborted colonies, 
which uniformly terminally differentiate. A “meroclone” shows intermediate 
properties between holoclone and paraclone and is deduced to be a transitional stage. 
The proportion of the different clone progenitor types also varies with age, as mouse 
foetal epidermal cells mostly give rise to holoclones, while older donors gave rise to a 
higher proportion of paraclones and lower proportion of holoclones. As there is no 
doubt that high clonogenic potential predicts a higher probability of this property in 





subsequent cultures, this is one of the best assays for recognizing stem cell properties 
in keratinocytes. 
As recognized by Potten and Loeffler (Potten & Loeffler, 1990), one of the 
major difficulties in defining stem cell populations by their capabilities is that 
assessing the “stemness” of epidermal cells mostly requires perturbing their 
microenvironmental niche which may itself alter their characteristics. Nevertheless 
the greater proliferation potential of niche-derived cells has consistently shown 
agreement between in vivo niche identification and culture. Cells within stem cell 
niches have also been shown to express significantly longer telomeres (Flores et al., 
2006). 
Label-Retaining Cells 
One way of identifying epidermal stem cells in situ is using the expectation that these 
cells are probably slow cycling, or rarely dividing, and thus can be identified as label-
retaining cells (LRC) (Bickenbach, 1981). The presence of label-retaining cells in the 
epidermis was seen in extended pulse-chase experiments on neonatal mice (Potten, 
2004). Animals are exposed to a pulse of tagged DNA precursors (e.g. 3H-thymidine) 
which are incorporated into epidermal cells during DNA synthesis, followed by an 
extended chase period, after which frequently-dividing cells will have lost the label by 
dilution (Potten & Booth, 2002), whilst slow-cycling cells will retain label. Infrequent 
mitoses will protect stem cells against DNA replication errors. However, a second 
mechanism that could account for retention of the DNA label by stem cells would be 
the so-called “immortal strand” hypothesis. This was suggested by Cairns in 1975 
where the 3H-thymidine label is distributed asymmetrically, with retention by the stem 
cell of the parental DNA strand at each division (Cairns, 2006). This too would be a 





powerful mechanism for minimizing DNA replicative errors in the stem cell 
population. 
A label-retaining cell (LRC) has a tendency to be located at the center of the 
EPU, where stem cells are believed to be located, and can be shown to give rise to 
colonies in culture and to be involved in the clonal regeneration processes following 
injury in vivo (Morris & Potten, 1994). Although they have subsequently shown to 
share a number of other properties with stem cells, they cannot be universally 
assumed to be synonymous with stem cells because label retention would only be 
relative to that of neighbouring cells if based on absence of dilution. Consequently, 
sustained tissue renewal is a safer criterion as a stem cell characteristic rather than 
label retention. 
2.3.2 Epidermal Stem Cell Niches 
Stem cells are likely to be sequestered in long-term persisting pockets of the tissue 
microenvironment, or stem cell niches in which they are stably anchored and 
physically protected (Schofield, 1978; Scadden, 2006). In these niches, stem cells 
interact with their neighbouring cells as well as their external environment to regulate 
their fate, maintaining the right balance between tissue regeneration and cell 
quiescence (Hall & Watt, 1989). Such niche sites have been identified in several 
stratified squamous epithelia using the label-retaining cell classification, including the 
limbus of the cornea (Cotsarelis et al., 1989; Schermer et al., 1986), the rete pegs in 
palmoplantar skin (Lavker & Sun, 1983; Watt, 1998), and the deeper parts of the hair 
follicle (Cotsarelis et al., 1990; Lavker et al., 1993; Lane et al., 1991; Morris et al., 
2004; Reynolds & Jahoda, 1996; Snippert et al., 2010). The best-studied epidermal 





stem cell niches are those in the hair follicle, a uniquely mammalian structure that 
hosts a massive amount of cell proliferation. 
The Cycling Hair Follicle  
The most dramatic feature of the hair follicle is that this complex structure grows 
(anagen phase) and dies back (catagen phase) repeatedly throughout the life span of 
the organism. Pathways of differentiation are reinitiated every time the follicle 
regresses by apoptosis to start a new cycle. In human scalp hair these cycles average 
around 1000 days. There are at least four stem cell niches in the pilosebaceous tract 
from which this regenerating maintenance proceeds. Cells in all these niches have 
great proliferation capacity, but their potentiality for multiple differentiation pathways 
appears to be more limited in some than others. The identified stem cell niches of the 
hair follicle in increasing order of differentiation potential are as follows. 
The Sebaceous Gland Niche 
Cells at the periphery or at the base of this exocrine gland are responsible for 
proliferation. As differentiating cells accumulate their secretory product (sebum) in 
the cytoplasm, they move toward the duct and rupture to release their contents into the 
pilosebaceous canal (Downing & Strauss, 1982) which joins the hair canal. It has 
been shown that a small cluster of cells at the base of the sebaceous gland which are 
marked by the expression of the transcriptional repressor Blimp1, can give rise to all 
of the cells within the sebaceous gland (Horsley et al., 2006). This is probably the 
most specific, or restricted, progenitor population in the pilosebaceous tract. 
 
 





The Hair Bulb Niche  
The hair bulb niche is located at the deepest tip of the follicle where hair follicle stem 
cells were believed to reside. This site harbours many proliferating cells (germinal 
epithelium cells) that can be readily seen by light microscopy. There is a critical 
epithelial-mesenchymal cross-talk that takes place at the base of the hair bulb, without 
which no hair follicle will develop properly (Reynolds & Jahoda, 1996). Throughout 
the hair cycle the bulb cells appear to be the least differentiated. When follicle depth 
has been reached, these bulb cells start to give rise to all lineages of differentiation 
including the outer and inner root sheath layers as well as the hair fibre itself until 
catagen, when the follicle shrinks and goes into apoptosis. Upper hair bulb cells and 
bulge cells (see below) are marked by expression of Lgr5, or leucine-rich G protein-
coupled receptor 5 (Jaks et al., 2008; Snippert et al., 2010), first described as a stem 
cell marker in the small intestine (Barker et al., 2007). Hair bulb cells have high 
proliferative potential, but they are not label-retaining and do not show slow-cycling 
characteristics predicted of classic stem reservoir cells. 
The Bulge Niche 
The hair bulb is destroyed every time the hair goes through its cycle, thus potentially 
destroying the stem cells and its niche. A more compelling niche for long-lived stem 
cells is an area between the permanent and transient sections of the follicle where the 
arrector pili muscle is attached. This anatomical site was named the “Wulst” (Stöhr P, 
1903), or bulge, and is the deepest point of the hair follicle that persists from cycle to 
cycle. This region was proposed to be a stem cell niche based on the localization of 
label retaining cells (Madsen, 1964; Cotsarelis et al., 1990). Bulge-derived cells are 
involved in the re-initiation of hair follicle growth at the start of each new cycle, and 





may continue to move down to the bulb, providing a conveyor belt of stem cells 
(Reynolds & Jahoda, 1996; Kobayashi et al., 1993). Besides containing some label 
retaining cells, the bulge is characterized by expression of several stem cell associated 
markers, including K19 (Lane et al., 1991; Michel et al., 1996; Commo et al., 2000) 
and K15 (Lyle et al., 1998), CD34 and high integrin levels. Bulge-derived cells are 
multipotent as shown by fate mapping and regeneration assays, having the capacity to 
generate several epidermal lineages including those of the hair follicle and the 
sebaceous gland. However they will only contribute to interfollicular epidermis in 
response to an epidermal wound (Ito et al., 2005; Levy et al., 2007; Blanpain et al., 
2004; Oshima et al., 2001; Morris et al., 2004), and do not contribute to the routine 
maintenance of the interfollicular epidermis during homeostasis. 
The Junctional Zone Niche 
Another population of stem cells has been identified within the junctional zone, 
between the permanent and transient sections of the follicle (Jensen et al., 2008; 
Nijhof et al., 2006). These cells were identified by their expression of MTS24, a cell 
surface marker and later more specifically by Lrig1 (Jensen et al., 2009), and possibly 
also now by Lgr6 (Snippert et al., 2010). When junctional zone cells are transplanted 
they can give rise to interfollicular epidermis, hair follicle and sebaceous gland, 
demonstrating that junctional zone stem cells are multipotent (Jensen et al., 2008). 
Lineage tracing analysis has confirmed that cells from this zone do contribute, like the 
bulge cells, to wound healing of the interfollicular epidermis (Levy et al., 2007). In 
homeostatic conditions junctional zone cells contribute to interfollicular epidermis 
and sebaceous gland only (Jensen et al., 2009), a complementary pattern to that of the 





bulge cells. Thus the junctional zone stem cells appear to be another quiescent 
reservoir of stem cells. 
Interfollicular Epidermal Stem Cells  
The interfollicular epidermis and glabrous skin sites also require considerable 
regenerative cell populations for their maintenance. Morphological heterogeneity 
amongst epidermal basal cells has been recognized histologically for some time 
(Lavker & Sun, 1983) as well as (more anecdotally) by some unaccountably variable 
antibody staining patterns.  
Support for the existence of interfollicular epidermal stem cells comes from 
studies demonstrating a subpopulation of basal cells with a high proliferative potential 
and the ability to reconstitute the epidermis in vitro and in vivo (Li et al., 2004). 
Label-retaining cells have also been detected in the interfollicular epidermis of tail 
and dorsal skin of mouse (Braun et al., 2003), and candidate stem cells in 
interfollicular epidermis were identified using pulse-chase labeling to identify label-
retaining cells in mouse skin (Bickenbach, 1981). Lineage tracing techniques have 
been used to unequivocally demonstrate the stem cell potential of interfollicular 
epidermal cells by (Kolodka et al., 1998) and (Ghazizadeh & Taichman, 2001). (Jones 
& Watt, 1993) observed that the proliferative potential of basal cells was correlated 
with levels of integrin expression. As these high integrin cells proliferated best in 
culture, they might be enriched for stem cells.  
Antibodies to integrins could be used to identify “integrin-bright” regions in 
the epidermis as potential stem cell niches. Integrin staining highlighted patches of 
basal cells closest to the epidermal surface in undulating thin skin. Interestingly, they 





also identified clusters at the innermost tips of the rete pegs in thick palmoplantar skin, 
in agreement with results from label retaining experiments (Lavker & Sun, 1983). The 
rete pegs in palmoplantar epidermis also harbor small clusters of cells expressing K17, 
another keratin which may highlight stem cells in certain locations (Swensson et al., 
1998). The explanation for this discrepancy is not known, but it is possible that the 
shorter rete pegs of thin epidermis are more transient structures, whereas the deep rete 
pegs of thick skin are more permanent. 
 
2.4 SKIN REPAIR IN VIVO 
In order to fully understand the differences between skin regeneration and the normal 
outcome of tissue repair, it is useful to review the processes of normal wound repair. 
The primary function of the skin is to provide a protective barrier against the 
environment. When the integrity of skin is loss as a result of injury, multiple 
biological pathways will be activated involving crosstalk between many cell types. In 
contrast to regeneration, wound repair commonly will result in scar, a non-functioning 
mass of fibrotic tissue, which is only at best 70% as strong as the original tissue 
(Gurtner et al., 2008). Adult wound healing is essentially a repair process, with its 
main purpose is to rapidly recover tissue integrity to join wound edges and fill tissue 
voids. Recent advances in cellular and molecular biology have expanded our 
understanding in the process involved in wound healing and have led to 
improvements in the treatment of wounds. A review of the physiologic process is 
described below.  
 





2.4.1 Features of Skin Wound Repair 
The skin wound healing process can be divided into three, overlapping processes – 
inflammation, tissue formation, and remodelling. 
Inflammation 
The first feature of wound healing starts immediately after tissue damage, with 
platelet aggregation and the formation of fibrin clot, which establish hemostasis to 
prevent further fluid loss and provide a scaffold for cell migration. Platelets also 
secrete cytokines and growth factors, such as platelet-derived growth factor (PDGF) 
and transforming growth factor β1 (TGF-β1) to attract and activate neutrophils, 
macrophages and fibroblasts (Henry & Garner, 2003). Due to their high concentration 
in circulation, the first responders are neutrophils which produce degradative enzymes, 
phagocytose, and kill microorganisms. After 2 to 3 days, monocytes infiltrate the 
wound site and differentiate into macrophages, coordinating later events in injury 
response. They release cytokines and growth factors such as PDGF and vascular 
endothelial growth factor (VEGF) into the wound environment, as well as 
phagocytose and scavenge dead neutrophils. Monocytes and macrophages bind to the 
extracellular matrix by their integrin receptors which induce phagocytosis (Brown, 
1995). This inflammatory phase typically lasts for 4 days. 
However, studies show that neutrophils and macrophages are not essential to 
normal healing (Simpson & Ross, 1972; Martin et al., 2003), and are thought to be 
compensated for by the redundancies in the inflammatory response. Moreover, when 
both neutrophils and macrophages are absent, the result is less scar formation (Martin 
et al., 2003). When macrophages persist, they produce high amounts of cytokines that 





activate fibroblasts to deposit excessive amounts of collagen (Niessen et al., 1999). 
Thus, the importance of these cells in wound repair is incompletely understood. 
Tissue Formation 
The second feature of wound repair is characterized by cellular migration and 
proliferation of different cell types. Re-epithelialization is the first event which begins 
within hours after injury, where basal keratinocytes at the border of the wound 
become “activated” (Freedberg et al., 2001), detach from the basement membrane and 
migrate laterally over the injured dermis. The new stroma, or granulation tissue, starts 
to replace the fibrin matrix about four days after injury. Angiogenesis occurs to 
sustain the newly formed granulation tissue consisting of collagen, fibronectin, and 
hyaluronic acid as fibroblasts and macrophages move into the wound space at the 
same time (Clark, 1985; Clark et al., 1982). The granulation tissue forms a new 
substrate where the keratinocytes migrate from the wound edges and proliferate on the 
granulation tissue, under the clot. If the hair follicles are not destroyed, these 
structures also contribute keratinocytes for large wound areas, or else re-
epithelialization will be very slow and skin grafting becomes necessary (see section 
2.3). The migration of keratinocytes at the leading edge continues until they meet in 
the middle, and keratinocytes that are behind proliferate and differentiate, restoring 
the barrier function. Proteinases such as urokinase type-plasminogen activator (uPA), 
tissue-type plasminogen activator (tPA), and matrix metalloproteinases (MMP) 1, 2, 3, 
9, and 13 are needed for the migrating keratinocytes to invade the clot and into the 
wound (Pilcher et al., 1997; Vaalamo et al., 1997).  
In addition to growth factors released by platelets and macrophages during the 
first stage, epidermal cells, fibroblasts, and endothelial cells now secrete growth 





factors. Examples of growth factors that are important in regulating wound re-
epithelialization are hepatocyte growth factor (HGF)(Raja et al., 2007), fibroblast 
growth factors 7 and 10 (FGF7, FGF10), transforming growth factor-α (TGF-α), and 
heparin-binding epidermal growth factor (HB-EGF) (Braun et al., 2004; Martin et al., 
2003). Important regulators of angiogenesis are VEGFA and FGF2; or basic FGF 
(Werner & Grose, 2003; Gurtner et al., 2008). Fibroblasts deposit a proteoglycan-rich 
provisional matrix and collagen, as a result of the action by TGF-β1 and TGF-β2 
(Clark et al., 1995). Some fibroblasts differentiate into myofibroblasts characterized 
by higher expression of smooth muscle actin. Myofibroblasts are contractile cells that 
bring the edges of the wound together. Once a threshold is reached, collagen synthesis 
and fibroblast accumulation is suppressed by collagenases and tissue inhibitors of 
metalloproteinases (TIMPs).  
Remodelling 
Remodelling begins second to third week of healing and lasts for a year or more, 
during which the time the scar tissue becomes less vascular, and macrophages and 
myofibroblasts undergo apoptosis, leaving a mass that contains few cells and mostly 
of collagen and other extracellular-matrix proteins. During the first three weeks, 
fibrillar collagen accumulate rather rapidly. Thereafter accumulation of collagen is 
much slower and remodelled with the formation of larger collagen bundles. The 
acellular matrix is actively remodelled from mainly random oriented type I and type 
III collagen to one predominantly composed of type I collagen which is organized 
parallel to the lines of skin tension (Lovvorn et al., 1999). A scar will never attain the 
same breaking strength of uninjured skin, and at maximal strength, only 70% as 
strong (Levenson et al., 1965). 





2.5 CURRENT TREATMENTS FOR FULL-THICKNESS SKIN WOUNDS 
Wounds are clinically categorized into epidermal, superficial partial-thickness 
(epidermis and superficial part of dermis), deep partial-thickness (epidermis and 
greater dermal damage) and full-thickness (complete destruction of skin), with 
different treatment approaches (Papini, 2004). While partial-thickness wounds still 
contain hair follicles and sweat glands which are capable of contributing to epithelial 
regeneration across the wound surface, full-thickness injuries heal by contraction, as 
they cannot epithelialize on their own, leading to extensive scarring and functional 
defects (Papini, 2004). In major full-thickness burn injuries, an early excision of 
eschar is required to prevent complications such as infection and uncontrolled 
inflammatory response (Burke et al., 1976). The time taken for wound closure and 
wound size have important roles in the outcome of the injury. Delayed treatment leads 
to severe hypertrophic scarring (Cubison et al., 2006), and the mortality rate depends 
on the percentage of total body surface area (TBSA) burned. Recent advances in 
burns treatment now allow successful treatment of extensive burns previously 
considered lethal. In a study conducted between 1942 to 1952, none of the patients 
survived with 60% of TBSA burns (Bull & Fisher, 1954). A study undertaken in 
Singapore from 1998 to 2003 showed a reduction in mortality rate of patients with 60% 
TBSA burns, to only 41.4% (Chua et al., 2007). Nevertheless, treatment of deep 
extensive burns still pose a substantial challenge to surgeons. 
2.5.1 Autografts, Allografts and Xenografts 
For wounds that extend deep into the dermis, skin grafting with an autograft is the 
treatment of choice, since with the patient’s own cells there is no risk of rejection. In 
fact, the current gold standard for full-thickness injuries is the split-thickness 





autologous grafting, in which the epidermis and a portion of dermis is removed using 
a dermatome from an undamaged skin donor site and applied to the full-thickness 
wound (Stanton & Billmire, 2002). Skin autografting is very well established and has 
been consistently improved since the earliest recorded attempt in India around 1000 
B.C. (Hauben et al., 1982). Graft ‘take’ occurs when capillaries from the split skin 
graft form anastomoses into the existing wound capillary network for graft survival 
(Converse et al., 1975). In contrast to split-thickness grafts, a full-thickness graft 
provides improved coverage and decreased wound contraction at the site of 
application but the donor site will be more compromised and take longer to heal 
(Rudolph, 1976), hence such grafts are less common. Grafts can be meshed and 
stretched to cover larger wound areas, but this results in greater graft contraction, 
delayed healing, and more scar tissue formation than standard split-thickness grafts.  
 For deep extensive burns with more than 50% TBSA, donor sites are severely 
limited as patients have only less than 50% of undamaged skin left for harvesting. 
Although donor sites of split-thickness autografts will heal within a week and can be 
used for reharvesting, the process may be very painful and the donor site will heal 
with scars. In this instance, wounds are covered with allografts harvested from 
cadaver skin, which are stored frozen in skin banks, to provide a mechanical barrier to 
prevent fluid loss and microbial contamination. Allografts can be used whenever 
needed but they will only serve as a temporary barrier as they typically get rejected by 
the host’s immune system, requiring a subsequent application of an autograft (Burd & 
Chiu, 2005). Furthermore, allografts are limited in supply as skin donation is not 
widely accepted (Chua et al., 2004). In Singapore, local skin donations only account 
for 20% of total skin needed for grafting (Press Release: The Straits Times, Local skin 
donations critically low; 26 August 2011, Pg C06). 





Xenografts taken from skin of another species offer another possibility in 
solving the shortage of skin grafts. Porcine and frog skin have been used as temporary 
dressings (Chang et al., 1973). However, their use is still far from clinical reality 
given the immunological issues and risks of pathogen transfer (Hammer, 2001). There 
is therefore an overwhelming need for readily available, transplantable skin grafts 
worldwide, to meet the ever increasing demand. 
2.5.2 Tissue Engineered Skin Constructs 
As split-thickness grafts are not always available in sufficient quantity for treatment 
of extensive full-thickness wounds, the search for alternative life-saving approaches 
has given rise to the clinical need for the development of tissue engineered 
alternatives. Significant progress has been made since the development of 
keratinocyte culture techniques and the clinical use of these products, although there 
are still considerable challenges to be met (Horch et al., 2005; Clark et al., 2007; 
Pham et al., 2007; MacNeil, 2007). Skin-replacement products with ‘off-the-shelf’ 
availability or producing sufficient quantities of epithelium capable of permanent 
wound closure will be of great importance and demand for extensive deep injuries.  
Commercialized Tissue Engineered Skin Constructs 
Table 2.1 summarizes commercially created skin constructs. Specifications of 
representative products are reviewed in this section. They can be categorized into 
acellular (matrix-based) products and cell-based products, which can be further 
classified into epidermal constructs, dermal constructs and composite constructs based 
on the layer of the skin that is generated. 
  





Table 2.1   Commercial tissue engineered skin constructs. Modified from Shevchenko 
et al., 2009; Metcalfe & Ferguson, 2007; Límová, 2010; Supp & Boyce, 2005. 




Plainsboro, NJ, USA) 
Synthetic silicone and 
bovine collagen I/GAG 
matrix bilayer 
Deep partial or full-
thickness burns, soft 
tissue defects 
Requires definitive 
closure with autograft, 








Deep partial or full-
thickness burns, soft 
tissue defects 
Requires definitive 
closure with autograft, 
problems of graft 










wounds, soft tissue 
coverage 
Requires definitive 








Soft tissue coverage, 
hypertrophic scar 
revision and burn 
wounds 
Requires definitive 




Arlington, TN, USA) 
Allogeneic acellular pre-
meshed human dermis 
Protection and 
support for tendon 
and low extremity 
wounds repair 
Requires definitive 














(Brennen Medical, Inc., 
MN, USA) 
Xenogeneic acellular 
porcine derived dermal 






OASIS® Wound Matrix 
(Cook Biotech Inc., 
West Lafayette, IN, 
USA) 
Xenogeneic acellular 
porcine derived intestinal 
submucosa 
Superficial and deep 









bovine derived dermal 





closure with autograft 
Biobrane® / Biobrane®-L 
(UDL Laboratories, 
Inc., Rockford, IL, USA) 
Synthetic silicon film and  




Temporary cover of 
excised burns 
    





















Synthetic silicone, bovine 
lyophilized cross-linked 
collagen sponge made of 
heat-denatured collagen 
Full-thickness burns Temporary coverage 
Pelnac® 




silicone gauze and 
collagen sponge derived 
from pig tendon 
Full-thickness burns Requires definitive 
closure with autograft 
Suprathel® 
(Institute of Textile and 
Process Engineering, 
Denkendorf, Germany) 
Synthetic wound dressing 






(Aubrey, Inc, Carlsbad, 
CA, USA) 
Synthetic silicone and 
nylon knit bilayer with 




Cellular – Epidermal Constructs 
Epicel® 
(Genzyme Biosurgery, 
Cambridge, MA, USA) 
Autologous keratinocytes Deep partial and full-
thickness 
burns >30% TBSA 
Long time required to 
produce fragile sheets, 







in fibrin sealant 

















from ORS hair follicles 
Chronic leg ulcers Long time required to 
produce, fragile 
Myskin™ 
(Altrika Ltd, Sheffield, 
UK) 
Autologous keratinocytes 




Long time required for 
cell expansion, repeated 
application 
CellSpray® 
(Clinical Cell Culture 
(C3), Perth, Australia) 
Autologous keratinocytes 




Cellular – Dermal Constructs 
Dermagraft® 
(Advanced Biohealing, 
Inc., New York, NY and 
La Jolla, CA, USA) 
Allogeneic neonatal 
fibroblasts embedded in a 
3D polyglactin 
bioabsorbable scaffold 
Chronic diabetic foot 
ulcers, full-thickness 
burns 
Autograft required for 
full-thickness burns, 
temporary coverage 









Autologous fibroblasts in 









Inc., New York, NY and 
La Jolla, CA, USA) 
Allogeneic neonatal 
fibroblasts embedded in a 
collagen coated nylon 
mesh with a thin silicone 
layer 
Deep partial and full-
thickness burns 
Temporary coverage, 
nylon mesh not 
biodegradable, possible 









Risk of rejection 






keratinocyte layer + 
neonatal fibroblast 
embedded in bovine 
collagen type I gel 
Chronic foot ulcers, 
venous leg ulcers, 
burn wounds and 
epidermolysis 
bullosa 
Risk of chronic graft 










and fibroblasts in a 
microperforated HA 
membrane 
Chronic wounds and 
burns 




Inc., New York, NY, 
USA) 
Allogeneic neonatal 
keratinocyte layer + 
allogeneic neonatal 
fibroblasts embedded in a 





biological dressing, risk 





Madison, WI, USA) 
Allogeneic immortalized 




Risk of chronic graft 
rejection and disease 
PolyActive® 















(Regenicin Inc., NJ, 
USA) 
Autologous keratinocytes 
and fibroblasts in bovine 
collagen matrix 
Deep partial and full-
thickness 
wounds >50% TBSA 
Long time required for 
cell expansion 
GAG: glycosaminoglycan; TBSA: total body surface area; HA: hyaluronic acid; ORS: outer root 
sheath; ECM: extracellular matrix; PEO: polyethylene oxide terephthalate; PBT: polybutylene 
terephthalate 
  






The first engineered skin constructs consist of acellular matrices which function as 
templates for dermal regeneration. Once this has become well vascularized, an 
autograft must be provided to re-epithelialize the wound. Integra® (1981) is the first 
commercially available engineered skin construct and comprises a dermal matrix of 
cross-linked bovine collagen and shark chondroitin sulfate with a silicone membrane 
that functions as a temporary epidermal barrier (Stern et al., 1990). The matrix 
undergoes degradation while the host’s cells invade and proliferate within it, thus 
promoting dermal regeneration while inhibiting wound contraction, leading to a better 
graft take and scar reduction (Stiefel et al., 2010). Another skin construct, AlloDerm® 
is made from decellularized donor skin by a method of freeze-drying which maintains 
the tissue structure including the architecture of the collagen bundles and vascular 
channels (Livesey et al., 1995). This reduces the risk of an allogeneic immunological 
response and also reduces the risk of disease transmission. Similar to Integra, an 
autograft must be eventually applied to the wound. 
Epidermal Constructs 
Cultured skin grafting began when methods for harvesting keratinocytes from skin 
and proliferating the cells in vitro became available (Rheinwald & Green, 1975; 
Rheinwald & Green, 1977). Populations of keratinocytes can be grown in relatively 
large numbers over a period of two to three weeks. A fundamental basis for 
generation of skin substitutes comes about from the utilization of this rapid growth of 
cells. This pioneering work led to the first documented case of using cultured 
keratinocyte sheets for the treatment of burn patients (O’Connor et al., 1981), and the 
development of Epicel™, a cultured autologous epidermis first produced in 1988 for 





permanent wound coverage. This construct is only a few cells thick and does not have 
a dermis, and so is very fragile and difficult to use, as well as very costly ($US825 per 
50 cm2 graft) (Bello et al., 2001). These constructs also failed to produce a 
consistently satisfactory response in deeper burns and full-thickness wounds 
(Williamson et al., 1995). Because of the fragility of epidermal sheets, scaffold 
materials are being used for easier handling in some epidermal constructs. Laserskin® 
uses a hyaluronic acid membrane as a carrier for cultured keratinocytes, 
microperforated to allow cells to grow to confluence. BioSeed®-S uses autologous 
keratinocytes resuspended in a fibrin sealant (Tissucol Duo S Immuno, Baxter Hyland 
Immuno) which is injected or sprayed onto the wound bed, with increased wound 
healing efficiency for the treatment of chronic ulcers (Vanscheidt et al., 2007; 
Johnsen et al., 2005). However, this may not prove to be an optimal delivery system 
as keratinocytes lack receptors for fibrin or fibrinogen (Kubo et al., 2001). As in the 
case of cultured epithelial autografts, a lengthy time is required for a skin biopsy to be 
expanded into sufficient autologous cells for clinical use. 
Dermal Constructs 
Dermagraft® is a cryopreseved construct composed of biodegradable polyglactin 
mesh seeded with allogeneic neonatal dermal fibroblasts, with shelf life of up to 6 
months (Eaglstein, 1998). The mesh degrades within a month as fibroblasts produce 
growth factors and extracellular matrix components, helping to reconstitute the 
dermal layer. It is the first tissue engineered, living dermal substitute licensed for 
treatment of chronic diabetic ulcers and venous ulcers (Omar et al., 2004; Marston et 
al., 2003). However, multiple applications are sometimes necessary to ensure 
successful grafting and there are safety issues owing to the allogeneic cells used in 





this construct. Hyalograft® 3D is another dermal construct based on hyaluronic acid 
derivatives strengthened by growth factors and cytokines secreted by the cultured 
autologous fibroblasts, but served as a temporary dressing to stimulate wound 
regeneration (Stark et al., 2004).  
Dermo-epidermal (Composite) Skin Constructs 
Composite skin constructs aim to mimic the histological structure of skin where both 
epidermal and dermal layers are present. These constructs are not only the most 
advanced and sophisticated, but also the most expensive (Jones et al., 2002). Early 
work by Bell et al. (Bell et al., 1979; Bell et al., 1981) demonstrated that a bilayered 
composite composed of a collagen lattice seeded with dermal fibroblasts contracted 
and keratinocytes applied were able to form stratified layers. This led to the 
development of the first bilayered skin construct Apligraf®, using bovine type I 
collagen with allogeneic neonatal foreskin fibroblasts and keratinocytes (Eaglstein & 
Falanga, 1998).  Apligraf® has shown to be beneficial in chronic diabetic foot ulcers 
(Veves et al., 2001) and venous statis ulcers (Brem et al., 2001) when compared to 
conventional therapy. Due to its high cost ($28 per cm2) and short shelf life (5 days) 
as well as the temporary nature of the grafted allogeneic cells, its widespread use for 
large wounds such as extensive burns remains doubtful. Although Apligraf® does not 
cause immune rejection, allogeneic cells do not remain viable beyond one to two 
months in vivo (Eaglstein et al., 1999). Another tissue engineered skin product, 
TissueTech® Skin Autograft System, is based on autologous keratinocytes and 
fibroblasts grown on microperforated hyaluronic acid membrane (Uccioli & 
TissueTech Autograph System Italian Study Group, 2003). This system combines the 
epidermal construct Laserskin® and dermal construct Hyalograft® 3D, and is not a 





‘true’ bilayered skin substitute where both epidermal and dermal layers are present. 
More recently, in 2012, the USA’s Food and Drug Administration (FDA) granted 
Orphan Status approval for PermaDerm® (http://www.regenicin.com/), the only 
tissue engineered skin prepared from autologous fibroblasts and keratinocytes which 
has achieved clinical use (http://www.prnewswire.com/news-releases/fda-issues-
orphan-status-approval-for-permaderm-158603845.html). The product was designed 
by Boyce and colleagues (Boyce et al., 2006) and aims to deliver permanent wound 
closure. Although the product is still being developed, it appears to be promising for 
the treatment of catastrophic, full-thickness burns covering over 50% of the total body 
surface area. 
Drawbacks of Current Commercialized Skin Constructs 
Although current tissue-engineered skin constructs have been observed to increase 
healing rates of burn and chronic wounds, several intrinsic shortcomings limit their 
use. At present, no manufactured skin construct has provided an outcome consistently 
comparable to an autograft. Predominantly, they serve as temporary biological active 
dressings, donators of cytokines and structural molecules necessary for wound healing 
while the patient’s own skin regenerates. 
 One of the problems with currently available skin constructs is their failure to 
adequately vascularize, as cultured skin lacks a vascular plexus unlike a split-
thickness autograft. This has led to grafted cells dying and ultimately sloughing away, 
thus the inability to ‘take’. Although some constructs allow angiogenesis to occur, 
there is still an area for improvement (Metcalfe & Ferguson, 2007; Black et al., 1998; 
Sahota et al., 2003). Constructs for skin substitution can only partially replace the 
protective barrier function of skin with their absence of differentiated structures such 





as hair follicle and sweat gland appendages, pigmentation, nerve supplies, and 
immune regulation. Functions, such as touch and temperature sensation, excretion, 
perspiration, thermoregulation, protection from ultraviolet rays, and synthetic as well 
as aesthetic function, are thus not restored. Also, they do not mimic the three-
dimensional architecture and mechanical properties of normal skin. In addition, 
present skin constructs that integrate well often suffer from scarring problems at the 
graft margins, which are of inferior functional quality. Current technologies are not 
sophisticated enough to recapitulate the developmental morphogenesis for creating 
skin naturally. Skin substitutes should also have appropriate mechanical and handling 
properties that allow clinicians to use and apply them optimally. For autologous skin 
constructs, cells taken from patients can take between two to three weeks to isolate 
and expand to sufficient numbers for grafting purposes. This time interval is too long 
for patients with urgent clinical requirements. Although the use of allogeneic skin 
cells offer a means to develop an ‘off-the-shelf’ skin replacement therapy for 
immediate application to large surface area burns and some skin disorders, these cells 
may not survive in vivo. Therefore, cell persistence may be desirable when covering a 
large wound area. Furthermore, allogeneic or xenogeneic skin substitutes may carry 
infectious agents such as prions or viruses that are able to transform human cells. 
Finally, the costs of research and development process for bringing a new tissue-
engineered product to the market place have to be taken into consideration, as these 
can be very costly and have resulted in many smaller companies file for bankruptcy 
(Bouchie, 2002).  
All of these limitations suggest that further improvements are required as 
tissue-engineered skin constructs are continually being developed and improved. 
Hopefully, advances in research and development technologies will overcome most, if 





not all, of the above problems and will probably evolve as we gain a better 
understanding of skin development, wound repair, and regeneration. 
 
2.6 TRANSPLANT REJECTION AND IMMUNOLOGICAL RESPONSES 
Any transplantation of organ or cells from one individual to another will result in 
immune rejection from the recipient, as the immune system of the recipient attacks the 
transplanted organ. In most cases, adaptive immune responses to the grafted tissues 
are the major barrier to effective transplantation. Skin allograft rejection has been 
demonstrated to be mediated primarily by T cells, with little evidence for a major role 
of antibodies (Cerny et al., 1988). The primary targets for T cells against allogeneic 
grafts are the histocompatibility antigens between individuals, as they determine 
whether implanted cells are accepted or rejected by the immune system. Although 
transplant rejection can be reduced by the use of immunosuppressant drugs or by 
matching haplotypes of histocompatibility antigens, the risk of rejection remains high. 
Histocompatibility antigens are divided into major histocompatibility complex 
(MHC) molecules, minor histocompatibility antigens (minor H antigens) (Roopenian 
et al., 2002) and ABO blood group antigens (Watkins, 2001). The most prominent 
trigger of graft rejection is initiated by the recognition of the graft’s nonself MHC 
molecules by host T cells, although minor H antigens also contribute to graft rejection 
but much less potent (Barth et al., 1956). The rapidity and severity of rejection of 
allogeneic skin grafts is mainly determined by the number of mismatched alleles 
between the graft and host, and whether it is a primary (unprimed) response or a 
secondary (primed) response. Allogeneic skin grafts are rejected in a primary 





response about 8 to 12 days after grafting (Barth et al., 1956). Other factors also affect 
the course of graft rejection such as the source of graft (tail skin is rejected more 
slowly than trunk skin in rodents because of relative deficiency of Langerhans cells in 
tail) (Chen & Silvers, 1983; Bergstresser et al., 1980; Bergstresser et al., 1980), graft 
size (smaller skin and cardiac grafts are rejected more acutely than larger grafts) (He 
et al., 2004), and age of donor (neonatal skin being less immunogenic than adult skin) 
(Wachtel & Silvers, 1971).  
Although efforts are being made to match as many MHC alleles as possible to 
improve the success rate of transplantation, it does not prevent rejection reactions. 
Furthermore, it is particularly hard to match MHC haplotypes between genetically 
unrelated individuals since these genetic determinants are highly polymorphic as there 
are up to several hundreds alleles encoding for the three MHC class I (MHC I) genes 
(human leukocyte antigen (HLA)-A, -B and –C) and at least three pairs of MHC class 
II (MHC II) genes (HLA-DP, -DQ, -DR). MHC classes I and II are known to affect 
transplantation outcomes. MHC I molecules are ubiquitously expressed on all 
nucleated cells and MHC II expressing antigen presenting cells (APCs) and dendritic 
cells (DCs) are present in most tissues. 
2.6.1 The Skin as an Immunologic Organ 
Skin is a barrier to the outside world. As the first line of host defense to any pathogens, 
it is biased towards a rejection response. The skin can act as an immunologic organ 
because it contains the components necessary for a cell-mediated response, with 
approximately half of its cells having immunological function (Bos et al., 1987). The 
cells in the epidermis and dermis may both play a role in the particular susceptibility 
of skin to rejection. Cells of the skin can control immune reactions, inflammation and 





selectively recruit lymphocytes into the skin. Macrophages, Langerhans cells, and 
dermal dendrocytes represent the skin’s mononuclear phagocyte system. Of the many 
specialized immune cells within the skin, Langerhans cells are likely to be the most 
important as the immunogenicity of skin allografts correlates directly with the density 
of Langerhans cells they contain (Chen & Silvers, 1983; Bergstresser et al., 1980; 
Bergstresser et al., 1980). Langerhans cells are dendritic cells located within the 
epidermis capable of performing tasks such as phagocytosis, antigen processing, 
antigen presentation, and interaction with lymphocytes. Langerhans cells can also 
release IL-1 to help chemotaxis and lymphocyte activation (Sauder et al., 1984). 
The dermis is composed predominantly of collagen and glycosoaminoglycan 
matrix, which are only weakly immunogenic (Hoffmann et al., 2002; Wu et al., 1995). 
However, this highly structured environment contains a high concentration of 
lymphocyte adhesion molecules, thereby making an ideal platform from which 
effector cells can mount an immune response. Furthermore, the dermis is highly 
vascular which allows for rapid immune cell trafficking to the skin. 
2.6.2 Recognition and Responses to Alloantigens 
The function of MHC molecules is to present processed cellular and extracellular 
antigens to circulating T-cells. During development, T cells that recognize self-
antigens are depleted in the thymus, thus leaving mature T cells to respond only to 
foreign antigens bound by MHC molecules. In the context of transplantation, cells 
expressing allelic variants of MHC proteins act as antigens themselves to unmatched 
recipient. Due to similarity in structure, non-self MHC molecules may interact with 
the recipient’s T cells, mimicking self-MHC molecules presenting foreign peptides 
(Suchin et al., 2001). “Direct allorecognition” therefore occurs between host T cells 





and transplanted cells leading to sensitization, proliferation and cytotoxic response 
against the graft (Morelli & Thomson, 2003). This response is initiated primarily by 
passenger dendritic cells from the donor that migrate from transplanted organs to 
lymph nodes of the recipient where they activate naïve T cells specific for graft 
antigens. The initiation, propagation and termination of a direct alloresponse depend 
also on additional stimulatory signals provided by the APCs (Gould & Auchincloss, 
1999). Indeed, when an allograft is depleted of APCs by treatment with antibodies or 
by incubation conditions, rejection occurs only after a much longer time (Coulombe et 
al., 1999; Zhang et al., 2009). Graft rejection by direct allorecognition is 
predominantly acute and unless treated with immunosuppressive drugs will result in 
rapid graft failure.  
Although immunosuppressive therapy slows immune rejection processes, a 
large proportion of tissue grafts succumb to chronic rejection that results in graft 
failure. Chronic rejection is thought to result primarily from processing of donor 
antigens by the recipient’s own APCs, such as dendritic cells and macrophages, and 
their presentation to T cells by self MHC molecules, in contrast to the direct 
recognition by T cells of allogeneic MHC molecules expressed on donor cells (Kreisel 
et al., 2002). “Indirect allorecognition” is largely analogous to physiologic antigen 
processing and is assumed to mediate graft rejection by activating macrophages, 
which cause tissue injury and fibrosis, and are likely to be important in the generation 
of alloantibodies (Bolton et al., 2008; Gould & Auchincloss, 1999). As virtually most 
alloantigens are ingested and processed by APCs, chronic immune processes could 
target numerous proteins that differ in structure between donor cells and the recipient. 
The majority of these processes are targeted at MHC proteins due to their high 
polymorphism, but any polymorphic antigens, such as minor histocompatibility 





antigens, may be targeted. Chronic rejection may occur months to years after 
transplantation, and be associated with clinically hard-to-detect gradual loss of graft 
function. 
2.6.3 Expression of Immune Regulatory Molecules 
Besides MHC interaction, co-stimulatory molecules are vital signals for the initiation 
and clonal expansion of T-cells. The CD80 (B7-1) and CD86 (B7-2) ligands are of 
importance as they are necessary for binding the activatory receptor CD28 on T cells. 
These molecules are primarily expressed on activated APCs and in conjunction with 
indirect or direct alloantigen presentation they have a central role in the graft rejection 
response. The absence of full co-stimulation will lead to partial T-cell activation, 
causing T-cell anergy or deletion. Analysis of co-stimulatory molecules on cultured 
keratinocytes showed that they do not express these molecules (Ohki et al., 1997), 
unless stimulated with interferon (IFN)-γ (Basham et al., 1984), suggesting that 
cultured keratinocytes may be rejected by the host. Although some observations 
suggested that allografted cultured keratinocytes do not induce rejection by the host 
due to the lack of MHC II molecules and the absence of APCs (Hammond et al., 1987; 
Morhenn et al., 1982; Thivolet et al., 1986), some experiments showed rejection of 
the cultured allografts, albeit slow, even after depletion of APCs (Fabre & Cullen, 
1989; Auböck et al., 1988), implying that APCs are not the only cells in the epidermis 
that can stimulate the immune system of the host. Other molecules involved in co-
stimulation of T cells include intercellular adhesion molecule (ICAM) -1 and -3 as 
well as members of the B7 family (B7-H1, -H2 and –H3) (Suh et al., 2003). On the 
other hand, some ligands have inhibitory effect on T cells, including the Fas ligand 
(FasL) which is recognized by lymphocytes expressing the Fas receptor (death 





receptor). Activation of Fas induces apoptosis in lymphocytes and is known to have 
roles in the termination of T cell responses and restriction of immune responses in 
immune-privileged sites of the body, such as the cornea and testis (Green & Ferguson, 
2001). 
2.6.4 Role of Natural Killer Cells 
Natural killer (NK) cells are cytotoxic lymphocytes that possess innate immune 
activities and also play a role in adaptive immune responses. NK cell mediated cell 
lysis is regulated by the balance of activating and inhibitory signals that they 
recognize on target cells, which play important roles including self tolerance and NK 
cell activity (Vivier et al., 2011). NK cells lyse cells that lack MHC I expression, or 
exhibit an “altered self” state. Prominent NK cell inhibitory ligands include classical 
MHC-I family as well as the non-classical HLA-E and HLA-G (Iannello et al., 2008). 
Some studies on the role of NK cells in the rejection of skin allografts reported that 
NK cells were not recruited to the graft bed and were neither necessary nor sufficient 
to induce allogeneic skin rejection (Yamamoto et al., 1998; Zijlstra et al., 1992), but 
may contribute to skin allograft rejection via the indirect allorecognition pathway (Ito 
et al., 2008). Furthermore, NK cells which are fully activated, and not in a resting 
state, can induce acute skin allograft rejection in the absence of T cells (Kroemer et 
al., 2008). Conversely, NK cells may contribute to allograft tolerance via regulation 
of the direct allorecognition pathway through killing of donor-derived APCs, 
preventing them from priming T cells efficiently (Laffont et al., 2008; Yu et al., 2006). 
Further studies are required to determine whether NK-cell response will be a 
significant obstacle for engraftment of skin cells.  
 






Figure 2.3   Pathways of interaction between transplanted cells and the immune 
system (direct / indirect allorecognition). (A) Direct allorecognition occurs when 
recipient T cells recognize allogeneic MHC molecules on the surface of donor antigen 
presenting cells (APCs). The sensitization and propagation of T cells depend also on 
additional stimulatory signals provided by the APCs. (B) Indirect allorecognition occurs 
when recipient APCs process donor-derived proteins, usually MHCs, and present them to 
recipient T cells. Modified from Drukker, 2008. 
 





2.7 POTENTIAL OF FOETAL SKIN CELLS FOR WOUND HEALING 
AND SKIN REGENERATION 
Foetal cells come in between embryonic and adult cells in the developmental 
continuum. Studies of these cells have provided information and insights into the 
biology of stem cells in general. These cells have also been considered for therapeutic 
applications, as alternative cell sources to embryonic and adult stem cells. Foetal 
tissue as a source of cells for regenerative medicine have already been in clinical use 
since the first allogeneic umbilical cord blood transplant in 1989 (Gluckman et al., 
1989). Umbilical cord blood cells are now widely used to treat hematological 
disorders (Kurtzberg, 2009). Foetal neural tissue has also been used therapeutically in 
Parkinson’s disease, with some evidence of clinical improvement (Kordower et al., 
1995; Lindvall, 2003).  
As juvenescent cell sources, foetal cells may be relatively free of mutations 
that can accumulate over the lifetime of an organism. They may also possess greater 
proliferative potential and plasticity than adult stem cells. Although all stem cells are 
self-renewing and multipotent by definition, it is believed that stem cells from a 
younger donor should have greater potential (Van & Liang, 2003; Roobrouck et al., 
2008).  
In addition, foetal cells may potentially possess immunomodulatory properties 
associated with the foetal/maternal interface, which has been known as an immuno-
privileged site. Studies of foetal stem cells are being performed to further our 
understanding of the immune modulation during pregnancy and to investigate their 
potential use in autoimmune diseases or in cell transplantation. 





2.7.1 Wound Healing of Foetal Skin 
Under physiologic conditions, adult wound healing process prioritizes protection from 
infection, contamination, and further injury above cosmetic outcomes. Therefore, 
adult wound repair results in scar (see section 2.4). On the other hand, foetal wound 
repair is a regenerative process, characterized by an absence of scarring and ﬁbrosis , 
in addition to the renewal of skin appendages such as hair follicles and sebaceous 
glands (extensively reviewed by (Lo et al., 2012; Ferguson et al., 1996; Wilgus, 2007; 
Colwell et al., 2003; Buchanan et al., 2009)). This observation was initially reported 
in 1979 when the first human foetal surgery was performed (Rowlatt, 1979). Wounds 
made in foetal tissues heal via diﬀerent mechanisms and the characteristics of scar-
free healing after incisional wounding have been shown in various studies (Ferguson 
& O'Kane, 2004). Such healing is believed only to occur through a gestational age of 
approximately 24 weeks. 
Studies have showed that the ability to heal skin wounds without a scar is 
intrinsic to foetal skin and that the in utero environment does not seem to be essential 
or sufficient for scarless foetal repair. Marsupials such as opossums which are born 
foetal-like heal without scarring despite not being kept within a sterile amniotic 
environment (Armstrong & Ferguson, 1995). In another study, adult sheep skin 
grafted onto foetal lambs in utero and later wounded healed with scar and fibrosis 
(Longaker et al., 1994). 
Differential expression and correct deposition of several major components of 
the extracellular matrix such as collagen, hyaluronic acid, and tenascin-C have been 
noted to contribute to the remarkable scarless healing ability of foetal skin (Whitby & 
Ferguson, 1991a; Whitby & Ferguson, 1991b). Human foetal skin, with higher 





proportion of collagen type III fibres which are smaller and finer than type I fibres, 
heals with well-organized reticular pattern of fibre deposition that resembles 
uninjured skin. In contrast, adult skin wounds contain densely arranged parallel 
collagen bundles that are oriented perpendicular to the wound surface. Increased 
expression of cell surface collagen receptor discoid domain receptor-1 (DDR-1) on 
fibroblasts may modulate collagen production and contribute to the unique properties 
of scarless foetal wound healing (Bullard et al., 2003; Chin et al., 2001). Early 
gestational foetal skin is also rich in hyaluronic acid (a glycosaminoglycan) and 
fibromodulin (a protoglycan), but poor in decorin (protoglycan) compared to matured 
foetal skin or adult. Foetal fibroblasts possess more rapid intrinsic rates of migration 
than those seen in adult skin fibroblasts. Scarless foetal wounds have markedly 
reduced inflammatory response (Martin & Leibovich, 2005), and consisting of poorly 
differentiated inflammatory cells. Introduction of inflammation into normally 
scarless-healing wounds results in increases in collagen deposition and scarring. 
Differences between scarring and scarless collagen architecture may be partly 
explained by phenotypic differences between adult and foetal fibroblasts. 
Embryonic healing wounds show elevated levels of TGF-β3 (skin 
morphogenetic molecule), and reduced levels of TGF-β1 and TGF-β2. By contrast, 
adult wounds contain insignificant amount of TGF-β3, but predominantly TGF-β1 
and TGF-β2, which is released from degranulating platelets and inﬂammatory cells. It 
appears that the relative proportion of TGF-β isoforms, and not the absolute 
concentration of any one isoform, determines the wound repair outcome (Beanes et al., 
2003; Lin & Adzick, 1996). Neutralizing antibodies to TGF-β1 or TGF-β2 or 
exogenous addition of TGF-β3 to healing adult wounds results in markedly reduced or 
absent scarring during adult wound healing (Ferguson & O'Kane, 2004). Interestingly, 





neutralization of all three TGF-β isoforms (TGF-β1, TGF-β2 and TGF-β3) did not 
improve scarring, suggesting that neutralization of TGF-β3 may be detrimental 
(Ferguson and O’Kane, 2004). From these studies, it can be seen that TGF-β isoform 
protein expression plays a major part in both processes of repair and regeneration. 
Factors other than TGF-β including molecules within the TGF-β superfamily could 
also have a role in scarless repair. For instance, extracellular matrix constituents 
fibromodulin or decorin are known to modulate TGF-β activity. 
 Although much knowledge has been gained over the past decade, the precise 
mechanisms of how foetal cells promote regeneration and wound remains unclear and 
attempts to mimic the scarless wound phenotype have not been completely successful 
to prevent scar formation. Work will also need to study the role that stem cells play in 
both adult and foetal wound repair. Identification of more key genes involved in skin 
regeneration may have implications in adult skin wounds and repair in the future and 
may lead to the reduction or even prevention in the formation of scar tissue in other 
organ systems. 
2.7.2 Immune Escape and Suppression by Human Foetal Cells 
As discussed in Section 2.6, transplant rejection is caused by immune responses to 
alloantigens on the tissue. However, one tissue that is repeatedly grafted and repeated 
tolerated is the human foetus even though the foetus carries MHC molecules derived 
from the father and other foreign antigens. 
For the mother’s immune system to avoid attacking the foetus, processes of 
immune tolerance or immunesuppression may be required. The mechanisms of how 
this happens have not been fully understood yet. Studies have indicated that hormonal 





and cytokine environment have a significant impact (Saito, 2000). The placenta seems 
to sequester the foetus away from the mother’s T cells. The outer layer of the placenta, 
the interface between foetal and maternal tissues, is the trophoblast which invades 
into the decidualised uterus during placentation. Classical MHC I molecules, which 
are ubiquitously expressed in almost all nucleated cells, are down-regulated in 
trophoblast cells (Carosella et al., 2008; Kovats et al., 1990), making it resistant to 
recognition and attack by maternal T cells. Tissues lacking MHC class I expression 
are, however, vulnerable to NK cells cytotoxicity (Section 2.6.4). The trophoblast 
might be protected from attack by NK cells by expression of a nonclassical and 
minimally polymorphic HLA class I molecule — HLA-G, discovered in trophobalsts 
in 1986 (Ellis et al., 1986). HLA-G is thought to have a specific tissue distribution in 
the trophoblast, which indicated specific functions in the modulation of immune 
tolerance during pregnancy. This protein has been shown to bind to the two major 
inhibitory NK cell receptors, killer cell immunoglobulinlike receptors-1 (KIR1) and 
KIR2, and to inhibit NK cell killing.  
The placenta may also sequester the foetus from the mother's T cells by an 
active mechanism of nutrient depletion. The enzyme indoleamine 2,3-dioxygenase 
(IDO) is expressed at a high level by cells at the interface between foetus and mother. 
This enzyme catabolizes, and thereby depletes, the essential amino acid tryptophan at 
this site (Munn et al., 1998). Proliferation of infiltrated T cells was inhibited by IDO 
generating a tryptophan deficient environment in placenta. Moreover, pregnant mice 
treated with IDO inhibitor 1-methyl-tryptophan causes rapid rejection of allogeneic 
fetuses (Munn et al., 1998). This supports the hypothesis that maternal T cells, 
alloreactive to paternal MHC proteins, may be held in check in the placenta by 
tryptophan depletion. 





Other foetal tissues also demonstrate reduced immunologic properties. 
Characterization studies on foetal-liver-derived mesenchymal stem cells (MSCs) and 
foetal bone cells have reported an intermediate amount of MHC I, but not MHC II 
expression (Götherström et al., 2004; Montjovent et al., 2009). This phenotype is 
widely regarded as non-immunogenic and suggests that they may be effective at 
inducing tolerance. Both cell types did not induce proliferation of allogeneic 
lymphocytes and suppressed activated alloreactive lymphocytes (Montjovent et al., 
2009; Götherström et al., 2004). Because of their immunological profiles, foetal cells 
present an interesting potential for allogeneic transplantation. 
2.7.3 Contributions of Human Foetal Skin in Wound Healing and Skin 
Regeneration 
Wound healing in adults usually results in scar, which can cause functional limitations 
and restrictions in movement, as well as negative physical and psychological effects 
on the patient. Excessive healing that causes hypertrophic scars and keloids is also a 
burden, and is difficult to treat medically. One of the main challenges for research into 
wound healing is to induce adult wounds to heal like embryonic ones in a process 
resembling regeneration. The developing foetus has the remarkable ability to heal 
dermal skin wounds by regenerating normal epidermis and dermis with restoration of 
the extracellular matrix architecture, strength, and function in the absence of any scar 
formation (Bullard et al., 2003). The biology responsible for scarless wound healing 
in skin is a paradigm for ideal tissue repair, and foetal skin cells provide hope for this 
outcome. However, there is a need for further research to understand the cellular and 
molecular events involved in the development, renewal, repair and regeneration of the 
skin and its associated structures. Understanding the mechanisms by which foetal 





wounds heal could result in a real breakthrough in adult wound healing with the 
possibility of real skin regeneration rather than defective and inferior scar-like skin 
repair (Ferguson & O'Kane, 2004). 
At present, skin constructs that are used are not fully functional in that they 
lack hair follicles and other appendages. Because of their potential therapeutic 
applications, skin stem cells have evoked great excitement. However, it is still 
impossible to identify a stem cell within an intact human skin tissue without 
ambiguity (Tumbar & Fuchs, 2006). Epithelial stem cells have been isolated from hair 
follicles and grown into epithelial sheets for clinical use but not seem to restore hair 
follicles or sweat glands. Interestingly, stem cells isolated from adult skin become 
active only after induction signals are received from the surrounding mesenchymal 
dermis (Rendl et al., 2005), suggesting that human cutaneous regeneration may lie in 
understanding both intrinsic resident stem cell behavior and the environmental cues 
needed to activate these cells. Adult stem cells may have the same regenerative 
capacity as their embryonic counterparts, but this capacity is not activated in adult 
tissue. By using foetal skin as a prototype for regenerative wound healing, the 
environment in the adult tissue may be manipulated to be more receptive for stem cell 
activity for regenerative healing in adult tissues. Studies of mesenchymal-epithelial 
interaction in foetal skin may also reveal important new insights into the biology of de 
novo hair follicle formation during development. By defining their transcription 
profiles and molecular signatures, foetal skin cells may reveal hitherto undiscovered 
roles of genes responsible for hair development. 
Unlike adults, neonatal epidermal cells are able to release growth factors that 
stimulate other epidermal cells (Sauder et al., 1988; Gilchrest et al., 1983; Stanulis-





Praeger & Gilchrest, 1986). Allografts of cultured neonatal foreskin cells accelerate 
healing and relieve pain in patients with acute and chronic skin ulcers by delivering 
growth factors and extracellular matrix to the wound bed (Phillips et al., 1989; 
Ehrenreich & Ruszczak, 2006). Given that foetal epidermal cells are developmentally 
younger and have unique properties, they may be able to deliver a better growth factor 
profile for wound healing. 
2.7.4 Ethical Related Issues in Foetal Cell Therapy 
Although there is high medical support for developing cellular-based therapies to 
reach as many patients as possible, there are ethical issues associated with the 
collection and use of foetal tissue for research as the source of foetal cells is primarily 
from abortions. The ethics of transplantation of human foetal tissue continues to be a 
topic of heated debate. Concerned political and religious groups have lobbied against 
funding for research in the use of foetal tissues, restricting progress in the field. A 
similar debate on the ethics of donated tissue has arisen in the area of therapeutic 
cloning and oocyte donatation, and perhaps lessons can be learned from the resulting 
discussions.  
Foetal stem cell research may ethically resemble either adult or embryonic 
stem cell research and must be evaluated accordingly. It can be argued that foetal cells 
are currently obtained from terminated foetuses, thus using tissue that would 
otherwise be discarded. However, if the abortion of foetuses is the means by which 
foetal cells are obtained, then an unethical means is involved. 
Medical doctors and scientists have used foetal tissue since the 1930s as an 
essential tool in the development of vaccines and as a means to understand cell 





biology. The 1954 Nobel Prize for Medicine was awarded to immunologists who 
developed the polio vaccine using cultures of human foetal kidney cells. The WI-38 
cell line, derived from aborted foetuses has also been used to produce vaccines for 
Measles, Mumps, and Rubella (Hayflick, 1965). Unfortunately, in 1988 the Reagan 
Administration (US government) stopped funding transplantation research of foetal 
tissue from abortions (Garry et al., 1992), leaving  foetal cell research only  to  the  
private  sector where there is no medical peer review of adapted therapies. In 
Singapore and most other countries, foetal skin is considered as an organ donation by 
law. This process is highly regulated, including ethics committee approval of the 
procedure and all information for the donor.  
Even though termination of pregnancy is legally allowed, there will always be 
strong opponents, and laws will remain patient centered. Some area for further 
discussion include collaborations between scientists working in countries with 
different ethical standards, the protection of tissue donors, and the avoidance of 



















MATERIALS AND METHODS 
 
3.1 MATERIALS 
3.1.1 Chemicals and Reagents 
 
Table 3.1   Chemicals and Reagents 
Chemicals and reagents Company 
Agarose  Invitrogen (Carlsbad, USA)  
Dimethylsulfoxide (DMSO)  
Calcium chloride dihydrate  
Sodium chloride  
Ethylenediaminetetraacetic acid (EDTA)  
Paraformaldehyde  
Epidermal growth factor (EGF) 
Sigma-Aldrich (St. Louis, USA)  
Power SYBR® green PCR master mix  Applied Biosystems  
Tris buffer (pH 8.0)  
Tris-buffered saline (TBS)  
1st base  
Triton X-100  VWR International Ltd (Radnor, USA)  










Table 3.2   Antibodies used for Immunochemistry 
Antigen Clone Dilution Factor Source Animal Raised 
Keratins 
K14 LL001 Neat In-house Mouse 
K18 LDK18 Neat In-house Mouse 
K19 LP2K Neat In-house Mouse 
K15 LHK15 1:50 Novocastra Mouse 
K17 E3 1:20 Novocastra Mouse 
Basement Membrane Proteins 
Collagen IV PHM12 1:100 Novocastra Mouse 
Collagen VII LH7.2 1:50 Novocastra Mouse 
Laminin 332 D4B5 1:50 Chemicon Mouse 
Extracellular Matrix Proteins 
Fibronectin 568 1:100 Novocastra Mouse 
Intermediate Filament Proteins in Connective Tissue 
Vimentin V9 1:50 Novocastra Mouse 
Proliferation 
Ki67 MM-1 1:50 Novocastra Mouse 
Differentiation 
Involucrin SY5 1:50 Novocastra Mouse 
K10 LH1 Neat In-house Mouse 
Filaggrin 15C10 1:50 Novocastra Mouse 
Stem Cell-Associated Markers 
p63 4A4 1:50 Gift from Frank 
McKeon 
Mouse 
K19 LP2K Neat In-house Mouse 
K15 LHK15 1:50 Novocastra Mouse 
K7 OV-TL 12/30 1:100 Novocastra Mouse 
Major Histocompatibility Complex (MHC) Proteins 
HLA-ABC W6/32 1:100 Dako Mouse 
HLA-DP, DQ,DR CR3/43 1:100 Dako Mouse 
Others 
Lamin B LN43 Neat In-house Mouse 
nucleoli LP4N Neat In-house Mouse 
CD31 Polyclonal 1:50 Novus Biologicals Mouse 
α-smooth muscle actin 1A4 1:100 Abcam Mouse 
 





Table 3.3   Antibodies for Flow Cytometry 
Antibody Clone Dilution Factor Source Animal Raised 
HLA-ABC W6/32 1:10 Dako Mouse 
HLA-DP, DQ,DR CR3/43 1:10 Dako Mouse 
 
3.1.3 Skin Biopsies 
Human foetal tissues were collected from the Department of Obstetrics and 
Gynecology, Yong Loo Lin School of Medicine, National University of Singapore 
(NUS) with ethical approval from the NUS Institutional Review Boards (NUS IRB). 
Human foetal skin samples were harvested from the back of aborted foetuses and 
were obtained from fully informed, consenting patients undergoing terminations of 
pregnancy. The gestational ages ranged from 13 to 24 weeks. The skin samples were 
transported to the laboratory on ice. Human adult skin samples were obtained from 
donors after informed consent, according to institutional guidelines. A portion of the 
skin sample was used for cell isolation, while the rest was fixed in 10% neutral 
buffered formalin and snap frozen in liquid nitrogen for haematoxylin and eosin 
staining (H&E) and immunohistochemistry. 
3.1.4 Primary Cells 
All cell cultures used in this study were maintained in tissue culture treated dishes or 
flasks, kept in 37oC incubator with 5% CO2, and stored in liquid nitrogen for 










Severe combined immunodeficiency (SCID) mice were used in this study. SCID mice 
were supplied by Biological Resource Centre (BRC), A*STAR, Singapore. They 
were housed at the animal holding rooms at BRC Department 3, an SPF (Specific 
Pathogen Free) facility. The mice were held in individually ventilated cages at 
constant temperature (24 – 26oC) and humidity (30 – 50%). SCID mice were kept in 
sterile, animal biosafety level 2 (ABSL2) facilities. All the mice were transported in at 
around 4 – 6 weeks of age. Two weeks were allowed for the animals to settle and 
accommodate to the environment. Xeno-transplantation of human cells was carried 
out on mice at 6 – 8 weeks of age. 
3.1.6 Drugs 
Anaesthetic drugs, analgesic drugs, and antibiotics were supplied by the Biological 
Resource Centre, A*STAR, Singapore for animal studies. Inhalant anaesthesia was 
used before surgery, with 3% isoflurane, 2 L/min oxygen flow rate for induction and 2% 
isoflurane, 1 L/min oxygen flow rate for maintenance. Metacam (0.3 mg/kg) was used 
as an analgesic supplied in drinking water. Enroflaxacin (10 mg/kg) was used as 
antibiotics and was administered subcutaneously once a day for 3 days post-op. 
3.1.7 Microscopes 
Microscopes were used for observing and imaging of experiments wherever 
appropriate. Brightfield microscopy was used for histological sections or 
immunoperoxidase stained sections. This was done on Zeiss Axioimager Upright 
Microscope. Phase contrast microscopy was used for cultured cells. Confocal 
microscopy was used for detection of fluorescent labeled cells. This was done on 





Olympus FV1000 Inverted Confocal Microscope. Immunofluorescence labeled tissue 
sections were visualized using Olympus FV100 Upright Confocal Microscope or 
Zeiss LSM510 confocal microscope. 
3.1.8 Culture Media 
DermaLife K Serum-free Media 
A commercially available serum-free media, DermaLife K (Lifeline Cell Technology) 
was used for culture of primary keratinocytes. The basal medium was supplemented 
with growth factors including L-glutamine (6 mM), Extract P™ (0.4%), epinephrine 
(1 μM), recombinant human (rh) TGF-α (0.5 ng/mL), hydrocortisone hemisuccinate 
(100 ng/mL), rh insulin (5 μg/mL), apo-transferrin (5 μg/mL), and 1% penicillin / 
streptomycin. 
Complete DMEM 
Complete Dulbecco’s Modified Eagle Medium (DMEM) consisted of DMEM 
supplemented with 10% foetal bovine serum, 1% L-glutamine and 1% penicillin / 
streptomycin. The medium was used for routine culture of primary fibroblasts. 
Complete Ready Mix (RM) Media 
Complete Ready Mix (RM) growth medium consisted of a 3:1 mixture of DMEM and 
Ham’s nutrient mixture F12 medium supplemented with 10% foetal bovine serum, 1% 
L-glutamine, 1% penicillin / streptomycin, mitogens including 5 µg/ml insulin, 0.4 
µg/ml hydrocortisone, 5 µg/ml transferrin, 1.8 × 10-4 M adenine, 10 ng/ml epidermal 
growth factor (EGF) and 2 × 10-11 M triiodothyronine. Complete RM+ media 
contained all the growth factor components and was used for the co-culture of 





fibroblasts with keratinocytes. During air-liquid interface of organotypic co-culture, 
cells were cultured without EGF and serum. Complete RM– media contained all the 
components except for EGF.  
 
  






3.2.1 Histological Techniques 
Tissue Processing and Microtomy 
Skin biopsies were either fixed in 10% neutral buffered formalin or snap frozen in 
liquid nitrogen. Skin biopsies that were fixed were sent to Institute of Molecular & 
Cell Biology (IMCB) Histopathology Laboratory and processed for paraffin 
embedding and sectioning. Some specimens were embedded in tissue freezing 
medium, Tissue TekOTC compound (Sakura Finetek Europe, Zoeterwoude, The 
Netherlands) and snap-frozen in liquid nitrogen for a few minutes until equilibrium 
was reached. Specimens were then stored at –80°C until use. Paraffin blocks were 
sectioned with a rotating microtome (Leica RM2255 Microtome, Leica Microsystems) 
to obtain 5 – 7 μm thick sections. Frozen cryoblocks were sectioned on a cryo-
microtome (Leica CM3050 Cryostat, Leica Microsystems) to obtain 6 – 8 μm thick 
sections. Frozen sections were stored at –80°C prior to immunofluorescence staining.  
Haematoxylin and Eosin (H&E) Staining 
For Haematoxylin and Eosin (H&E) staining, paraffin sections were first 
deparaffinized through descending percentages of alcohol, while frozen sections were 
rinsed in deionized water to remove tissue freezing medium. They were then stained 
with Gill 2 Haematoxylin (Richard-Allen Scientific, #7231) for 5 min at room 
temperature and subsequently rinsed extensively in tap water until stained sections 
turned blue. Stained sections were differentiated in 1% acid alcohol and washed in 
Scott’s tapwater before staining with Eosin (Sigma-Aldrich) for 2 min. The sections 
were dehydrated in increasing percentages of ethanol series of 70%, 80%, 90% and 





100%, and cleared in 100% xylene before mounting with DPX mountant (Sigma-
Aldrich) and glass coverslips. 
Immunoperoxidase Staining for Formalin-Fixed Paraffin-Embedded Sections 
Paraffin sections were collected and dewaxed in xylene and rehydrated through 
descending percentages of alcohol to water. Endogenous peroxidase was quenched by 
incubation with 1% H2O2 (Merck) in methanol for 30 min. Antigens were 
subsequently heat-retrieved (121oC) with citrate at pH 6. A hydrophobic boundary 
was created surrounding the section and sections were blocked in 10% goat serum 
(Dako). Sections were incubated with primary antibodies for 90 min in a humidified 
chamber, washed with tap water for 10 min in a flow chamber, followed by 
incubation with secondary antibody using EnVision™ system (Dako) for 30 min at 
room temperature. After washing for 10 min, peroxidase activity was detected using 
diaminobenzidinetetrahydrochloride (DAB) substrate (Dako) for 3 min. Sections were 
rinsed in water to stop DAB reaction and counterstained with haematoxylin. The 
sections were dehydrated in increasing percentages of ethanol and cleared in xylene 
before mounting with DPX and allowing to dry overnight. 
Immunofluoresecence Staining for Frozen Sections 
For immunofluorescence, frozen sections were either unfixed or fixed in methanol / 
acetone at –20°C for 10 min and air dried before washing in 1× PBS twice for 3 min. 
A hydrophobic boundary was created surrounding the section and sections were 
blocked in 10% goat serum (Dako). Sections were incubated with primary antibodies 
for 60 min in a humidified chamber, washed with tap water for 10 min in a flow 
chamber, followed by incubation with secondary antibody conjugated with 





fluorochrome for 30 min. After washing for 10 min, sections were counterstained with 
4',6-diamidino-2-phenylindole (DAPI) (1:2500) (Dako) and mounted in an aqueous 
non-fluorescing mountant (Hydromount) (National Diagnostics) with 2.5% DABCO 
to reduce photobleaching before leaving in the dark to dry overnight. 
Herovici’s Staining 
Paraffin sections were sent to Institute of Molecular & Cell Biology (IMCB) 
Histopathology Laboratory for staining. 
3.2.2 Isolation and Culture of Epidermal Keratinocytes and Dermal 
Fibroblasts 
Isolation of Primary Human Keratinocytes from Foetal Skin 
Foetal skin biopsies were cleaned and washed in 1× phosphate buffered saline (1× 
PBS) before placing into 4× antibiotic antimycotic solution (Sigma) for 20 min. The 
skin was cut into small pieces (less than 1 mm2) and incubated with 10× TrypLE 
Select (Life Technologies) at 4oC overnight. Specimens were resuspended with 
pipette and dissociated into single cell suspensions. Complete Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% serum was added to neutralize 
trypsin and the cell suspension was filtered using a 100 µm cell strainer (BD Falcon) 
to remove tissue debris. After centrifugation at 1400 rpm for 6 min, the isolated cells 
were seeded on a gelatin-coated (Stemcell Techonologies) T25 flask (Corning 
CELLBIND) containing 1× antibiotic antimycotic solution and incubated at 37oC in a 
humidified atmosphere with 5% CO2 for at least three days before first medium 
change. Cells were cultured in DermaLife K serum-free keratinocyte culture media 
(Lifeline Cell Technology) supplemented with 1% Penicillin / Streptomycin solution 





(Sigma-Aldrich) to establish keratinocyte cultures which were designated as P0. 
Contaminating fibroblasts were removed by treating with 0.02% 
ethylenediaminetetraacetic acid (EDTA) (Sigma) for 5 min or TrypLE Select (1:3) 
(Life Technologies) for 1 min. 
Isolation of Primary Human Fibroblasts from Foetal Skin 
For fibroblast cultures, the isolated cells were seeded on a T75 flask (Corning) 
containing 1× antibiotic antimycotic solution and incubated at 37oC in a humidified 
atmosphere with 5% CO2 for at least three days before first medium change. 
Fibroblasts were designated as P0 and established using Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% serum. 
Isolation of Primary Human Keratinocytes from Adult Skin 
Full-thickness skin samples were transported from the hospital to the laboratory in 
sterile containers. Sterile surgical gloves were worn when handling the skin samples 
with hand. The skin samples were first rinsed in sterile 1× PBS and subsequently 
disinfected by dipping shortly into 0.05% sodium hypochlorite and then washed 
extensively in sterile 1× PBS. Subcutaneous adipose tissue was distinguished by the 
yellowish appearance and was mechanically removed with sterile surgical instruments 
to minimize heterogeneity in the cell population. Samples were then cut into pieces 
not larger than 5 × 10 mm and immersed in 2.4 U/ml Dispase II (Roche, Basel, 
Switzerland) in DermaLife K serum-free keratinocyte culture media (Lifeline Cell 
Technology) for 16 hrs at 4°C to break down epidermal-dermal junctions. The 
epidermis was then gently peeled off and separated from the dermis using forceps. 
The skin pieces were kept small to ensure thorough dispase digestion of the basement 





membrane, allowing easy and complete separation of the epidermis from the dermis. 
The epidermis was collected and incubated with 0.125% trypsin for 20 min to break 
up cell-cell junctions.  The cell suspension was vortexed and filtered using a 100 µm 
cell strainer (BD Falcon) to remove tissue debris before centrifuging at 1200 rpm for 
5 min. The isolated cells were seeded on tissue culture flasks containing 1× antibiotic 
antimycotic solution and incubated at 37oC in a humidified atmosphere with 5% CO2 
for at least three days before first medium change. Cells were cultured in DermaLife 
K serum-free keratinocyte culture media supplemented with 1% 
Penicillin/Streptomycin solution (Sigma-Aldrich) to establish keratinocyte cultures 
designated as P0. Some adult keratinocyte cultures were established by Carol Teong 
and Anita Balakrishnan from the Skin Cell Bank. 
Isolation of Primary Human Fibroblasts from Adult Skin 
Adult fibroblasts were isolated using the explant method. To isolate human dermal 
fibroblasts, the dermal pieces were transferred into a T175 culture flask containing 
just enough medium (DMEM supplemented with 1% Penicillin-Streptomycin and 10% 
FBS) to wet the entire vessel surface so as not to disturb the tissue. The samples were 
distributed over the culture surface to maximize space and incubated at 37oC in a 
humidified atmosphere with 5% CO2 undisturbed for at least three days before first 
medium change. The flask was tapped gently during trypsinization to prevent the 
dermal pieces from lifting off. 
Culture of Epidermal Keratinocytes and Dermal Fibroblasts 
Keratinocytes were cultured without feeder cells in DermaLife K serum-free 
keratinocyte culture media (Lifeline Cell Technology) supplemented with 1% 





Penicillin-Streptomycin solution (Sigma-Aldrich). Subculturing was carried out at 80% 
confluence by first rinsing the cultures with 1× PBS and then trypsination with 
TrypLE Select (Invitrogen) for 7 min at 37°C. The trypsin was diluted with 1× PBS 
and cells were counted on a haemocytometer in combination with trypan blue 
viability exclusion dye. Viable keratinocytes were seeded at a density of 5000 
cells/cm2 in culture flasks (CELLBIND Corning). Keratinocytes at the desired 
passage number were similarly harvested and used in each study. Primary 
keratinocytes can be cultured up to passage 7 – 13 using the serum-free feeder-free 
culture technique described here. Higher passages usually result in senescence, when 
keratinocytes terminally differentiate and are sloughed off. 
Fibroblasts were cultured in DMEM supplemented with 1% Penicillin-
Streptomycin and 10% FBS. Subculturing was carried out by trypsination with 0.125% 
trypsin for 3 min at 37°C. The trypsin was neutralized with complete DMEM and 
cells were counted on a haemocytometer in combination with trypan blue viability 
exclusion dye. Viable fibroblasts were seeded at a density of 2500 cells/cm2. 
Fibroblasts at the desired passage number were similarly harvested and used in some 
studies. 
3.2.3 Cryogenic Preservation and Storage of Primary Cells 
Primary Human Keratinocytes 
Subconfluent cell cultures were trypsinized, pelleted and counted. The cell 
concentration was adjusted to 2 × 106 cells/ml in serum-free keratinocyte media. The 
same amount of cold 2× freezing media containing 40% serum-free keratinocytes 
media, 40% FBS and 20% dimethylsulphoxide (DMSO) was added into the cell 





suspension with gentle swirling to give a final concentration of 70% cell suspension, 
20% FBS and 10% DMSO. One ml cell suspensions containing 1 x 106 cells were 
then aliquoted into labeled cryovials, placed into Mr. Frosty freezing container 
(Nalgene, NUNC) and kept at –80°C overnight before transferring the storage vials to 
liquid nitrogen tank for long-term storage. 
Primary Human Fibroblasts 
Subconfluent cell cultures were trypsinized, pelleted and counted. The cell 
concentration was adjusted to 2 × 106 cells/ml in complete DMEM media. The same 
amount of cold 2× freezing media containing 80% FBS and 20% dimethylsulphoxide 
(DMSO) was added into the cell suspension with gentle swirling to give a final 
concentration of 50% cell suspension, 40% FBS and 10% DMSO. One ml cell 
suspensions containing 1 x 106 cells were then aliquoted into labeled cryovials, placed 
into “Mr. Frosty” freezing container (Nalgene, NUNC) and kept at –80°C overnight 
before transferring the storage vials to liquid nitrogen tank for long-term storage. 
3.2.4 Thawing of Primary Cells 
When thawing either keratinocytes or fibroblasts, frozen cryotubes were taken out of 
the liquid nitrogen tank and warmed quickly in a 37°C water bath. The cells were 
rapidly thawed and then transferred into 9 ml of culture medium. The cell suspension 
was pelleted by centrifugation, resuspended in culture medium and seeded into a 
tissue culture flask to allow for overnight adhesion of cells to the vessel surface. The 
medium was then changed to discard dead cells and the cells were cultured as normal 
(above).  
 





3.2.5 Karyotype Analysis 
Keratinocytes were seeded at a density of 5000 cells/cm2 in 100 mm culture dishes. 
At 80% confluence, the dishes were sent to the Human Genetics Lab in the Genome 
Institute of Singapore (GIS) for karyotyping. Cells were treated with colcemid for 
mitotic arrest and harvested by standard hypotonic treatment and methanol: acetic 
acid (3:1) fixation.  Slides were prepared by standard air drying method Giemsa-
stained for G-band karyotype analysis following standard laboratory protocols used in 
GIS. 
3.2.6 Immunocytochemical Staining for Fluorescence Microscopy 
40,000 – 50,000 primary cells were seeded onto 8 well ibiTreat chambers (Ibidi 
GmbH) until 90% confluence and were fixed for 10 min in methanol/acetone at –20oC 
or 4% paraformaldehyde at room temperature. After fixation, cells were washed twice 
with 1× PBS and soaked in 10% goat serum at room temperature for 20 min to block 
non-specific staining. The fixed cells were incubated for 90 min with primary 
antibodies in a humid atmosphere and were then washed three times for 5 min each in 
1× PBS. The primary antibodies were detected using the respective secondary 
antibodies conjugated with fluorochrome by incubating for 45 min in the dark. Cells 
were then washed in 1× PBS and counterstained with 4',6-diamidino-2-phenylindole 
(DAPI) (1:2500) for 20 min. Cells were subsequently washed 3 times in 1× PBS for 5 
min each before visualization.  
  





3.2.7 Calculation of Proliferation Index 
Ki67, a widely accepted marker for proliferation, was used to assess the spatial and 
temporal distribution of proliferating cells within the developing skin. 
Immunoperoxidase staining was performed on paraffin sections using Ki67 antibody 
clone MM-1 (1:50) (Novocastra). The proliferation index (PI) is defined as the 
number of Ki67-positive basal cells divided by the total number of basal cells × 100%. 
Cells were counted at the light-microscopic level (magnification 630×) at five 
randomly chosen regions in each section. The resulting values are expressed as the 
mean PI of each gestational age. Proliferation Index on tissue sections were calculated 
using the equation provided below: 
𝑷𝒓𝒐𝒍𝒊𝒇𝒆𝒓𝒂𝒕𝒊𝒐𝒏 𝑰𝒏𝒅𝒆𝒙 =  𝑵𝒐 𝒐𝒇 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒍𝒚 𝒍𝒂𝒃𝒆𝒍𝒆𝒅 𝒄𝒆𝒍𝒍𝒔 𝒂𝒍𝒐𝒏𝒈 𝒃𝒂𝒔𝒆𝒎𝒆𝒏𝒕 𝒎𝒆𝒎𝒃𝒓𝒂𝒏𝒆
𝑻𝒐𝒕𝒂𝒍 𝒏𝒐 𝒐𝒇 𝒃𝒂𝒔𝒂𝒍 𝒄𝒆𝒍𝒍𝒔 𝒄𝒐𝒖𝒏𝒕𝒆𝒅 𝒂𝒍𝒐𝒏𝒈 𝒃𝒂𝒔𝒆𝒎𝒆𝒏𝒕 𝒎𝒆𝒎𝒃𝒓𝒂𝒏𝒆 × 𝟏𝟎𝟎%  
3.2.8  Cell Proliferation Experiments using Real-time and Dynamic Monitoring 
Cell Analyzer 
A real-time and dynamic monitoring cell analyzer (xCELLigence, Roche Diagnostics) 
was used to evaluate the proliferation of foetal and adult keratinocytes. Cells from 
flasks were trypsinized and counted. Wells of 2500 cells were established in five 
replicates. After seeding 150 μl of the cell suspensions into the wells of the E-plate 96 
(Roche Diagnostics), cells were allowed to adhere to the E-plate for 6 hr before 
analysis. Keratinocyte growth was monitored every hour for a period of one week. 
The doubling time was calculated using RTCA software 1.2.1 (Roche Diagnostics). 
3.2.9 Colony Forming Assay and Rhodamine Staining of Keratinocyte Colonies 
Freshly isolated keratinocytes were seeded at 200 cells or 500 cells onto tissue culture 
dishes (6 cm dishes) in triplicates and cultured for two weeks in DermaLife serum-





free medium at 37oC with 5% CO2. The medium was changed at day 10. Cells were 
fixed with 10% neutral buffered formalin for 1 hr and stained with 1% (w/v) 
Rhodamine B (JT Baker) in distilled water for 30 min. The dishes were then rinsed in 
distilled water to elute excess stain. Colony forming efficiency (CFE) was expressed 
as the percentage of colonies (>1 mm2) formed divided by the number of cells seeded. 
3.2.10 Detection of Telomeric DNA Using Genomic DNA of In Vitro Cell 
Cultures 
TeloTAGGG Telomere Length Assay kit (Roche) was utilized for telomere length 
experiments. The mean telomere length of primary keratinocytes were assessed using 
Southern analysis of terminal restriction fragments (TRF) obtained by digestion of 
genomic DNA using frequently cutting restriction enzymes. 
Isolation and Digestion of Genomic DNA 
2 µg of genomic DNA were isolated from keratinocytes using DNeasy® Blood & 
Tissue Kit (Qiagen, Germany). To obtain maximum yield, two T75 flasks were 
prepared for primary keratinocytes. Cells were pelleted by centrifugation and 
resuspended in 200 µl PBS. 20 µl proteinase K and 4 µl RNase A (100 mg/ml) were 
added and mixed by inverting the tube, and incubated for 2 min at room temperature. 
The pellet was lysed in 200 µl Buffer AL and incubated at 56oC for 10 min. 200 µl 
ethanol (96-100%) was added to the sample, and mix thoroughly by inverting the tube 
to yield a homogeneous solution. The mixture was pipetted into the DNeasy Mini spin 
column, centrifuged at 8000 rpm for 1 min, before discarding the flow-through. 500 
µl Buffer AW1 was added into the spin column, centrifuged for 1 min at 8000 rpm, 
followed by adding 500 µl Buffer AW2 into the spin column and centrifuging for 3 





min at 14000 rpm to dry the DNeasy membrane since residual ethanol may interfere 
with subsequent reactions. Following centrifugation step, the DNeasy Mini spin 
column was placed in a clean 1.5 ml centrifuge tube and 100 µl Buffer AE was added 
directly onto the DNeasy membrane. After incubating at room temperature for 1 min, 
the tube was centrifuged for 1 min at 8000 rpm for elution. Elution was repeated for 
maximum DNA yield using a new centrifuge tube for the second elution step to 
prevent dilution of the first eluate. The tubes were stored in 4oC overnight before 
measuring DNA concentration. The DNA quantity and concentration were determined 
using Nanodrop ND-1000. At least 120 ng/µl of DNA was required for subsequent 
steps. If needed, some DNA samples were concentrated by vacuum spin for 15 – 25 
min at 45oC. 2 µg of purified genomic DNA was mixed with frequently cutting 
enzymes Hinf I and Rsa I (20 U/µl each) for a total volume of 20 µl and digested for 2 
hr at 37oC, then 1 µl aliquot of digested DNA sample was removed and separated on a 
0.9% agarose gel. A complete digestion should give a smear along the lane of the gel. 
Digestion of the genomic DNA was prolonged if multiple bands appear above the 
smear. 
Gel Electrophoresis and Southern Blotting 
A 0.9% (w/v) agarose gel (about 15 cm in length) was prepared by adding 1.35 g of 
agarose into 150 ml of fresh 1× TAE buffer and microwaved until the agarose powder 
was dissolved. Lonza GelStar* nucleic acid gel stain was added to the melted agarose, 
poured into the gel casting apparatus and allowed to solidify for at least 30 min. 4 µl 
of 5× loading buffer was mixed 2 µg (20 µl) of each digested DNA sample and loaded 
onto the wells of the gel submerged in 1× TAE buffer, with the digoxigenin (DIG) 
molecular weight marker loaded to each side of the gel, flanking the sample lanes. 





The gel was electrophoresed at 2.5 V/cm in 1× TAE buffer overnight until the 
bromophenol blue tracking dye was separated about 10 cm from the starting wells. 
The gel was exposed and visualized using the Fujiflim LAS4000 illuminator where a 
smear should be observed along the lane of the gel. The gel was then immersed in 
depurination solution (0.25 M HCl solution) for 10 min and rinsed twice with tap 
water. The gel was then submerged in denaturation solution (0.5 M NaOH, 1.5 M 
NaCl) twice for 15 min to denature DNA, making it single-stranded and accessible for 
the later applied probe. After rinsing twice with tap water, the gel was submerged in 
the neutralization solution (0.5 M Tris-HCl pH 7.4, 1.5 M NaCl) twice for 15 min. 
The gel was subjected to Southern transfer of DNA fragments to a nylon membrane 
by capillary action overnight at room temperature using 20× SSC as a transfer buffer.  
Prehybridization and Hybridization 
After DNA fixation by UV-crosslinking at 120 mJ, the blotting membrane was 
washed twice with 2× SSC before submerging the blot in the hybridization tube with 
prehybridization solution (DIG Easy Hyb) and rotated in a hybridization oven at 42oC 
for 4 hr. The blotted DNA fragments was then hybridized with telomere-specific, 
digoxigenin (DIG)-labeled hybridization probe (TTAGGG) and rotated overnight at 
42oC.  
Chemiluminescence Detection of DIG-labeled DNA 
After hybridization, the membrane was washed twice with wash buffer I (2× SSC, 0.1% 
SDS) for 5 min at room temperature, and then washed twice with pre-warmed wash 
buffer II (0.2× SSC, 0.1% SDS) for 20 min at 50oC. The membrane was blocked, and 
incubated with Anti-DIG antibody covalently coupled to alkaline phosphatase (diluted 





to a final concentration of 75 mU/ml) at room temperature for 30 min. The membrane 
was then washed twice at 15 min each and incubated in detection buffer for 5 min at 
room temperature. and incubated with CDP-Star, a highly sensitive chemiluminescent 
substrate was applied to the membrane and incubated for 5 min at room temperature 
in the dark. The alkaline phosphatase on the antibody metabolizes CDP-Star, 
producing a visible signal that indicates the location of the immobilized telomere 
probe and hence, the telomere restriction fragment (TRF) on the blot. The membrane 
was exposed using Fujiflim LAS4000 illuminator and to X-ray film. The average TRF 
length was determined by comparing the location of the TRF on the blot relative to a 
molecular weight standard. 
3.2.11  Establishment of 3D Organotypic Co-Cultures to Analyze Differentiation 
Functions of Cultured Keratinocytes In Vitro 
Primary fibroblasts and primary keratinocytes were used in this experiment. The 
procedure for creating a three-dimensional organotypic construct is divided into 3 
stages as follows. 
Construction of Fibroblast-Populated Collagen Matrix 
Human fibroblasts were cultured so that they were confluent when the collagen matrix 
is to be casted. On the day of gel casting, fibroblasts were trypsinized, centrifuged and 
resuspended in complete DMEM at a concentration of 2 × 106 cells/ml. Fibroblasts 
embedded in rat tail collagen I (BD Biosciences) were prepared by adding 8 ml 
collagen and 1 ml DMEM, followed by neutralizing with 1M NaOH drops, then 1 ml 
of fibroblast suspension was added. 2 ml of collagen gel mixture was placed into each 
cell culture insert (BD Biosciences) (4 × 105 cells per well) in 6-well plates and 





incubated at 37oC for 3 to 4 hr to allow mixture to gel completely. Complete RM+ 
media was then added into the culture insert and the wells. For 12-well cultures, 
120,000 cells were added into the gel and placed into a 12-mm hanging cell culture 
inserts (1 µm Millicell; Millipore) in 12-well plates.  
Seeding of Keratinocytes and Differentiation of the Epidermal Layer at the Air-
liquid Interface 
Keratinocytes (5 × 105 cells in 200 µl suspension for 6-well cultures; 1 × 105 cells in 
50 µl suspension for 12-well cultures) were seeded on top of the collagen gel 
dropwise and incubated at 37oC for 3 hr without media to allow them to fully adhere. 
DermaLife serum-free keratinocyte media was then added into the culture insert and 
complete RM+ media was added into the wells. Keratinocytes were cultured in 
submerged state for 7 days, after which the culture was lifted to the air-liquid 
interface, exposing the keratinocyte layer to air while the fibroblast-embedded 
collagen gel remained in contact with the medium. The culture inserts were 
transferred into deep well plates (Beckton Dickinson Labware) and the medium was 
switched to cornification media (Complete RM– media) without serum. The cultures 
were harvested after 14 days. 
Processing of Tissues for Morphological and Immunohistochemical Analysis 
At the end of the growth period, the cultures together with the insert membrane were 
removed from the culture insert using a scalpel, and were cut into three parts. The 
culture pieces were sandwiched between two foam pads in a cassette and immersed in 
10% neutral buffered formalin for fixation and subsequently embedded in paraffin for 
histology. Some culture pieces were embedded in OCT embedding media and snap 





frozen in liquid nitrogen for cryosectioning and histochemistry. Sections were stained 
with haematoxylin and eosin. 
3.2.12 Fluorescence-Activated Cell Sorting (FACS) 
Cultured keratinocytes were trypsinized, counted and a single cell suspension was 
prepared in FACS buffer (1× PBS with 10% Foetal Bovine Serum). 100,000 cells to 1 
million cells were used for each analysis. 50 µl of cell suspension was placed in 
FACS tube (BD Bioscience). 1 ml of ice-cold 70% ethanol fixative was added slowly 
into each tube and incubated at –20oC overnight. The tubes were centrifuged at 1200 
rpm for 5 min and the supernatant was carefully aspirated as much as possible. 20 µl 
of primary antibody (1:10) or isotype control IgG diluted in FACS buffer was gently 
mixed with the cells and incubated on ice for 30 min. The cells were washed by 
adding 1 ml of cold FACS buffer and centrifuged at 1200 rpm for 5 min. After the 
supernatant was carefully aspirated, 20 µl of secondary antibody conjugated with 
fluorochrome at dilution of 1: 500 and propridium iodide (PI) (10 µg/ml) in FACS 
buffer were gently mixed with the cells and incubated on ice for 30 min in the dark. 
The cells were washed by adding 1 ml of cold FACS buffer, centrifuged for 5 min, 
and the supernatant aspirated. Finally, the cells were resuspended in 500 µl FACS 
buffer. Flow Cytometry was performed with a fluorescence activated cell sorter, BD 
LSR II Flow Cytometer (Becton Dickinson, Franklin Lakes, NJ) equipped with a 15-
mW argon ion laser. The filter settings used were FITC (530 nm). Cells were counted 
(10,000 events) and data were analyzed with gating using FlowJo research software. 
  





3.2.13 Transplantation Assay 
Preparation of Plasma-based Dermal Equivalent 
Human fibroblasts were cultured so that they were confluent when the fibrin matrix is 
to be casted. Fibroblasts were trypsinized, centrifuged and resuspended in complete 
DMEM at a concentration of 1 × 106 cells/ml before proceeding with plasma gel 
preparation. A 3 ml mixture of plasma, fibroblasts and thrombin were added into each 
6-well culture inserts (BD Biosciences). Filtered porcine plasma (Equitech-Bio, Inc.) 
was first mixed with fibroblast suspension at a ratio of 10:1 and 1.5 ml of mixture was 
added into each 6-well inserts. To initiate clotting, 1.5 ml of thrombin (6 NIH units/ml) 
in 1% calcium chloride was then added slowly, avoiding trapping air bubbles, into the 
inserts to give a total volume of 3 ml. Clotting should occur within 5 – 10 min and 
should also be free of any visible fibres. The mixture was incubated at 37ºC for 2 hr to 
allow it to gel completely. Complete RM+ media was then added into the wells and 
inserts, submerging the plasma gel, checking that the fibroblasts had started spreading 
in the gels. The following day, keratinocytes were trypsinized to obtain single cell 
suspension and counted. 5 × 105 cells in 200 µl suspension were seeded dropwise on 
top of the plasma gel dropwise and incubated at 37oC for 3 hr without media to allow 
them to fully adhere. DermaLife serum-free keratinocyte media was then added into 
the culture insert and complete RM+ media was added into the wells. Keratinocytes 
were cultured in submerged state until they reached confluence for transplantation. 
For organotypic co-cultures, the culture was lifted to the air-liquid interface, exposing 
the keratinocyte layer to air while fibroblast-embedded plasma gel in remained 
contact with the medium. The culture inserts were transferred into deep well plates 





(BD Biosciences) and the medium was switched to cornification media (Complete 
RM– media) without serum. The cultures were harvested after 14 days. 
Transplantation of Human Skin Equivalents onto Immunodeficient Mice  
Two mobile anaesthesic machines (Surgivet) were prepared and borrowed from the 
Biological Resource Centre (BRC). For induction of anaesthesia, the mice were 
subjected to 3% isoflurane and 2 L/min oxygen flow rate. For maintenance of 
anaesthesia, the mice were subjected to 2% isoflurane and 1 L/min oxygen flow rate. 
The mouse (6 – 8 weeks old) was weighed and placed in the anaesthesia chamber for 
2 min until it passed out. The mouse was transferred to the anaesthesia breathing tube 
and the appropriate amount of antibiotics (Enroflaxacin (Baytril), 10 mg/kg) was 
administered subcutaneously. The ear punch was placed at the desired location and 
the dorsal trunk of mouse was shaved with electric clippers. Using a marker, a 3 cm × 
3 cm square section was drawn on the skin comparable in size to the graft. An 
incision was made and a square section of the skin was cut and transferred into a 50 
ml Falcon tube. A cotton gauze was soaked in 1× PBS and placed over the open 
wound to keep the wound moist. The excised skin was snap-frozen by dipping in 
liquid nitrogen for 2 min and then heated in an 80ºC water bath to thaw for 2 min. 
This freeze-thaw process was repeated for another 2 more times to kill all the mouse 
skin cells. The dead skin was then used as a biological bandage: it was placed over the 
wound fixed in place with a continuous running stitch suture around half of the 
devitalized skin flap to form a pocket. The culture insert membrane with the skin 
equivalent was carefully cut away from the insert frame. Using a spatula, the skin 
equivalent with keratinocytes facing up was carefully lifted and placed inside the 
wound pocket. A continuous suture was performed to close the wound. No further 





bandaging was required. The mouse was placed in a clean and warm environment to 
recover. 5.7 ml of analgesics (Metacam, 0.3 mg/kg) was added into 100 ml drinking 
water for 3 days. Food pellets were placed on the bottom of cage and animals were 
monitored every day. 
Euthanasia and Necropsy 
Mice were euthanized by CO2 asphyxiation in a gas chamber, at a scheduled time 
points of the transplantation studies. 
3.2.14 Statistical Analysis 
Data was presented as mean and standard deviation (SD) where appropriate.  All 
experiments were carried out in duplicate or more. Data analysis was performed by 
one-way analysis of variance (ANOVA) followed by post hoc Tukey’s test for 
multiple comparisons of at least three groups or unpaired Student’s t-test for two 






















The epidermis which is found at the interface between organism and the environment 
is required to withstand both chemical and physical stress, while maintaining normal 
tissue turnover. Much of this stress resistance is provided by specialized cytoskeletons 
formed: actin filaments, microtubules, and intermediate filaments. Unlike the two 
other classes, intermediate filaments show tissue-specific expression (Lane, 1982; 
Moll et al., 1982a). Intermediate filaments are 10-nm diameter cytoplasmic structures 
that include the keratin filaments, vimentin filaments, desmin filaments, glial 
filaments, and neurofilaments. Among these keratins are found predominantly in the 
epithelia and are relatively abundant and stable. Many proteins including keratins and 
non-keratins are expressed specifically during the process of epidermal differentiation, 
the stage of differentiation, and the location of the keratinocytes within the epidermis. 
Hence, they are ideal for use as markers in the characterization epithelial cells 
including the epidermis. 
  





Table 4.1   Keratin markers expressed in different human epithelial types. 
Keratins Type Typical tissue expression pattern 
Keratin 1 Type II Spinous and granular layers paired with keratin 10, a marker for 
early epidermal differentiation 
Keratin 2 Type II Upper spinous layer 
Keratin 3 Type II Corneal epithelium paired with keratin 12 
Keratin 4 Type II Differentiated layers of the mucosal and esophageal epithelia paired 
with keratin 13 
Keratin 5 Type II Basal cells in all stratified epithelium with keratin 14  
Keratin 6 Type II Paired with keratin 16 and/or keratin 17 in filiform papillae of 
tongue, the stratified epithelial lining of oral mucosa and esophagus, 
outer root sheath of hair follicles and the glandular epithelia 
Keratin 7 Type II Most glandular and transitional epithelia (ovary, lung, and breast 
epithelia) 
Keratin 8 Type II Simple epithelial tissues paired with keratin 18 
Keratin 9 Type I Terminally differentiated epidermis of palms and soles 
Keratin 10 Type I Suprabasal layers (Spinous and granular layers) of the epidermis 
paired with keratin 1, a marker for early epidermal differentiation 
Keratin 12 Type I Corneal epithelia paired with keratin 3 
Keratin 13 Type I Suprabasal layers of non-cornified stratified epithelia paired with 
keratin 4 
Keratin 14 Type I Basal cells in all stratified epithelium and appendages with keratin 5  
Keratin 15 Type I Some progenitor basal cells within complex epithelia, in the bulge 
and the bulb of follicle 
Keratin 16 Type I Paired with keratin 6 in hyperproliferative (including tissue culture), 
traumatized and wound healing epidermis; Buccal stratified 
squamous epithelia 
Keratin 17 Type I Nail beds, hair follicles, sebaceous glands and other epidermal 
appendages 
Keratin 18 Type I Simple epithelial tissues paired with keratin 8 
Keratin 19 Type I Periderm, the transiently superficial layer that envelopes the 
developing epidermis; follicle bulge stem cell marker for epidermal 
stem cells in outer root sheet, basal epidermis and deep rete ridges 
Keratin 20 Type I Mature enterocytes and goblet cells in the gastric and intestinal 
mucosa 
 





Epithelial cells show a pattern of keratin expression that defines the tissue type 
and the differentiation status of the cells. Keratins are divided into two major 
subgroups, type I keratins and type II keratins. Keratin filaments are assembled from 
parallel heterodimers, containing one polypeptide of each type I and type II keratins, 
which are bundled into mature filaments. Specific pairs of keratins are expressed in 
different epithelial tissues. Table 4.1 lists the keratin markers expressed in different 
human epithelial types based on the original catalog (Moll et al., 1982a; Moll et al., 
1990). The underlined groups are used for the immunological analysis in this research 
to characterize the stage of skin development. 
In all stratified epithelia, basal cells express K5 with K14 (Purkis et al., 1990), 
but this expression in downregulated during epidermal differentiation and switched to 
newly expressed keratins including K1 and K10 as cells migrate into suprabasal layers.  
The differentiation of human foetal epidermis has been investigated and 
performed in a few studies, which include keratins (Moll et al., 1982c; Dale et al., 
1985; Coolen et al., 2010) and other differentiation markers expression (Loureno et 
al., 2008; Akiyama et al., 1999; Lee et al., 1999; Dale et al., 1985). Other studies 
were performed on different epithelial tissues or animal species. During development, 
the epidermis changes from a simple epithelium covered by the periderm to a 
stratified, keratinized epithelium at about 22 to 24 weeks. The basal cell keratins, K14 
and K5, are present at 8 weeks of gestation, when the foetal epidermis consists of a 
basal layer and periderm (Dale et al., 1985). Differentiation-specific keratins (K1 and 
K10) are induced between 9 and 10 weeks, when a third layer of cells, the 
intermediate layer, forms between the basal and periderm layers. Other keratins, such 
as K19, is expressed in foetal epidermal basal cells in a variety of species, but are 





absent in the adult epidermis (Dale et al., 1985; Lane et al., 1985; Banks-Schlegel, 
1982). Proteins involved in the formation of the cornified cell envelope, such as 
loricrin and involucrin were found from 14 – 16 weeks while filaggrin was detected at 
the granular and horny layer from 24 weeks (Lee et al., 1999). However, there are 
some discrepancies in the literature with regard to the exact expression time and 
localization of these proteins (Dale et al., 1985; Lee et al., 1999; Moll et al., 1982c), 
perhaps due to the different body sites analyzed for different studies. 
The composition of the foetal dermis have also been analyzed by several 
investigators (Smith et al., 1986; Hantash et al., 2008; Wilgus, 2007; Johnson & 
Holbrook, 1989). It was shown that the extracellular matrix (ECM) of foetal skin 
differs from the ECM of adult skin. Foetal skin contains a higher ratio of type III 
collagen to type I collagen than adult skin (Smith et al., 1986; Knight et al., 1993; 
Merkel et al., 1988). Foetal skin also contains is a higher level of glycosaminoglycans 
(GAGs) in the ECM compared to adult skin, with higher amounts of both hyaluronic 
acid and chondroitin sulfate (Mast et al., 1991; Whitby & Ferguson, 1991b). It was 
suggested that GAGs play a role in foetal scarless wound healing (Mast et al., 1992).  
Although foetal skin composition has been investigated in many previous 
studies, a complete evaluation of the components of the foetal skin in a single study 
has not been performed. Furthermore, there is a need to characterize foetal skin which 
is obtained to show consistency with previous studies. Some results that have been 
presented also differed with respect to the location and timing of the expression of 
various proteins, possibly due to body site differences which are harvested for 
analysis. For instance, the limbs (Dale et al., 1985; Coolen et al., 2010) and trunk 
(Moll et al., 1982c) may have different stage of development, and further work is 





needed to clarify this inconsistency. Various animal models have also been used in 
many studies to investigate foetal skin constituents, which may differ from that in 
humans. As the expression of several developmental genes are different in humans 
and animals, protein profiles in the human foetal skin may deviate from that in animal 
foetal skin (Fougerousse et al., 2000). There are also few foetal skin components that 
have not been thoroughly investigated yet. Therefore, the aim of this chapter is to 
characterize second trimester human foetal dorsal skin, which was the most common 
source of skin for culturing keratinocytes (see later chapters),  in order to give a more 
complete understanding about the tissue and its differences with adult skin. 
  






4.2.1 Foetal Skin Morphology 
To understand morphological changes of the skin during development, dorsal trunk of 
foetal skin at different gestational ages during the second trimester of development 
were sampled and compared with adult skin. Skin sections were stained with 
hematoxylin and eosin (H&E) and observed histologically. In adult skin, the outer 
epidermis is about 0.1 mm thick, consisting of some 6 cell layers of outwardly-
moving and progressively differentiating keratinocytes. In contrast, foetal epidermis 
(at 13 – 14 weeks gestation) contains a basal layer, a single intermediate layer and a 
periderm (Figure 4.1). The foetal dermis had higher density of fibroblasts and 
consisted of finely fibrillar dermis. From 15 weeks of gestation, hair pegs were seen 
projecting into the dermis with increasing number of intermediate layers. The number 
of epidermal cell layers continue to increase during further development and the hair 
pegs matured into hair follicles at about 17 weeks. 
4.2.2 Collagen Composition of Foetal Skin 
Extracellular matrix composition is known to differ between foetal and adult skin. 
Foetal skin has a higher ratio of type III to type I collagen (Smith et al., 1986). With 
maturation, the relative amount of type III collagen decreases (Whitby & Ferguson, 
1991b; Hallock et al., 1993). Herovici’s stain is capable of distinguishing between 
types I and III collagen (Herovici, 1963; Levame & Meyer, 1987), where the thick 
and coarser fibres (type I collagen) stain pink than those fine fibres (type III collagen) 
which stain blue. Figure 4.2 shows Herovici’s staining on foetal and adult skin. Nuclei 
were stained black or dark blue. Collagen III (stained blue) was the predominant 





collagen in foetal skin. Starting at week 20, collagen I (stained pink) started to appear 
at the reticular dermis. The reticular dermis of the adult skin consisted mainly of 
collagen I, and a distinct layer of blue-staining fine collagen III fibres can be seen 
immediately underneath the epidermis. 
  














Figure 4.1   Histology of 13, 15, 17, and 22 weeks’ gestation foetal skin and of adult 
skin. At 13 weeks, the epidermis consisted of a basal layer and periderm. Hair pegs were 
visible at 15 weeks with increasing number of intermediate cell layers. At 17 weeks 
developing hair follicles were visible. The adult skin contained basal, spinous, granular and 
cornified layers. 
 













Figure 4.2   Herovici’s staining of 14, 15, 20 and 22 weeks’ gestation foetal 
(dorsal) skin and of adult skin. At 14 weeks, the epidermis consisted of a single 
layer and periderm, and little collagen is evident. Hair pegs were visible at 15 
weeks with increasing number of intermediate cell layers in the epidermis. 
Collagen III (stained blue) was the predominant collagen in the dermis. Collagen I 
(stained pink) starts to appear at the reticular dermis at 20 weeks. The reticular 
dermis of the adult skin consisted mainly of Collagen I. Scale bar, 100 μm. 





4.2.3 Biomarkers for Tracking Changes in Skin Development 
Keratins 
Epidermal differentiation follows a well-ordered sequence. In normal interfollicular 
epidermis, cells divide exclusively in the basal layer. K5 and K14 are the major 
keratin intermediate filament proteins of basal keratinocytes and are down-regulated 
in the differentiating suprabasal cell layers (Fuchs & Green, 1980). Stratification of 
the foetal epidermis was investigated by staining with antibodies directed against K14. 
Similar to the adult skin, K14 was observed in the basal layer of the foetal epidermis 
at 13 weeks of gestation (Figure 4.3). K14 was also detected in the outer root sheath 
of the developing hair follicles. 
The keratin K8 and K18 typically are co-expressed and constitute the primary 
keratin pair of simple epithelial cells, and are the first keratins to appear in 
embryogenesis (Jackson et al., 1980). To study whether K18 is expressed in 
developing stratified epithelia, sections were stained using K18 antibodies. K18 was 
expressed in the basal layer as well as the periderm in foetal epidermis (Figure 4.3). 
Hair follicles were also stained positive with K18 in foetal skin. However, K18 was 
not expressed in adult epidermis.  
Expression of K17 proteins has been associated with abnormal differentiation 
and hyperproliferation, and appears in response to stress, but it is also a constitutive 
component of some sites, including foetal epidermis. To examine this, the presence of 
K17 was studied in the foetal and adult skin. K17 was absent from adult interfollicular 
epidermis (Figure 4.3). In contrast, K17 was present in the basal layer and in the 
periderm of the epidermis, with weaker expression in the hair follicles. The 





expression of K17 in the epidermis gradually reduced during further development, 
and at week 22 there was no expression in the epidermis although expression of K17 
in the hair follicle still persists. 
Differentiation Markers 
Once keratinocytes leave the basal layer, the cells switch to synthesizing large 
amounts of suprabasal keratins (K1 and K10) and strengthen their cytoskeleton and 
intercellular connections to provide better resistance to mechanical stress. Epidermal 
differentiation during gestation was studied by staining foetal epidermis with 
epidermal differentiation markers. Differentiated keratinocytes were identified using 
K10, an accepted marker of keratinocyte differentiation. K10 was expressed in the 
suprabasal layers of foetal epidermis as early as 13 weeks and in some parts of the 
periderm with weaker staining, indicating the presence of differentiated keratinocytes 
(Figure 4.4).  
Involucrin is a component of the cornified envelope which can be found in the 
cytoplasm, and is crosslinked to membrane proteins by transglutaminase. It is a 
marker of keratinocyte terminal differentiation and is expressed in the granular and 
cornified layers of stratified squamous epithelium (Carroll et al., 1993). Involucrin 
was expressed in the granular and cornified layers of adult epidermis. In foetal 
epidermis, involucrin was present in the intermediate layers as well as the periderm 
(Figure 4.4). 
Filaggrin is a histidine-rich, basic protein in epithelia and its precursor is 
associated with keratohyalin granules. Profilaggrin is synthesized and phosphorylated 
in the stratum granulosum, and proteolysed to generate filaggrin. Filaggrin is believed 





to promote the lateral aggregation of keratin filaments, forming compact microfibrils. 
Filaggrin is a major contributor to effective skin barrier function and water retention, 
because loss of filaggrin predisposes to dry skin and eczema (Palmer et al., 2006; 
Kezic et al., 2012). Filaggrin is one of the markers for intermediate keratinocyte 
differentiation (Lynley & Dale, 1983). Adult epidermis expressed filaggrin at the 
granular and cornified layers (Figure 4.4). Filaggrin showed a very weak staining at 
16 weeks, suggesting that epidermis at this age has a less well-developed barrier than 
adults. 
  




















































































































































































Basement Membrane and Extracellular Matrix Proteins 
The presence of basement membrane at the dermal-epidermal junction was assessed 
during development. Foetal and adult skin was stained with antibodies directed 
against collagen type IV, collagen VII and laminin 332, which are components of the 
basement membrane. At week 15, collagen type IV, collagen type VII and laminin 
332 were detected along the basement membrane zone of the dermal-epidermal 
junction (Figure 4.5). Collagen IV was also detected around the blood vessels in 
foetal and adult skin as all basement membranes express collagen IV while collagen 
VII is only expressed in  epithelial basement membrane. 
The extracellular matrix during foetal skin development was investigated by 
staining skin sections with antibodies against fibronectin. Fibronectin was observed in 
the dermis of foetal skin, with stronger staining in the papillary layer of the dermis 
(Figure 4.6). In adult, fibronectin was weakly stained in the dermis.  
Intermediate Filament Proteins in Connective Tissue 
Expression of vimentin, a type III intermediate filament expressed in mesenchymal 
cells was observed to be higher in foetal skin compared to adult skin (Figure 4.6), 
possibly due to the higher numbers of fibroblasts present in the foetal dermis. 
  






Figure 4.5   Immunofluorescence staining of basement membrane proteins. Presence of 
collagen IV, collagen VII and laminin 332 in foetal (A, C, E) and adult epidermis (B, D, F).  
 






































































































Stem Cell-Associated Markers 
K15 is a specific basal cell component of the epidermis and seems to be completely 
restricted to the basal cell layer of stratified squamous epithelia (Lyle et al., 1998). 
Antibody against K15 detects putative stem cells residing in the hair follicle bulge and 
thus might be used as a stem cell marker in hair follicle biology (Lyle et al., 1998). To 
study the expression of K15 in foetal skin, sections were stained with antibodies 
directed against K15. K15 was detected in the basal layer of foetal epidermis, but not 
in the periderm. The hair follicle bulge of the foetal skin was also stained positive for 
K15 (Figure 4.7).  
K19 was also reported to be expressed in the bulge region of the hair follicle. 
In adults, K19-expressing cells are absent from the interfollicular epidermis in hair-
bearing skin but are present in many specific locations in simple and stratified 
epithelial tissues, including oral epithelia, ductal epithelia, and nipple skin (Stasiak et 
al., 1989), and has been suggested to be associated with progenitor populations 
(Michel et al., 1996; Lane et al., 1991). Foetal epidermis expresses K19 (Figure 4.7). 
K19 was strongly stained in the basal layer and in the periderm, but weakly stained in 
the outer root sheath of the hair follicle. K19 was not detected in the adult epidermis, 
but present in the hair follicle. 
The skin is constantly replenished with new cells produced by stem cells. One 
of the genes that is vital for maintaining epithelial stem cells is p63 which thus 
provides an excellent marker for locating these cells in the epidermal layer of skin. In 
all the layers of skin during development, p63 staining was detected in the nuclei of 
epidermal cells, more so in the basal cells in both foetal and adult epidermis (Figure 
4.7). Dermal tissue, however, did not contain any individual p63-positive cells. 






Lamin B, a type V intermediate filament which provides functional support in the cell 
nucleus was examined in foetal and adult skin. Lamin B was present in every cell, but 
foetal fibroblasts have a higher expression than foetal keratinocytes (Figure 4.8). In 
adults, the expression is evenly distributed. 
The presence of blood vessels during foetal skin development was examined 
by the expression of CD31 and α-smooth muscle actin (SMA). Blood vessels were 
visible in the foetal skin at week 14 (Figure 4.9), indicating the skin is well-
vascularized at this point of time. 
  






















































































































Figure 4.8   Immunofluorescence staining of Lamin B.  
 
Figure 4.9   Immunostaining of blood vessels. Presence of blood vessels in 14 week 
gestation foetal skin stained with CD31 and α-smooth muscle actin (SMA). 
 





Table 4.2   Immunohistochemical staining of various markers in foetal and adult skin. 
Marker Foetal Skin  Adult Skin Clone 
Keratins  
K14  ++ (basal); + (follicle) ++ LL001 
K18 ++ (basal); ++ (periderm);  
++ (follicle)  
– LDK18 




K10  ++ (suprabasal);  
+ (periderm) 
++ (suprabasal) LH1 
Involucrin  ++ (suprabasal);  
++ (periderm) 
++ (suprabasal) SY5 
Filaggrin + (suprabasal) ++ (suprabasal) 15C10 
Basement membrane proteins  
Collagen IV  ++ (BM); ++ (bl vessels) ++ (BM);  
++ (bl vessels) 
PHM12 
Collagen VII  ++ (BM) ++ (BM) LH7.2 
Laminin 332  ++ (BM) ++ (BM)  D4B5 
Extracellular matrix proteins  
Fibronectin  ++ (pap dermis);  
+ (ret dermis) 
+ (dermis) 568 
Intermediate filament proteins in connective tissue  
Vimentin  ++ (dermis) + (dermis) V9 
Stem cell-associated markers  
K15  ++ (basal);  + (follicle) +  LHK15 
K19  ++ (basal); ++ (periderm); 
+ (follicle) 
– (basal); + (follicle) LP2K 
p63  ++ (epidermal nuclei) ++ (epidermal nuclei) 4A4 






Lamin B ++ (nuclei) ++ (nuclei) LN43 
CD31 ++ (bl vessels) ++ (bl vessels) Polyclonal 
α-smooth muscle actin ++ (bl vessels) ++ (bl vessels) 1A4 
BM: basement membrane; bl: blood; pap: papillary; ret: reticular 
  






The work in this chapter has presented a systematic overview of the differences 
between adult and foetal skin composition, by assessing  protein expression profiles 
of different epidermal and dermal components in the foetal dorsal skin between 13 
and 24 weeks’ gestation.  
Human foetal skin was reported to have a higher ratio of type III to type I 
collagen (Smith et al., 1986). Herovici’s stain is capable of distinguishing between 
types I and III collagen (Herovici, 1963; Levame & Meyer, 1987), where the thick 
and coarser fibres (type I collagen) stain pink than those fine fibres (type III collagen) 
which stain blue. By using Herovici’s stain, the differences in collagen composition 
between foetal and adult dermis can be observed under light microscope. As 
fibroblasts are the principle source of collagen, the differences in collagen profiles 
may be partially explained by the different gene expression of foetal and adult 
fibroblasts. 
Compared to haematoxylin and eosin (H&E) staining, Herovici’s staining 
provides more information about composition of connective tissue in terms of 
collagen distribution. It is possible to perform immunostaining using antibodies 
specific to different components of the extracellular matrix, but this technique often 
requires frozen sections, more time consuming, more expensive, and fraught with 
non-specific staining and variability when multiple antibodies are used. To date, this 
is the first report of using Herovici’s staining on human foetal skin to analyze the 
extracellular matrix composition of collagen, although a variation of this staining was 
performed on foetal sheep skin (Cuttle et al., 2005). Furthermore, Herovici’s staining 
can be used to evaluate scar tissue formation, as scar tissue architecture involves 





changes in collagen fibre alignment, collagen fibre diameter as well as tissue 
cellularity. 
This study showed that the expression patterns of some epidermal and dermal 
proteins were different in the human foetal skin than in adult skin. K18, K17, and K19 
were prominent components in the foetal epidermis. The foetal dermis expressed 
more fibronectin as well as vimentin, due to relatively abundant fibroblasts compared 
to adult dermis. The expression profiles of epidermal differentiation markers, 
basement membrane proteins, and blood vessels were similar in the human foetal skin 
and adult skin.  
The purpose of this study was to relate morphologic changes of the skin to 
biochemical changes in the structural proteins during development, as well as to 
confirm previous data and to be sure that the techniques used here are robust to and 
reproducible. In this study, the expression pattern of some proteins was comparable to 
previous reports. Similar to previous studies, K14 is present in the basal layer and 
K10 is visible in the suprabasal layers (Dale et al., 1985; Loureno et al., 2008; Coolen 
et al., 2010). Involucrin was also expressed in suprabasal layers and periderm during 
foetal development, similar to Lee et al. and Akiyama et al. (Lee et al., 1999; 
Akiyama et al., 1999), thus showing that foetal keratinocytes are capable of 
differentiation as early as 13 weeks in vivo.  
Some results that have been presented also differed with respect to the location 
and timing of the expression of various proteins, possibly due to body site differences 
which are harvested for analysis. For instance, the limbs (Dale et al., 1985; Coolen et 
al., 2010) and trunk (Moll et al., 1982c) may have different stage of development. 
Lourenço et al. (Loureno et al., 2008) only found presence of involucrin in the 





periderm of foetal skin, but not in the suprabasal layers. As the foetal skin specimens 
were collected from several regions of the body, differences in biopsy location may 
explain this inconsistency. In this study, the evaluation of various protein expression 
was performed on foetal dorsal skin, while another study performed on foetal limb 
skin (Coolen et al., 2010). Dale et al. also performed an extensive evaluation of 
keratin expression in human foetal skin, (Dale et al., 1985), but most of the antibodies 
were broad spectrum antibodies toward keratins.   
The findings that basement membrane proteins and blood vessels were found 
in the foetal skin is consistent with previous studies (Fine et al., 1984; Hentula et al., 
2001; Johnson & Holbrook, 1989; Hertle et al., 1991). Fibronectin was more 
abundantly present in the foetal dermis than in adult dermis. Both collagen 
composition and fibronectin were different in foetal skin than adult skin. The different 
extracellular matrix composition may affect cell phenotype and behaviour, as studies 
show that the extracellular matrix provides signalling cues that regulate fibroblast 
functions, such as proliferation and migration during wound healing and homeostasis 
(Eckes et al., 1999; Lukashev & Werb, 1998). The extracellular matrix is also 
important in the formation of the appendages and influences terminal differentiation 
of keratinocytes (Jones & Jones, 2000; Agren et al., 1997). Therefore, it is also 
possible that extracellular matrix molecules play an important role in foetal scarless 
healing.  
K15, K19 and p63 in some situations are associated with stem cells (Lyle et al., 
1998; Poblet et al., 2006; Lane et al., 1991; Michel et al., 1996; Koster & Roop, 2004; 
Pellegrini et al., 2001). K19 is expressed in the foetal epidermis, and not in adults. 
The expression of K18 and K19 in foetal epidermis suggests that the epidermis is 





perhaps derived from the simple epithelial layer and was phased after development. It 
was reported that mRNA expression of K15 in basal cells is downregulated in 
organotypic cultures, hyperproliferation or upon wounding, suggesting that K15 
expression is not compatible keratinocyte activation and is downregulated to maintain 
the activated phenotype (Waseem et al., 1999). The continuous staining of K15 on 
foetal epidermis may also suggest that this keratin may be important for keratinocytes 
growth and differentiation. p63 was proposed to function in the maintenance of stem 
cells populations (Senoo et al., 2007; Yang et al., 1999). In both foetal and adult skin, 
p63 was stained in all of the epidermal cells, mostly in basal cells. As p63 has 
alternatively spliced isoforms, differences in p63 isoform expression patterns may 
reflect different functions of the proteins. 
Early gestation foetal skin has the unique ability to heal wounds without the 
formation of a scar. Since the the ability to heal skin wounds without a scar is intrinsic 
to foetal skin rather than the in utero environment , the constitution of foetal skin may 
be important in scarless healing (Armstrong & Ferguson, 1995; Longaker et al., 1994). 
Therefore, knowledge of the expression profiles and the components of foetal skin 
may contribute to the understanding of foetal wound healing biology as well as clues 
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ISOLATION AND CULTURE TECHNIQUES: IN VITRO 
CHARACTERIZATION OF FOETAL SKIN CELLS 
 
5.1 INTRODUCTION 
Studies on the development of foetal skin cell transplantation therapies require 
isolation and culture of foetal keratinocytes and fibroblasts. Foetal skin has been 
characterized and described in vivo in the literature, but were less studied in vitro. 
Furthermore, there were no established methods for isolating human foetal 
keratinocytes in the literature. This chapter aims to establish isolation techniques for 
the routine culture of foetal keratinocytes, applicable to all gestational ages used in 
serum-free medium, as well as characterization of these cells.  
Epidermal cells can be grown and studied in tissue culture because of the 
improvement in our understanding of the distinct culture requirements and the 
progress made in cell culture technology. Early attempts at keratinocyte culture 
involving organ culture resulted in contamination by ﬁbroblast growth while  attempts 
in culturing disaggregated epidermal keratinocytes showed that the cultures grew only 
to a limited extent and could not be subcultured satisfactorily (Prose et al., 1967; 
Cruickshank et al., 1960; Briggaman et al., 1967; Karasek & Charlton, 1971). The 
deficiency of keratinocyte growth in vitro is due to the absence of mesenchymal 
influences. Attempts to study the influence of mesenchymal cells on epidermal cells 
led to the development of the feeder-layer co-culture method of expanding primary 
keratinocytes developed by Rheinwald and Green (Rheinwald & Green, 1975), which 





led to successful in vitro studies on keratinocytes and are now accepted as state-of-
the-art. Rheinwald and Green demonstrated that a feeder layer of irradiated mouse 
embryonic connective tissue fibroblast cells which were rendered post-mitotic 
permitted the clonal growth of keratinocytes but not other cell types. These feeder 
cells were still functionally competent and were able to upregulate growth factors 
necessary for keratinocyte proliferation. Subsequently, this led to the development of 
serum-free culture media wherein keratinocytes could grow without a requirement for 
the mouse feeder cells (Maciag et al., 1981; Boyce & Ham, 1983). The relative merits 
of these systems are listed in Table 5.1. One of the most widespread uses for human 
keratinocyte cultures has been in the treatment of burns and skin ulcers with sheets of 
epithelial autografts (Compton et al., 1989; Límová & Mauro, 1995), proving that 
keratinocyte culture to be valuable for clinical applications. 
Table 5.1   Comparison of keratinocyte culture methods 
Culture method  Advantages  Disadvantages  
Serum-Free 
Medium 
• Straightforward procedure  
• Low contamination of 
fibroblasts  
• Easy trypsination  
• Low risks of cross species 
contamination  
• Higher plating density (at least 
2,000/cm2)  
• Smaller expansion of cell 
numbers, shorter culture 
lifespan 
• Costly media  
3T3 Feeder 
Layer  
• Lower plating density 
• Larger expansion of cell 
numbers, longer culture 
lifespan 
• More physiological signalling 
from paracrine growth factors 
secreted by feeder layer  
• Lengthy and tedious procedure 
• Undefined growth factors from 
serum and 3T3  
• Tedious preparation of medium 
• Costly and hazardous reagents 
and supplements required 
(cholera toxin) 
• Risks of cross species 
contamination with mouse 
viruses or genetic material 
• Difficulty in complete removal 
of feeder cells for analysis  





Cultured primary keratinocytes proliferate very fast in vitro and are most 
likely to be in a state of regeneration rather than in the homeostatic steady state 
observed in vivo. Keratinocytes from the epidermis express stable and abundant 
keratins characteristic of the tissue from which they were derived, which are ideal for 
use as markers in the characterization of cultured epithelial cells and for observing 
cell differentiation, as they can be readily detected immunologically. Many 
monoclonal antibodies against keratins are available, and some of them react 
speciﬁcally with stratifying epithelial cells, which are true keratinocytes (Lane, 1982; 
Woodcock-Mitchell et al., 1982). However, the expression of some keratins is not 
seen at all (Sun & Green, 1978), and the expression of certain keratins can be altered 
in vitro. To confirm which markers could be used to define cultured human foetal 
keratinocytes in a basal state and during differentiation, cultured foetal keratinocytes 
were characterized and their keratin expression is examined in this chapter. 
  






5.2.1 Establishing Isolation Techniques for Foetal Keratinocytes and Foetal 
Fibroblasts 
Characterization and manipulation of foetal skin cells requires robust methods for 
isolating viable cells and in vitro culture. Both epidermal keratinocytes and dermal 
fibroblasts can be cultured separately from adult and foetal skin (Figure 5.1). The 
method used for extracting keratinocytes from adult skin is detailed in Chapter 3 
Materials and Methods. Briefly, to isolate adult keratinocytes, skin was treated with 
dispase at 4oC overnight followed by separating the epidermis from dermis. The 
peeled epidermis was incubated with 0.125% trypsin for 20 min and the cell 
suspension centrifuged and seeded on tissue culture flasks. Adult fibroblasts were 
isolated using the explant method for outgrowth of cells. 
Foetal skin is relatively more sterile than adult skin because the foetus is not 
exposed to the external environment. Hence, extensive washing with ethanol or 
sodium hypochlorite was not needed. After washing with 1× PBS, foetal skin was 
incubated with 4× antimycotic/antibiotic solution for 20 min. As the developing skin 
is rather thin, the epidermis is difficult to be separated from the dermis. Therefore, the 
skin was cut into small pieces (less than 1 mm2) and incubated with 10× TrypLE™ 
Select at 4oC overnight (Figure 5.1). TrypLE™ is a purified, animal origin-free cell 
dissociation enzyme that is gentle on cells, without requiring inactivation with trypsin 
inhibitors or serum. 10× TrypLE™ Select was used for stronger dissociation of 
keratinocytes from the epidermis.  
  






Figure 5.1   Isolation and culture of foetal keratinocytes in serum-free medium. (A) 
Incubation of skin in antimycotic/antibiotic. (B) Skin is cut into small pieces and incubated 
with trypsin. (C) Filtration to obtain single cell suspension. Isolated cells can be cultured in 
(D) serum-free keratinocyte media, (E) complete RM+ media, or (F) co-cultured with 
irradiated 3T3 murine fibroblasts. (G) Removal of contaminating fibroblasts in serum-free 
media. The serum-free method of culture was adopted in all the experiments. (H) Confluent 
keratinocytes in serum-free media. All phase contrast images were taken at 4× objective. 





After filtering and centrifuging to obtain single a cell suspension, the cells 
were seeded onto gelatin-coated tissue culture dishes containing keratinocyte serum-
free medium to establish keratinocyte cultures. 0.1% gelatin solution, which is 
denatured type I collagen, was used to coat cell culture flasks for at least 30 min or 
overnight at 37oC to improve cell attachment for primary keratinocytes. For foetal 
skin less than 18 weeks, this helped the cells to attach onto flasks. Fibroblast 
overgrowth was a common problem but was avoided by treating cultures with 0.02% 
EDTA for 5 min, or with dilute TrypLE™ select (33% activity) for 1 min, as 
fibroblasts detach first before keratinocytes. Depending on donor and the size of the 
biopsy, keratinocyte colonies could be seen from 4 days to 14 days in a 25 cm2 
surface area.  
Keratinocytes could also be cultured as single cells in serum-containing RM+ 
media (see Materials and Methods), in which case foetal fibroblasts act as feeders to 
support keratinocyte growth (Figure 5.1E). However, this isolation method is not 
selective for keratinocytes, as fibroblasts tend to overgrow due to the enriched media-
containing serum which supports fibroblast growth and attachment. Complete RM+ 
media does not support the growth of keratinocytes without fibroblasts as feeders. 
Nevertheless, the use of this medium does result in a better yield of keratinocytes in 
culture after isolation. Isolated foetal keratinocytes can also be co-cultured with 
irradiated 3T3 Swiss mouse fibroblasts (Figure 5.1F). When there is only limited 
tissue available, explant cultures may sometimes be more effective, since there is less 
chance for cell loss in trypsinization and centrifugation. However, foetal skin explants 
were difficult to be established, using this method. The most important aspect is 
attachment of the tissue fragment to the dish. Furthermore, cells derived from the 
explants were not homogeneous and fibroblastic outgrowth was often obtained. 





To establish foetal fibroblast cultures, the cell suspension was cultured using 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% serum. Foetal 
fibroblasts were much easier to establish in cultures as they have much greater cell 
growth rate, achieving confluence in a T75 flask within 1 – 2 weeks. In addition, they 
do not require much manipulation. 
5.2.2 Morphology of Foetal Keratinocytes and Foetal Fibroblasts 
Morphologically, when foetal keratinocytes are cultured in the same media as adult 
keratinocytes, they show the same characteristic tight pavement-like appearance of 
cells in colonies as the adult cells but they are of significantly smaller size (Figure 
5.2). Foetal keratinocytes can be passaged in serum-free medium more times (9 to 11 
passages) than adult keratinocytes (6-8 passages) without showing senescence, 
although they still do not have a capacity for high passage numbers. Over this period, 
a minority of cells became larger, resembling terminally differentiated cells but some 
retained a small, undifferentiated, and tightly packed morphology.  
Foetal fibroblasts resembled adult fibroblasts in their growth patterns, and 
were spindle-shaped, as well as showing a typical “fingerprint” whorl at confluence. 
5.2.3 Cell Size Measurements of Foetal Keratinocytes 
The cell sizes of foetal keratinocytes and adult keratinocytes were measured and 
determined using Scepter Automated Cell Counter (Merck Millipore, Billerica, MA, 
USA) which uses the Coulter principle of impedance-based particle detection. Cells 
were cultured in serum-free medium and then measured at P4, and the average cell 
size was recorded. Foetal keratinocytes had an average cell diameter of 16.7 ± 0.06 
µm compared to adult keratinocytes with an average cell diameter of 20.81 ± 0.56 µm.  






Figure 5.3   Foetal keratinocytes are smaller in size compared to adult 
keratinocytes. (A) Average cell diameter of foetal and adult keratinocytes at P4 
cultured in serum-free medium. (B) Average cell volume of foetal and adult 
keratinocytes at P4 cultured in serum-free medium 
Figure 5.2   Morphology of cultured foetal keratinocytes and fibroblasts. Panels (A-
D) are phase contrast photomicrographs of foetal keratinocytes (A), adult keratinocytes 
(B), foetal fibroblasts (C), and adult fibroblasts (D). Phase contrast images were taken at 
4× (A, B) and 10× (C, D) objective. 
 
 





The average cell volume for foetal keratinocytes was 2.42 ± 0.03 pL while the 
average cell volume for adult keratinocytes was 4.74 ± 0.39 pL. 
5.2.4 Optimization of Serum-free Methods for Keratinocyte Culture 
To determine the optimal serum-free media for keratinocyte culture, different 
commercial media were analyzed. Four commercial serum-free media were evaluated: 
CnT-57 (CELLnTEC), DermaLife (Lifeline Cell Technology), EpiGRO (Merck 
Millipore), and Keratinocyte Serum Free Medium (KSFM) (Life Technologies). 
Table 5.2 lists the comparison between the components of the different keratinocyte 
serum-free media. 
Figure 5.4 shows the morphology of keratinocytes in different serum-free 
media. The morphology of the keratinocytes was similar in all tested serum-free 
media, with the exception that cells were more compact in KSFM. Comparing CnT-
57 and DermaLife, Dermalife formed more colonies at P0, although there was more 
fibroblast growth in DermaLife, probably because it might be more enriched. When 
subcultured, cells cultured in DermaLife became confluent faster at same seeding 
density (P1), even when the culture medium was switched from CnT-57 to DermaLife 
at P1.  
Figure 5.5 and 5.6 show the growth curves for foetal keratinocytes (16 wk, P3) 
and adult keratinocytes (P3) cultured in different media. A real-time cell analyzer 
(xCELLigence, Roche Diagnostics) was used to evaluate keratinocyte proliferation. 
Population doubling times were derived from the exponential phase of the growth 
curves. Foetal keratinocytes cultured in DermaLife have a shorter doubling time, thus 
proliferating faster compared to CnT-57 and KSFM (** p < 0.01) (Figure 5.5). The 





doubling times of DermaLife and EpiGRO were not significant. Similarly, adult 
keratinocytes cultured in DermaLife have a shorter doubling time compared to CnT-
57 and KSFM (* p < 0.05) (Figure 5.6). However, there were no significant 
differences between DermaLife and EpiGRO.  
The colony forming ability of foetal and adult keratinocytes was demonstrated 
for different serum-free media. 1000 cells were seeded onto 60 mm dish and assessed 
after 10, 14, and 18 days. There were more colonies formed when foetal keratinocytes 
(16 wk, P4) were cultured in DermaLife or EpiGRO compared to CnT-57 and KSFM 
after 10, 14 and 18 days in culture (Figure 5.7). On the other hand, adult keratinocytes 
cultured in EpiGRO showed a better colony forming ability compared to the rest 
(Figure 5.8). Thus because DermaLife was observed to support better growth and 
proliferation of both foetal and adult keratinocytes, this medium was selected for use 
in all subsequent experiments. 
  
















Supplement A  L-Glutamine L-Glutamine EGF 
Supplement B  Extract P™ EpiFactor P  BPE 
Supplement C  Epinephrine  Epinephrine   
Bovine Pituitary 
Extract (BPE)  






 Insulin  Insulin   
 Apo-Transferrin  Apo-Transferrin   
Table 5.2   Comparison between components of different keratinocyte serum-free media. 
Figure 5.4   Phase contrast light microscopy images of keratinocyte cultures in 
different serum-free keratinocyte media. All phase contrast images were taken at 4× 
objective. 
 



























































































































































































































































































































































































































































































































































Figure 5.7   Colony forming ability of foetal keratinocytes in different media. 1000 cells 
from the same foetal donor were seeded at passage 4 into a 60 mm dish. Colony formation 
was assessed after 10, 14, and 18 days in culture. More colonies were observed in 
DermaLife and EpiGRO serum-free media. 
 






Figure 5.8   Colony forming ability of adult keratinocytes in different media. 1000 cells 
from the same adult donor were seeded at passage 4 into a 60 mm dish. Colony formation 
was assessed after 10, 14, and 18 days in culture.  
 





5.2.5 Immunocytochemical Staining Analyses of Cultured Foetal Keratinocytes 
Primary cultured cells from epithelial tissues express keratin patterns similar to the 
tissue from which they were derived. Keratins are relatively abundant, stable and are 
readily detected immunologically, hence they are ideal for use as markers in the 
characterization of cultured keratinocytes. Figures 5.9-5.14 show the characterization 
of cultured foetal keratinocytes (from dorsal skin at 17-22 weeks gestational age) and 
their comparison with adult keratinocytes using monoclonal antibodies to keratins in 
indirect immunofluorescence. 
 K14 is expressed in basal keratinocytes and together with K5 form the primary 
keratin pair of the keratinocytes of stratified squamous epithelia. As with adult 
keratinocytes, foetal keratinocytes all express K14 (Figure 5.9). 
 K18 is co-expressed with K8 in simple epithelial cells, and these two are the 
first keratins to appear in embryogenesis, and are seen even in pre-implantation 
embryos (Jackson et al., 1980). K18 was strongly expressed in foetal keratinocytes 
(17-22 wk), but was not detected in adult keratinocytes. K18 may therefore be used to 
identify foetal keratinocytes (17-22 wk) from adult keratinocytes. 
 K19 is expressed in most simple epithelia and in some situations can be used 
as a stem cell associated marker. Foetal keratinocytes showed higher expression of 
K19 compared to adult keratinocytes. 
 K17 is a stress response protein that is inducible after skin injury. Keratins K6, 
K16 and K17 are switched on in regenerating and migrating epidermal keratinocytes 
upon wound healing. K17 is also expressed in cultured epidermal cells (Paladini et al., 





1996). In both cultured foetal and adult keratinocytes, K17 was expressed 
ubiquitously here. 
 K15 expression appears after confluence in adult keratinocytes. In the culture 
conditions used here, K15 was not expressed in cultured foetal keratinocytes although 
the antibody used detected K15 in the interfollicular epidermis and the hair follicle 
bulge in foetal skin at 14-22 weeks (refer to Figure 4.7). 
 In tissue culture, the foetal keratinocytes showed higher expression of K7 with 
more cells stained than adult keratinocytes, and may also be used to identify foetal 
keratinocytes. 
Table 5.3   Immunohistochemical markers in cultured foetal (from 17-22 wk dorsal 
skin) versus adult skin. 
Marker Foetal Keratinocytes  Adult Keratinocytes Clone 
K14  ++ ++ LL001 
K18 ++  – LDK18 
K19  + + LP2K 
K17  ++ ++ E3 
K15  – – LHK15 
K7 ++ + OV-TL 12/30 
++: abundant positive cells; +: positive cells consistently present; +: occasional few positive 
cells; –: no expression 
 
  






Figure 5.9   Expression of K14 in cultured foetal (A, B, C) and adult keratinocytes 
(D), seen at P5 grown to 80% - 100% confluence. 
 






Figure 5.10   Expression of K18 in cultured foetal (A, B, C) and adult keratinocytes 
(D), seen at P5 grown to 80% - 100% confluence. K18 was strongly expressed in 
foetal keratinocytes. 






Figure 5.11   Expression of K19 in cultured foetal (A, B, C) and adult keratinocytes 
(D), seen at P5 grown to 80% - 100% confluence. Foetal keratinocytes show higher 
expression of K19. 






Figure 5.12   Expression of K17 in cultured foetal (A, B, C) and adult keratinocytes 
(D), seen at P5 grown to 80% - 100% confluence. K17 was expressed in both foetal 
and adult keratinocytes. 






Figure 5.13   Expression of K15 in cultured foetal (A, B, C) and adult keratinocytes 
(D), seen at P5 grown to 80% - 100% confluence. 






Figure 5.14   Expression of K7 in cultured foetal (A) and adult keratinocytes (B), seen 
at P5 grown to 80% - 100% confluence. Foetal keratinocytes showed higher 
expression of K7. 





5.2.6 Karyotyping of Cultured Foetal Keratinocytes 
Karyotype analysis of adult and foetal cell cultures was carried out after 3 passages in 
culture. These assays were carried out by the Human Genetics Lab at the Genome 
Institute of Singapore, A*STAR.  
The karyotype of foetal cultures at P3 to P7 was observed to be normal, i.e. 46 
XX or 46 XY, and did not show any gross karyotypic abnormalities (Figure 5.15) as 
determined by G-banding. Chromosome complement remained normal as far as P7 in 
all foetal keratinocyte cultures tested. 
  






Figure 5.15   Foetal keratinocytes maintain normal karyotype after serial passaging. 
Karyotype analysis by G-banding was performed for different foetal keratinocyte cultures. 
Chromosome complement remained normal as far as P7 in all foetal ages tested. 






Cultured human keratinocytes have many potential clinical applications, but there is a 
major need to reduce the risks for patients receiving cultured cells. For patients that 
require cultured grafts, a reliable xenobiotic-free keratinocyte culture system that is 
able to obtain regulatory body approval is needed. Dermal substitutes that present 
lower risks to skin grafted patients than bovine collagen or allogeneic human dermis 
are also needed. The most frequent and common culture methodology for 
keratinocytes uses both mouse 3T3 fibroblasts and bovine serum (Rheinwald & Green, 
1975; Rheinwald & Green, 1977), raising concerns over the potential introduction of 
xenobiotic viruses and prion diseases. Although mouse feeder fibroblasts are 
subjected to lethal gamma radiation to reduce risk and serum is sourced from 
countries free from bovine spongiform encephalitis (BSE), the risks still remain. 
Furthermore if BSE spreads worldwide, serum-free media will become a necessity. 
Therefore, in order for foetal keratinocytes to be used clinically, a serum-free culture 
system that is independent of mouse feeder fibroblasts is required. 
There are a few records of human foetal keratinocyte culture in the current 
literature, with four groups reported growing human foetal keratinocytes in serum-
free medium (Haake & Lane, 1989; Oliver, 1990; Zhou et al., 2004; De et al., 2006), 
with a group reported having cultured up to P5. These cultured foetal keratinocytes 
were not completely characterized. While this thesis was being written, one group 
reported epidermal cell isolation methods that allowed 6 to 9 weeks culture of human 
foetal skin (Johnen et al., 2012). Other studies of foetal keratinocytes have been 
performed on animals. There could be a number of reasons for the relatively few 
studies in human foetal keratinocytes. Foetal cell research is not supported by 





government funding sources in some countries due to ethical concerns, hence limiting 
progress in the field. Furthermore, there are several limitations to isolating and 
growing foetal keratinocytes. Manipulation of foetal epidermis is difficult, as both 
epidermis and dermis are extremely fragile. Although the growth requirements of 
adult keratinocytes are well established, the conditions under which foetal 
keratinocytes have been cultured are most likely suboptimal due to lack of studies. 
Banks-Schlegel reported that rabbit foetal keratinocytes could be cultivated from 
explants, but keratinocyte cell suspensions did not yield keratinocyte colonies, 
presumably due to a failure of cell attachment (Banks-Schlegel, 1982).  
The cell suspensions generated from foetal skin contain keratinocytes but also 
dermal ﬁbroblasts as well as melanocytes, Merkel cells , and Langerhans cells. The 
ﬁbroblasts represent the most serious source of contamination of the keratinocyte 
cultures; melanocytes do not proliferate unless special culture conditions are used, and 
Merkel cells and Langerhans cells do not survive in culture (Naeyaert et al., 1991; 
Halaban et al., 1988; Halaban et al., 1987). Keratinocytes that are relatively small in 
size are attributed to progenitor cells that can form a rapidly growing clone 
(Barrandon & Green, 1985). Given that the average size of foetal keratinocytes is 
smaller than average adult keratinocytes, foetal keratinocytes may contain more 
progenitor cells, thus forming more proliferative clones with increased rate of 
multiplication. 
Comparison between different serum-free medium showed that DermaLife 
serum-free medium supports better foetal keratinocyte growth and proliferation. There 
were more colonies formed at isolation and cells became more confluent faster after 
subculture. Keratinocytes grown in DermaLife showed much better growth curve and 





more colonies were formed consistently. There was no significant difference in 
proliferation for keratinocytes grown in Dermalife and Epigro, as measured by the 
doubling time and colonies formed. As the components for both products are similar 
(Table 5.2), it is suggested that both media can be used for keratinocyte culture 
without degradation of quality. 
Cells cultured from foetal epidermis expressed K14, K18, K19, K17, similar 
to the pattern of expression of foetal basal keratinocytes in vivo. Thus some facets of 
the foetal keratinocyte in vivo phenotype are maintained in vitro. K17 is expressed in 
adult cultured keratinocytes, but not in the epidermis of adult skin, probably due to an 
‘activated’ phenotype in cultured keratinocytes. K7 was recently suggested to be 
associated with stem cells in other epithelia (Wang et al., 2011; Herfs et al., 2012), 
and is expressed in many internal tissues including foetal intestinal epithelia and 
cervical epithelia (Glass & Fuchs, 1988; Smith et al., 2002; van et al., 1991). K7 had 
a higher expression in foetal keratinocytes than adult keratinocytes, suggesting that 
foetal keratinocytes may have a higher pool of progenitor cells. 
Karyotyping analysis showed that the chromosomes of foetal keratinocytes 
remain stable after serial passaging, suggesting that it is possible to use these cells for 
therapeutic applications or transplantation. 
In conclusion, the work in this chapter has demonstrated that second trimester 
foetal keratinocytes can be stably and successfully cultured in vitro, whilst 
maintaining their normal phenotype and karyotype. Foetal keratinocytes are 
significantly smaller than adult keratinocytes, and can be further distinguished from 
their adult counterparts by foetal expression of simple epithelial keratins K18 (and 
probably K8), and more K7 and K19, than adult cells. The results presented here 





show that foetal keratinocyte growth without mouse feeder cells can be enhanced by 
culturing in DermaLife or EpiGRO commercial serum-free media. The evidence for 
greater growth potential of the foetal skin cells will be analyzed in more detail in the 
next chapter. As there is considerable therapeutic potential for foetal keratinocytes 
with their capacity for regeneration, results presented here support the possibility of 
cell-based therapy development for wound repair and regeneration. Future studies on 


















PROLIFERATION AND DIFFERENTIATION STUDIES 
 
6.1 INTRODUCTION 
Cell therapy strategies require the cell source to be endowed with high proliferative 
potential for high expansion and regeneration. In skin tissue engineering, this requires 
the cells to be able to differentiate and forming a functional barrier. This chapter aims 
to evaluate the proliferation and differentiation potential of foetal keratinocytes and 
compare them with adult keratinocytes, as well as exploring the possibility of using 
foetal skin cells to generate bioengineered skin. 
Although keratinocytes in monolayer culture have some ability to differentiate, 
the process is always incomplete and differentiation is compromised as properly 
stratiﬁed and cornified epithelia are not formed. Keratinocytes will be able to develop 
well-ordered epithelia only in three-dimensional in vitro culture systems, or in 
transplantation assays in vivo. To study epidermal differentiation in culture, 
organotypic co-cultures systems consisting of keratinocytes and fibroblasts are used. 
The keratinocyte differentiation program can best be observed by culturing the 
keratinocytes on fibroblast-embedded collagen gels until they become conﬂ uent, and 
then the collagen matrix with the keratinocytes is raised, so that the medium feeds the 
conﬂuent culture with growth factors and nutrients through the collagen at the bottom. 
It has been demonstrated that using this system, an essentially complete 
differentiation program is effected, and all the normal epidermal layers are generated 
in the epithelium (Asselineau et al., 1985; Kopan et al., 1987).  






6.2.1 Expression of Proliferation Markers of Foetal Skin Sections 
Ki67, a widely accepted marker for proliferation (Schlüter et al., 1993), was used to 
assess the spatial and temporal distribution of proliferating cells within the developing 
skin (Figure 6.1A). Ki67 antigen expression was identified in the nuclei of cells 
across the entire foetal skin, in the interfollicular epidermis and dermis. In older 
specimens (above 15 week), Ki67 immunoreactivity was concentrated in placodes, 
where hair pegs start to form.  Ki67 stained basal and suprabasal layers of the 
epidermis. There were more positive stained cells in the foetal dermis than in adult 
dermis. Fibroblasts are usually quiescent in adult skin in vivo, but in foetal skin, 
fibroblasts were seen to be proliferating in the dermis of foetal skin. 
6.2.2 Determination of the Ki67 Growth Fraction in Foetal Skin In Situ 
Ki67 staining was semi-quantitatively expressed as a proliferation index (PI), shown 
in Figure 6.1. As cell production in the epidermis arise from the basal layer of 
keratinocytes, only basal cells which were positive for Ki67 were counted. The 
sections used were all normal without any underlying diseases. The PI is calculated as 
the number of Ki67-positive basal cells divided by the total number of basal cells × 
100%. Cells were counted at the light-microscopic level (magnification 630×) at five 
random non-overlapping regions in each section. The resulting values are expressed 
as the mean PI of each gestational age. Proliferation Indices on tissue sections were 
calculated using the equation provided below: 
𝑷𝒓𝒐𝒍𝒊𝒇𝒆𝒓𝒂𝒕𝒊𝒐𝒏 𝑰𝒏𝒅𝒆𝒙 =  𝑵𝒐 𝒐𝒇 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆𝒍𝒚 𝒍𝒂𝒃𝒆𝒍𝒆𝒅 𝒄𝒆𝒍𝒍𝒔 𝒂𝒍𝒐𝒏𝒈 𝒃𝒂𝒔𝒆𝒎𝒆𝒏𝒕 𝒎𝒆𝒎𝒃𝒓𝒂𝒏𝒆
𝑻𝒐𝒕𝒂𝒍 𝒏𝒐 𝒐𝒇 𝒃𝒂𝒔𝒂𝒍 𝒄𝒆𝒍𝒍𝒔 𝒄𝒐𝒖𝒏𝒕𝒆𝒅 𝒂𝒍𝒐𝒏𝒈 𝒃𝒂𝒔𝒆𝒎𝒆𝒏𝒕 𝒎𝒆𝒎𝒃𝒓𝒂𝒏𝒆 × 𝟏𝟎𝟎% 
  






Figure 6.1   Proliferation index in the foetal and adult epidermis. (A) 
Immunoperoxidase staining of Ki-67 on human foetal skin sections. (B) The proliferation 
index (PI) was defined as the number of Ki67-positive cells at the basal layer divided by 
the total number of cells at the basal layer × 100%. 
 





Inclusion of hair placodes was avoided in the calculation of PI as this gave 
overestimated values because of the focal high density of Ki67-positive cells. 
Tabulated data show that the percentage of Ki67-expressing cells at the basal layer 
declined with increasing gestational age.  
6.2.3 Growth Curves and Population Doubling Times of Foetal Keratinocytes 
The proliferation rate of foetal keratinocytes of different gestational ages was 
compared to that of adult keratinocytes. A real-time cell analyzer (xCELLigence, 
Roche Diagnostics) was used to evaluate the proliferation of foetal and adult 
keratinocytes (Figure 6.2). Growth curves of foetal and adult keratinocytes have a 
sigmoidal shape, with foetal keratinocytes having a shorter lag phase after plating 
than adult keratinocytes. In addition, foetal keratinocytes have a steeper gradient 
during the exponential phase of growth. Population doubling times were derived from 
the exponential phase of the each growth curves (Figure 6.3A). The average 
population time for foetal keratinocytes was between 20 and 40 hours whist adult 
keratinocytes was between 40 to 60 hours. This demonstrates that foetal keratinocytes 
have a higher proliferation rate than adult keratinocytes. 
6.2.4 Cumulative Population Doublings of Keratinocytes 
To investigate whether foetal keratinocytes were more readily expandable than adult 
keratinocytes, their growth kinetics were compared, estimated by the cumulative 
population doubling up to 50 days. Foetal and adult keratinocytes were plated at a 
concentration of 5000 cells per cm2 in T75 flasks and successively subcultured at the 
same density when subconfluent. The cells were detached and the total cells were 
counted. The cumulative cells doublings of the populations were plotted against time 





in culture to determine the growth kinetics of foetal and adult keratinocytes expansion. 
The number of population doublings was determined by counting the number of 
adherent cells at the start and end of each passage. 
 The comparative growth kinetics of foetal and adult keratinocytes up to 50 
days at cell density of 5000 cells per cm2 showed that foetal keratinocytes had greater 
growth potential, achieving up to 20 population doublings in culture, whereas adult 
keratinocytes achieved up to 14. Cumulative population doublings progressively 
decreased for both foetal and adult keratinocytes. 
  





















































































































































Figure 6.3   Foetal keratinocytes have shorter doubling times and faster expansion 
times than adult keratinocytes. (A) Population doubling times are derived from each 
exponential phases of the growth curves respectively in Fig 6.2. (B) Comparison of 
proliferation rate of keratinocytes. The data were generated by counting the number of 
cells after each passage. Cells were subcultured at 70-80% confluence. **p<0.01, 
***p<0.001. 
 





6.2.5 Population Doubling Time and Cell Growth Characteristics of Foetal 
Fibroblasts 
The proliferation rate of foetal fibroblasts of different gestational ages was compared 
to adult fibroblasts. A real-time cell analyzer (xCELLigence, Roche Diagnostics) was 
used to evaluate the proliferation of foetal and adult fibroblasts (Figure 6.4). Growth 
curves of foetal and adult fibroblasts have a sigmoidal shape. Population doubling 
times were derived from the exponential phase of the each growth curves (Figure 6.4). 
The average population time for foetal keratinocytes was between 24 and 40 hours 
whist adult keratinocytes was about 60 hours. Thus, this showed that foetal fibroblasts 
have a higher proliferation rate compared to adult fibroblasts. 
6.2.6 Clonogenic Capacity of Foetal Keratinocytes 
Stem cells have the ability to form distinct clonal colonies when seeded at single cell 
density (Barrandon & Green, 1985). In contrast, non-stem cells are limited in their 
capacity to proliferate, and so the colonies they give rise to in culture are very small. 
To test the clonogenic potential of foetal versus adult cells, keratinocytes at different 
passages were seeded at low density in triplicate wells and colony formation was 
assessed after 14 days in culture. A linear relationship was observed between the 
number of cells seeded and the number of colonies formed, consistent with the 
behaviour of stem cells. A colony was defined as a cluster of > 1 mm2. The colony 
forming efficiency was calculated as the percentage of colonies formed over the 
number of cells seeded. Foetal keratinocytes formed more colonies compared to their 
adult counterparts (Figure 6.5). Colony forming efficiency was calculated to be as 
high as 36.7% in foetal keratinocytes and 6% in adult keratinocytes, indicating foetal 
keratinocytes have higher clonogenic potential and proliferative capacity. 

























































































































































































































































Figure 6.5   Foetal keratinocytes form more colonies than adult keratinonoycte. A 
comparison of colony-forming activity between cultured foetal and adult keratinocytes. 
Here, cells at different passages were plated in triplicate and the colony formation assessed 
after 14 days in culture, by counting the number of colonies that had formed in each dish. A 
colony was defined as a cluster of >1 mm2. After 14 days, the culture was arrested and the 
colonies stained with Rhodamine B. 
 
 





6.2.7 Telomere Length Analysis 
To determine whether foetal keratinocyte chromosomes have longer telomeres to 
account for the longer proliferative life span of the keratinocytes, the mean telomere 
length, in foetal keratinocytes versus adult keratinocytes, was assessed using Southern 
blot analysis of terminal restriction fragments (TRF), obtained by digestion of 
genomic DNA with frequently cutting restriction enzymes (Figure 6.6). The TRFs 
obtained contain DNA with uniform telomeric repeats (TTAGGG) as well as 
degenerate repeats from other chromosomal locations than at the distal end of the 
chromosome (sub-telomeric region). After digestion, the DNA fragments are 
separated by gel electrophoresis and blotted. TRFs were visualized by hybridization 
with labeled oligonucleotides complementary to the telomeric repeat sequence. Size 
distributions of the TRFs were compared to a DNA length standard. Mean TRF length 
was calculated to be 9894.48 bp at P4 for foetal (14 week) and 8132.79 bp at P4 for 
adult (27 yr).  
As progressive telomere shortening is associated with reducing replicative 
lifespan (Blackburn et al., 1989), these results concur with the observations that foetal 
keratinocytes have a longer proliferative life span than adult keratinocytes. In both 
adult and foetal keratinocytes, telomeres progressively shorten with increasing 
passage number. After 2 passages, the telomeres of adult keratinocytes shorten by 8.9% 
of its original length (P2 to P4) while the telomeres of foetal keratinocytes shorten by 
7.6% of its original length (P4 to P6). 
  






Figure 6.6   Foetal keratinocytes have longer telomeres compared to adult 
keratinocytes. Mean telomere restriction fragment (TRF) length of foetal and adult 
keratinocytes. 2 µg of DNA prepared from keratinocytes were digested with Hinf I and 
Rsa I, then separated on a 0.9% agarose gel by gel electrophoresis, transferred to nylon, 
probed with a Dig-labeled telomere probe (TTAGGG), and detected via 
chemiluminescense. The average TRF length was determined by comparing the location 
of the TRF on the blot relative to a molecular weight standard. In both adult and foetal 
keratinocytes, telomeres shorten with increasing passage number.  
 





6.2.8 Optimization of Organotypic Co-cultures 
The “living skin equivalent” (Bell et al., 1983), or three-dimensional organotypic 
culture model, is now widely used to investigate many aspects of cutaneous biology. 
A skin-equivalent organotypic model system was used to examine the differentiation 
capacity of cultured keratinocytes. Figure 6.7 shows a schematic diagram of the 
experimental method for organotypic co-culture, and this is described in detail in 
Chapter 3 (Materials and Methods). Briefly, primary keratinocytes are grown on top 
of a fibroblast-embedded collagen gel (dermal equivalent) and submerged in co-
culture medium. Once keratinocytes are confluent, the culture construct is raised to 
the air-liquid interface, leading to the differentiation of keratinocytes, in a 
stratification medium providing growth factors to the cells by diffusion through the 
base of the collagen gel. The cultures were harvested 2 weeks after raising to air-
liquid interface and processed for histochemistry.  
As keratinocytes were being cultured in serum-free media, adaptation of 
organotypic co-cultures was needed for optimal growth and differentiation of foetal 
keratinocytes. Foetal keratinocytes (16wk) were cultured with adult fibroblasts 
embedded in collagen. In the submerged phase, RM+ medium (with serum) or serum-
free medium was added to the keratinocytes (into the inserts) while RM+ medium was 
added into the wells outside. When the cultures were raised to the air-liquid interface, 
medium was removed from the insert while medium at the bottom of the wells was 
changed to either RM– medium, RM– medium with high calcium (3.2 mM), or RM– 
medium without serum. RM– medium contains all the components of RM+ medium 
except for epidermal growth factor (EGF), which is absent. 
  






Figure 6.7   Schematic illustration of experimental method for organotypic co-culture. 





Submerged culturing of keratinocytes with serum-free media gave rise to a 
better skin architecture compared to culturing them with RM+ medium (Figure 6.8 
and 6.9), with several skin layers and stratum corneum formation. Furthermore, basal 
cells were neatly aligned at the basement membrane. When serum-free medium was 
used in the submerged phase, there was no morphological difference when the 
organotypic cultures were cultured with RM– medium, RM– medium with high 
Calcium (3.2 mM), or RM– medium without serum at the air-liquid interface. 
To further analyze the keratinocyte differentiation, organotypic cultures were 
processed for immunohistochemistry and stained with antibodies directed against K14 
and K10. In all conditions, K14 was expressed at the epidermal layer (Figure 6.10 and 
6.11). When cells leave the basal layer, they start to synthesize differentiation proteins 
K1/K10 at the suprabasal layers. Organotypic cultures at air-liquid interface that were 
cultured with RM– medium without serum expressed K10 in the suprabasal layers 
immediately above the basal layer (Figure 6.11D), unlike those cultured with RM– 
medium with serum, or high calcium RM– medium with serum, in both of which K10 
was expressed much later at the top layers. This suggests that keratinocyte 
differentiation conditions were suboptimal when cultured with serum. Following these 
observations, subsequent organotypic experiments were always cultured with serum-
free media in the submerged phase and RM– medium without serum when cultures 
were raised to air-liquid interface. 
  





  Figure 6.8   Optimization of organotypic co-cultures. Comparison of culturing 
keratinocytes with RM+ media (A, B) and serum-free media (C, D) in the submerged phase, 
and at air-liquid interface with different calcium concentrations of RM– media (RM+ 
without epidermal growth factor). Culturing keratinocytes in serum-free media gives a better 
skin architecture similar to normal skin 
 
Figure 6.9   Optimization of organotypic co-cultures. Comparison of culturing 
keratinocytes with RM+ media (A, B) and serum-free media (C, D) in the submerged phase, 
and at air-liquid interface with RM– media (RM+ without epidermal growth factor) in the 
presence (A, C) and absence (B, D) of serum. Culturing keratinocytes in serum-free media 
gives a better skin architecture similar to normal skin. 
 






Figure 6.11   Immunoperoxidase staining of organotypic co-cultures with keratin 14 
(K14) and keratin 10 (K10). Keratinocytes were cultured with serum-free media in the 
submerged phase and at air-liquid interface with RM– media (RM+ without epidermal 
growth factor) in the presence (A, C) and absence (B, D) of serum. 
Figure 6.10   Immunoperoxidase staining of organotypic co-cultures with keratin 14 
(K14) and keratin 10 (K10). Keratinocytes were cultured with serum-free media in the 
submerged phase and at air-liquid interface with different calcium concentrations of RM– 
media (RM+ without epidermal growth factor).  
 





6.2.9 Differentiation Capacity of Foetal Keratinocytes In Vitro 
Using the optimized culture conditions for generating organotypical cultures, the 
ability of foetal cells to undergo normal differentiation was assessed. This was an 
important point if foetal cells were ever to be used in the future in place of adult cells 
for clinical applications such as grafting. Foetal keratinocytes were therefore seeded 
on adult fibroblasts and were able to stratify in vitro, giving rise to several layers as 











  Figure 6.12   Skin equivalents of cultured keratinocytes. Foetal and adult keratinocytes were seeded on a fibroblast-embedded collagen gel, cultured in a submerged condition, 
before initiating differentiation of the epidermal layer at the air-liquid interface for 14 
days. Foetal keratinocytes were able to stratify in vitro, and can be made usable as grafts. 
Scale bar, 100 µm. 






This chapter has examined the proliferation and differentiation potential of foetal 
keratinocytes. Foetal keratinocytes demonstrated higher proliferative potential than 
adult keratinocytes as seen by (1) their higher proliferative index (PI) in the epidermis 
in vivo (i.e. more cells are dividing), (2) their shorter doubling times and faster 
expansion times in vitro, and (3) their ability to generate more colonies at low cell 
density (greater clonogenic potential). They are also further from senescence as seen 
by their longer telomeres, which concurs with their ability to grow well at higher 
passage numbers than their adult counterparts (Chapter 5). Foetal keratinocytes were 
also shown to be able to stratify in vitro, although the cells had originated from 
immature tissue that showed distinct differences from adult in its expression of certain 
keratin differentiation markers (see Chapter 4). 
The high Ki67 proliferation index in the basal layer of second trimester foetal 
epidermis suggests that the epidermis was at this stage undergoing rapid expansion. It 
was also noted that the percentage of Ki67-expressing cells declined with increasing 
gestational age, suggesting that the expansion of the epidermis declines during the end 
of second trimester. This trend was broadly similar to that previously reported by 
Coolen et al. (Coolen et al., 2010), although the gestational ages were grouped. The 
calculation of the Ki67 proliferation index makes the assumption that all cells at the 
basal layer are keratinocytes. Ki67 may also stain other cell types in the epidermis, 
such as melanocytes and Langerhans cell, but these cell types comprise less than 5% 
in the epidermis and are not highly proliferative. 
The xCelligence System (Roche Diagnostics, Mannheim, Germany), also 
referred to as a real-time cell analyzer (RTCA), was used to collect data to construct 





growth curves of keratinocytes and fibroblasts. Cells that are adherent at the bottom of 
a 96-well plate generate a sensor impedance to current flow, which is displayed as 
arbitrary units known as cell index (CI) or normalized cell index (CI in relation to the 
corresponding CI at the indicated time point). The microelectronic cell sensing system 
allows a label-free determination of proliferation as well as cell vitality based on the 
detection of electrical impedance, which is dependent on the number of cells and their 
physiological conditions such as cell adhesion and morphology. As examined in 
Chapter 5, foetal keratinocytes have a smaller size than adult keratinocytes, and hence 
this difference in cell size morphology could affect CI values, presumably giving 
foetal keratinocytes slightly lower CI values in the data. However the calculation of 
doubling time takes into account only the gradient at the exponential phase of growth, 
independent of CI values, and thus truly reflects the proliferation rate of the cells as 
long as the cells do not change shape. 
As observed in the growth curves of keratinocytes and fibroblasts, 
keratinocytes have larger standard deviations for each genetic individual source 
compared to fibroblasts (Figure 5.5, Figure 5.6, Figure 6.2, Figure 6.4), thus the 
primary keratinocytes are always more heterogeneous. Foetal keratinocytes were also 
observed to show a shorter growth lag phase after plating, suggesting that they may 
recover from the stress of sub-culturing quicker than adult keratinocytes. Cells with 
shorter lag phase have also been suggested to have a longer lifespan and longer 
telomeres (Olofsson, 2010; Portugal et al., 2008). 
The “end-replication problem” (Levy et al., 1992) proposes that chromosomal 
ends progressively shorten with each replication cycle, as DNA polymerase is unable 
to replicate the very ends of the DNA. This phenomenon has been demonstrated in 





vitro and in vivo, and seems to be causatively linked to the progressive loss of 
proliferative capacity of normal ageing somatic cells (Harley et al., 1990). When 
telomeres are shortened beyond a crucial limit, certain genes can be activated to 
trigger senescence-related dysfunction and pathology (Vulliamy et al., 2001). Some 
cells, including germline cells and tumour cells, exhibit a prolonged or even infinite 
life span, because these cells possess a mechanism for maintaining or regenerating 
their telomeres (Greider & Blackburn, 1996). It has also been shown that long 
telomeres are a general feature of tissue stem cells (Flores et al., 2008). Stem cell 
compartments in small intestine, testis, cornea, and brain of the mouse are enriched in 
cells with the longest telomeres. In these different stem cell compartments, telomeres 
shorten with age, and this has been attributed to a decline in stem cell function. The 
tissue stem cells that are functioning in the foetus will need to be equipped to persist 
for the lifespan ahead of the organism and might therefore be expected to have long 
telomeres. Knowing the telomere length is relevant to cell therapy, as cells that have 
the longest telomeres might contain the most regenerative tissue stem cells. 
In organotypic cultures, keratinocytes are classically grown exposed to air on a 
matrix of type I collagen, often isolated from rat tail tendon. To function as a dermal 
equivalent, the collagen gel contains dermal ﬁbroblasts  that may proliferate in it and 
eventually reorganize this matrix by producing extracellular matrix components. 
While contracting the gels to a densely structured lattice with oriented collagen ﬁbrils, 
the ﬁbroblasts reduce their proliferative activity, alter their protein synthesis, and 
acquire a resting state comparable to that of dermis (Coulomb et al., 1986). 
Furthermore, in this model, the contact of the cultures with medium is restricted to the 
base of the gel so that ﬁbroblasts and  keratinocytes are nourished by diffusion from 
below.  





Conventional stratification medium (RM- medium) containing serum without 
epidermal growth factor (EGF) is widely used for initiating differentiation in 
organotypic cultures. Previous studies reported that differentiation was enhanced by a 
combination of low EGF and high calcium (Wille et al., 1984). Foetal bovine serum is 
also known to contain factors that have a strong suppressive actions on keratinocyte 
differentiation program, such as vitamin A (Fuchs & Green, 1981; Kopan et al., 1987). 
Therefore, the addition of calcium and the removal of serum in the RM- medium was 
introduced in the present experiments, and effect on differentiation were examined. 
In this study, the submerged phase of organotypic culture generation utilized 
RM+ medium (with serum) for culture in the lower wells, therefore this culture 
system was not completely serum-free. Further optimization is required for using 
defined serum-free media in these cultures. Without the interference of ill-deﬁned 
serum constituents, it will be possible to examine the intrinsic mesenchymal-epithelial 
interaction and to evaluate more precisely the responses of cells to different growth 
factors and other compounds in the culture medium.  
Prior to this work, it was not known whether foetal keratinocytes would 
continue to follow a normal pathway of differentiation when placed in tissue culture, 
or whether they would be unable to adopt an adult pattern of differentiation due to 
their immature state upon isolation. The study here has confirmed that foetal 
keratinocytes are capable of fundamentally normal differentiation in vitro, as they can 
form a stratified epidermal-like structure that is morphologically similar to, and 
expresses major structural proteins of, adult epidermis. 
The study in this chapter here showed that foetal keratinocytes are more 
proliferative than adult keratinocytes and can differentiate in vitro. Thus, with their 





capacity for regeneration and differentiation into a complete epidermis, there is 
















IMMUNOGENIC POTENTIAL OF FOETAL KERATINOCYTES 
 
7.1 INTRODUCTION 
Successful application of cultured allogeneic human keratinocytes requires the cells to 
have low immunogenicity properties and to not cause immune sensitization of the 
host. In this chapter, the immunogenic potential of foetal keratinocytes will be 
investigated, by examining their expression of immunological markers and assessing 
their functional immunogenicity using in vitro assays. 
As autografts, cultured human epidermal keratinocytes have been successfully 
applied to burn patients. Allografts however only serve as a temporary coverage of 
full-thickness burn wounds, mainly to promote faster re-epithelialization of partial-
thickness burns, leg ulcers, and excised burn scars (Bolívar-Flores et al., 1990; De 
Luca et al., 1992; McKay & Leigh, 1991). In burn wounds, these cultured allografts 
have been reported to not be rejected, which has been explained by the 
immunosuppressive effect induced by burn injury (Hultman et al., 1995). In non-
immunocompromised patients, cultured epidermal allografts do not appear to induce 
classical tissue rejection (Gielen et al., 1987), which has been attributed in part due to 
the low level of major histocompatibility complex (MHC) class II molecules at the 
cultured keratinocyte surface and to the absence of antigen presenting cells (APCs) in 
the culture of epidermal keratinocytes (Morhenn et al., 1982; Hammond et al., 1987; 
Thivolet et al., 1986). However, it has been shown that cultured human allografts do 
not engraft permanently, but are displaced and lost after re-epithelialization by the 





host cells (Auböck et al., 1988; Myers et al., 1995). Even after depletion of APCs, 
experiments showed loss of the cultured allografts, although the process was slow 
(Fabre & Cullen, 1989; Auböck et al., 1988).  
There are considerable pieces of evidence to support the idea that foetal 
keratinocytes like other embryonic cells are immunologically immature. It has been 
shown that various some tissues are resistant to immune rejection since they have low 
immune stimulatory potential (Dekel et al., 2003; Montjovent et al., 2009; 
Götherström et al., 2004). As foetal keratinocytes hold promise to serve as an 
alternative cell source for therapeutic transplantation, experiments were undertaken to 
assess the likely immunogenicity of allogeneic cultured foetal versus adult 
keratinocytes, and whether foetal keratinocytes would elicit an alloreactive response 
in vitro without the interference of APCs such as Langerhans cells normally found in 
the epidermis. These experiments are described in this chapter. 
  






7.2.1 Expression of Histocompatibility Antigens in Tissue Sections 
Major histocompatibility complex (MHC) determinants play an important role in the 
immune system and autoimmunity, as well as in graft rejection. The expression of 
MHC molecules in foetal skin was compared to that in adult skin. Foetal skin sections 
were stained with antibodies against HLA-ABC (MHC I) and HLA-DP, DQ, DR 
(MHC II) molecules (see Chapter 3 for Methods). Both MHC I and MHC II were 
weakly detected in foetal skin (Figure 7.1), with some positive cells in the dermis and 
hair germs in the epidermis, but most of the epidermis was negative for MHC I. The 
expression of MHC I appear to increase with increasing gestational age. In contrast, 
MHC I was expressed ubiquitously in adult skin (Figure 7.1). 
Expression of MHC II in foetal skin was scattered with sporadic positive cells 
in dermis and epidermis (Figure 7.1), probably due to the presence of Langerhans 
cells and other antigen-presenting cells which express MHC II. MHC II expression in 
adult skin was higher than foetal skin, but similarly scattered. 
7.2.2 Staining of Histocompatibility Antigens in Cultured Foetal Keratinocytes 
Cultured foetal and adult keratinocytes were stained with antibodies to MHC I and 
MHC II molecules to determine their expression in vitro. Foetal keratinocytes express 
less MHC I than adult keratinocytes (Figure 7.2). However, MHC I expression was 
observed to increase with increasing passage number. Neither foetal nor adult 
keratinocytes express MHC II (Figure 7.3). 
  












































































































Figure 7.2   Expression of MHC I by foetal and adult keratinocytes. Immunostaining of 
MHC I by foetal and adult keratinocytes. Foetal keratinocytes were observed to express 
lower levels of MHC I than adult keratinocytes. 






Figure 7.3   Expression of MHC II by foetal and adult keratinocytes. Immunostaining of 
MHC II by foetal and adult keratinocytes. Foetal and adult keratinocytes do not express 
MHC II. 
 





7.2.3 Flow Cytometric Analyses of Major Histocompatibility Antigens in 
Cultured Keratinocytes 
To evaluate the antigenic properties of foetal keratinocytes, the cell-surface 
expression of both MHC classes was measured by florescence-activated cell sorter 
(FACS). Protein expression assessed by flow cytometry showed a significant right 
shift (i.e. increasing % of cells expressing the marker) in the cell populations 
expressing MHC I in adult populations, whereas only a small shift was identified for 
foetal populations, indicating lesser expression of MHC I molecules (Figure 7.4). It 
was also noted that expression of MHC I molecules increased with passage as well as 
gestational age. Both adult and foetal keratinocytes appear to have low or no 
expression of MHC II, determinants which are usually expressed in antigen-
presenting cells (Figure 7.5). The lower expression of MHC molecules in foetal 
keratinocytes might indicate that they have lower immunogenicity. 
  

































































































































































































































































































































































































































































































7.2.4 In Vitro Analysis of Foetal Keratinocyte Immunogenicity 
In vitro T cell proliferation assays by co-cultivation of peripheral blood mononuclear 
cells (PBMCs) and T cells with keratinocytes were performed in collaboration with 
Dr John Connelly of the Immunomonitoring Platform Lab at the Singapore 
Immunology Network (SIgN), A*STAR.  
As T cell activation is one of the early, key events that may initiate allograft 
rejection (see section 2.6), T cell activation in an in vitro co-cultivation assay with 
foetal keratinocytes was explored. The outcome of T cell activation is a proliferative 
cell response, hence T cell proliferation was evaluated after peripheral blood 
mononuclear cells (PBMCs) labelled with carboxyfluorescein succinimidyl ester 
(CFSE) had been incubated for 8 days with cultured keratinocytes. Proliferation was 
determined by flow cytometry using the CFSE dilution method (Lyons & Parish, 
1994). Cells are stained with the cell surface dye CFSE and excess dye is washed 
away; the compound is retained on the cells but gradually dilutes as cells divide and 
share the remaining dye between the daughter cells. Thus the CFSE signal becomes 
increasingly diluted upon each cell division, resulting in lower fluorescence intensity 
in a proliferating cell population. As positive control, beads coated with anti-CD3 and 
anti-CD28 were used to stimulate T cells to divide in vitro , mimicking stimulation by 
antigen presenting cells (Trickett & Kwan, 2003).  
Neither adult nor foetal keratinocytes at P4 caused T cells to proliferate, as 
seen by the CFSEbrightCD4+ population (Figure 7.6). Experiments were carried out 
using 3 different adult and 3 different foetal donors, to allow for cell source variation. 
  






Figure 7.6   Proliferation of T-lymphocytes after 8 days of incubation with cultured 
keratinocytes. Peripheral blood mononuclear cells (PBMC) labelled with carboxyfluorescein 
succinimidyl ester (CFSE) were co-cultivated with keratinocytes for 8 days. PBMC were then 
stained with anti-CD4 to mark T-cells and analyzed by flow cytometry. Proliferating T cells 
(divided) were CFSEdim and resting T cells (undivided) remained CFSEbright. Adult and foetal 
keratinocytes did not cause T-cells to proliferate. 
 





As neither adult nor foetal keratinocytes appear to sensitize and activate naïve 
T cells in vitro, adult and foetal keratinocytes were investigated to see whether they 
could suppress an immune response. Isolated CD4+ T cells were stained with the cell 
surface dye CFSE prior to stimulation with CD3/28 beads and 200,000 cells were co-
cultured with adult or foetal keratinocytes with different seeding densities at P5. 
Lymphocyte cell division was assessed after 8 days. 3 different adult and 3 different 
foetal donors were used. In all experiments, CD3/28 beads induced lymphocyte 
proliferation at all keratinocyte seeding densities as shown with the increased CFSEdim 
population (Figure 7.7).  
To investigate the extent of T cell proliferation when different densities of 
keratinocytes were added, the mean fluorescence intensity (MFI) of CFSE was 
calculated for each sample (Figure 7.8). A lower MFI value indicates that there is 
more proliferation due to the dilution of CFSE as the cells divide. When stimulated T 
cells were co-cultured with adult keratinocytes, MFI values decreased with increasing 
number of keratinocytes seeded, indicating more proliferation of T cells. In contrast, 
when stimulated T cells were co-cultured with foetal keratinocytes, MFI value 
decreased initially but increased when more keratinocytes were seeded. This indicates 
that T cell proliferation decreases when more foetal keratinocytes are present, and 
suggests that foetal keratinocytes might mediate T cell activation by soluble mediators 
or other mechanisms that regulate the immune system. 
  






Figure 7.7   Proliferation of stimulated T-lymphocytes after 8 days of incubation with 
cultured keratinocytes. CD4 T cells were isolated from PBMCs and stained with 
carboxyfluorescein succinimidyl ester (CFSE). T cells were stimulated with CD3/28 beads 
and co-cultured with keratinocytes for 8 days before flow cytometry analysis. 







Figure 7.8   Mean Fluorescence Intensity (MFI) of CFSE. The average MFI of CFSE 
was calculated for each sample in Figure 7.5 and tabulated. Lower MFI values indicate 
more proliferation of cells due to the dilution of CFSE as the cells divide. (A) MFI of 
CFSE when co-cultured with adult keratinocytes. (B) MFI of CFSE when co-cultured with 
foetal keratinocytes. *p<0.05, **p<0.01, ***p<0.001. 
 






In this chapter, the expression of MHC molecules by foetal keratinocytes has been 
investigated. Foetal keratinocytes express immune-related cell surface markers 
including HLA-ABC (MHC I) as do most adult nucleated cells but negative for HLA-
DP, DQ, DR (MHC II). However, foetal keratinocytes demonstrated low expression 
levels of MHC I molecules. This chapter also described the results of the studies on 
the immunoregulatory properties of foetal keratinocytes, and has presented an initial 
attempt to address the graft rejection issue of foetal keratinocytes.  
By analyzing the expression of alloantigens, foetal keratinocytes was showed 
to express less MHC I and do not express MHC II molecules. Adult keratinocytes 
constitutively express MHC I but MHC II is induced only following cytokine 
stimulation with interferon-γ (IFN-γ) (Czernielewski & Bagot, 1986; Carr et al., 1986; 
Kim & Houh, 1987), suggesting that they may become active participants of the 
immune response. However, the expression of MHC molecules is not sufficient to 
draw solid conclusions about the immunogenicity of foetal keratinocytes. To 
overcome this, functional assays for alloimmunity against foetal keratinocytes were 
performed by mixing with allogeneic T cells, and the lymphocyte proliferation served 
as a measure for allorejection.  
Lymphocytes co-cultivated with foetal keratinocytes did not proliferate, and 
might be explained by lack of signals required for an effective immune response, 
probably due to the absence, or presence only at low levels, of MHC antigens or co-
stimulatory molecules at the keratinocyte surface. T cells which receive only MHC 
stimulus without co-stimulation are likely to become anergic (Walker & Abbas, 2002).   





To investigate whether foetal keratinocytes have immunosuppressive effects, 
stimulated T cells were co-cultured with foetal keratinocytes. Unlike adult 
keratinocytes, immunosuppression was seen with high number of foetal keratinocytes. 
A mechanism that might explain this is the production of soluble factors with 
immunosuppressive activity, such as transforming growth factor (TGF)-β and IL-10 
(Kehrl et al., 1986; Lúdvíksson et al., 2000; Taylor et al., 2006). Other mechanisms 
include that which exists in the state of mutual immune tolerance between mother and 
foetus during pregnancy, such as indoleamine 2,3-dioxygenase (IDO) and HLA-G 
expression (Munn et al., 1998; Meisel et al., 2004; Hunt et al., 2005), but further 
experiments are needed to verify this. The effects of foetal keratinocytes on regulatory 
T cells (Treg), which are capable of modulating tolerance in the immune response can 
also be investigated (Sakaguchi et al., 2001). Other populations of foetal cells, 
including foetal liver mesenchymal stem cells, have been shown to harbour various 
levels of inhibitory immune effects (Götherström et al., 2004). 
Nevertheless, the most reliable assays for post-transplantation rejection are 
those that are performed in vivo. However, there is difficulty in the development of 
animal models for tests of human allogeneic cell rejection, as they should carry 
functional human immune cells and provide the necessary environments for human 
immune responses. Humanized severe combined immunodeficient (SCID) mouse 
models of skin rejection (huPBMC-SCID) have been used to study rejection of skin 
grafts (Briscoe et al., 1999). After skin grafts were healed, these mice were infused 
with human peripheral blood mononuclear cells (PBMCs) that serve as human 
immune components, and T cell alloresponse against transplanted cells and tissues 
can be evaluated. A study which used this model demonstrated that human foetal skin 
allografts had prolonged survival in the huPBMC-SCID mouse model compared to 





neonatal skin grafts (Erdag & Morgan, 2002). It remains to be seen whether cultured 
foetal skin constructs, in absence of APCs, will be rejected in this mouse model. 
Nevertheless, these data indicate that foetal keratinocytes are functionally less 
immunogenic than adult keratinocytes. 
Based on in vitro data from this chapter, foetal keratinocytes were suggested 
to harbour an “immunological advantage”, which would be of significant benefit 
regarding future clinical use of these cells. Further research including in vivo studies, 
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Although the program of skin differentiation is operative in in vitro organotypic 
culture models, effects observed in vitro need to be confirmed under more 
physiological in vivo conditions to evaluate their biological and translational 
signiﬁcance. The xenotransplantation of human skin constructs onto immunodeficient 
animal models is considered to be the most reliable test to investigate growth and 
differentiation of grafted cells. This chapter will investigate in vivo aspects of 
engraftment and skin regeneration using cultured foetal cells, and the construction of 
bioengineered skin. 
Bioengineered skin constructs require a suitable scaffold, which must be 
biocompatible, and must promote cell adhesion and growth. Natural materials are 
frequently used as scaffolds for tissue engineering as they can best mimic the natural 
environment of the extracellular matrix that forms the framework of all tissues in the 
body. Such commonly-used materials include collagen, glycosaminoglycans and 
fibrin. Since fibrin is the body’s natural wound-closing matrix, its use as a scaffold 
matrix for tissue engineering is an appealing option. When compared to cells 
embedded in collagen, studies have suggested that cells embedded within fibrin gels 
produced more collagen and elastin (Grassl et al., 2002; Neidert et al., 2002; Long & 





Tranquillo, 2003). In skin constructs, fibrin has been used successfully as a 
keratinocyte carrier by injecting or spraying a suspension of cells with fibrinogen and 
thrombin onto the wound bed (Horch et al., 1998). The fibrin forms a gel in a few 
minutes, trapping keratinocytes within the wound bed and acting as an embedding 
media for the cells to proliferate and migrate, eventually covering the wound (Ronfard 
& Barrandon, 2001). The advantage of fibrin over other hydrogels is that it can be 
easily obtained from autologous sources. Fibrin also helps to ensure initial uniform 
cell distribution and more efficient cell seeding within a matrix (Sittinger et al., 1996). 
Hence, the work described here in this chapter uses fibrin as a scaffold for the 
construction of a bioengineered skin equivalent.  






8.2.1 Optimization and Construction of Plasma-based Dermal Equivalent 
The construction of plasma-based dermal equivalent was based on a modified 
protocol by Llames et al. (Llames et al., 2004; Llames et al., 2006). The method used 
for preparation of plasma-based dermal equivalent is detailed in Chapter 3 Materials 
and Methods. Plasma is whole blood with the blood cells removed. Plasma is 
therefore able to coagulate and form a fibrin matrix as it contains fibrinogen all the 
necessary catalytic factors from the coagulation cascade. Keratinocytes seeded onto 
fibroblast-containing plasma-derived fibrin scaffolds have been shown to have 
excellent growth features and can be used for the treatment of patients with severe 
skin injuries (Llames et al., 2004; Llames et al., 2006). Fibrin scaffolds can also be 
made by combining the purified components obtained individually from commercial 
sources, but preparation of fibrin gels directly from whole plasma is less time-
consuming and supports better cell growth, thus providing a more cost-effective and 
clinically suitable product.  
 In the original protocol (Llames et al., 2004), the addition of calcium chloride 
into the plasma prepared from fresh blood was used to initiate clotting, by reversing 
the anticoagulant effect of calcium chelation. Fresh blood is difficult to source locally, 
hazardous to handle and preparation of plasma from fresh blood is inconvenient and 
messy. The plasma must also be sterile filtered for use in cell culture. Sterile filtered 
porcine plasma was purchased externally for the preparation of plasma gels. However 
the plasma did not clot on the addition of calcium chloride.  





In order to form a fibrin clot, fibrinogen must be converted to fibrin by the 
enzyme thrombin. Thrombin is formed from prothrombin, which is cleaved in the 
presence of soluble calcium salts by thromboplastin. Unfiltered plasma separated by 
centrifugation still contains platelets, and the addition of calcium brings about the 
breaking down of platelets that liberates thromboplastin, which is essential for the 
production of a clot (Cramer & Pringle, 1913). Hence thromboplastin is not present in 
fresh filtered plasma in which the plasma has been completely depleted of platelets, 
and therefore no coagulation takes place on the addition of calcium. 
In order to initiate clotting in filtered plasma, thrombin was therefore added to 
the plasma in addition to calcium chloride. The concentration and volume of thrombin 
was adjusted so that the plasma gel formed had the correct consistency and thickness 
to enable mechanical handling, as well as having an optimal clotting time. A 1:1 ratio 
(v/v) of plasma and thrombin (6 NIH/ml) mixture was added with fibroblast 
suspension and allowed to gel completely. In contrast to collagen gels, fibroblast-
containing plasma-based dermal equivalents did not contract, or contracted minimally 
with a slight decrease in thickness during the culture period. 
To examine whether plasma-based gel supports the growth and differentiation 
of keratinocytes, the skin constructs were subjected to air-liquid interface exposure to 
initiate differentiation in vitro, as described in Chapter 6. As shown in Figure 8.1, 
plasma-based constructs supported the growth and differentiation of foetal and adult 
keratinocytes, forming epidermal-like structure and a cornified layer. This 
demonstrates that plasma-based bioengineered construct can be used for 
xenotransplantation studies. 
 






Figure 8.1   Organotypic cultures made with adult or foetal cells. Histological 
appearance of culture-generated human foetal skin using fibrin gel as a dermal 
equivalent. Fibrin gel-based constructs supported the growth and differentiation of foetal 
and adult keratinocytes, forming epidermal-like structure and a cornified layer. 
 





8.2.2 Transplantation of Human Skin Equivalents onto Immunodeficient Mice 
The grafting process is illustrated in Figure 8.2 and detailed in Chapter 3 Materials 
and Methods. Experimental grafting was performed using a surgical procedure 
described by Del Rio et al. (Del Rio et al., 2002). Briefly, mice were shaved and 
aseptically cleansed. Full-thickness 3 cm × 3 cm square wounds were then created on 
the dorsum of mice. The removed mouse skin was devitalized by three repeated 
cycles of freezing and thawing and used as a biological bandage to protect and hold 
the skin construct in place during the graft take process. The dead skin was fixed in 
place with a continuous running stitch suture. Dead mouse skin was sloughed off, 
generally within 14 days of grafting.  Grafting was performed under sterile conditions, 
using 6 – 8 weeks old female severe combined immunodeficient (SCID) mice. 
8.2.3 Selection of Anaesthetics, Analgesics and Euthanasia 
The anaesthetic drugs ketamine (75mg/kg) and medetomidine (1mg/kg) were initially 
used in combination to induce anaesthesia on immunodeficient SCID mice through 
peritoneal injection. The anaesthesia induction time was very short (< 30 sec), with 
animals losing consciousness rather quickly and the resuscitation time was long (> 4 
hr). However, one-third of the mice died after using this anaesthetic agent, and 
lowering the concentration did not give a surgical depth of anaesthesia, suggesting 
that young SCID mice appear to be very sensitive to this combination of drugs. The 
anaesthetic agent was therefore switched to isoflurane, an inhalant anaesthetic, as this 
was deemed safer. Induction time was still short but mice regained consciousness 
more quickly (< 30 min) upon removal from anaesthesia. All mice survived after 
surgery and were rapidly active, and showed no noticeable side-effects from the drug. 






Figure 8.2   Grafting of fibrin gel-based bioengineered skin constructs onto the dorsum 
of severe combined immunodeficient (SCID) mice. (A, B) Full-thickness skin wounds 
were created on the dorsum of mice. (C) The removed mouse skin was devitalized by three 
repeated cycles of freezing and thawing. (D) The skin construct was held in place by the 
dead skin. (E) The dead skin was fixed with continuous running stitch sutures. Dead mouse 
skin was sloughed off, generally within 14 days of grafting. (F) Complete closure of wound 
with sutures. (G) Appearance of the regenerated human skin 8 weeks post-grafting. (H) 
Fibrin gel-based skin equivalents were constructed in 6 well inserts. 
 





Mice were treated postoperatively with a non-steroidal anti-inflammatory drug 
(NSAID), Metacam, which was added to drinking water for 3 days. The drug did not 
affect the taste of the water as mice were not observed to refuse drinking.  
At scheduled time points of the transplantation studies, mice were euthanized 
by CO2 asphyxiation in a closed chamber. The regenerated human skin grafts were 
excised along with approximately 1 cm of surrounding mouse skin. Half of the graft 
was placed in O.C.T. medium and immediately snap-frozen in liquid nitrogen, and the 
remainder was placed in 10% neutral buffered formalin for paraffin embedding. 
8.2.4 Histological and Immunological Analyses  
Figure 8.3 shows the histological appearance of culture-generated human foetal skin 
on back of a SCID mouse. The central part of the transplant had differentiated to a 
state resembling normal human skin. The border between mouse and human tissue 
can be distinguished at the peripheral part of the transplant. Mouse epidermis 
consisted of 2-3 layers and can also be identified by the numerous hair follicles 
present in the dermis. A transitional zone can also be seen where the epidermis had a 
thickness between that of mouse and human epidermis (Figure 8.3B) (Jeppe-Jensen et 
al., 1993). 
 To evaluate the successful engraftment of human cells, and to distinguish 
human and mouse epidermis, different epidermal species-specific markers were used. 
The antibody LP4N has been reported to react with methanol-acetone fixed frozen 
sections and reacts with human but not mouse nuclei (Jeppe-Jensen et al., 1993). 
LP4N was therefore used for distinguishing human and mouse cells (Figure 8.4), 
where it stained the cell nuclei of human epidermis and the dermis in the transplant. 

























































































































Figure 8.4   Immunofluorescence staining with antibody LP4N specific for human 
cells. (A) H&E staining of frozen section. (B) Nuclei of human epidermis were stained, 
while nuclei of mouse epidermis were unstained. (C) LP4N staining on cultured human 
keratinocytes and (D) a section of intact human skin. 
 





 Other markers that were reported to distinguish human and mouse epidermis 
include involucrin antibody (clone SY5) (Llames et al., 2004). Monoclonal antibody 
LH1, which recognizes K10 antibody (Leigh et al., 1993), was also seen to be human-
specific, and could be used to differentiate human from mouse epidermis. Figure 8.5 
shows the staining of these human-specific epidermal markers and also other markers 
of differentiation, demonstrating normal stratification in grafted skin. The human 
leukocyte antigen (HLA) antibody was also shown to be human-specific, as well as 
the vimentin antibody V9 (Bohn et al., 1992), which stained only human cells in the 
dermis (Figure 8.6). 
 Figure 8.7 shows Herovici’s staining of culture-generated human foetal skin 
on back of a SCID mouse. Herovici’s stain is capable of distinguishing between types 
I and III collagen, where the fine type III collagen fibres (young collagen) stain blue, 
and the thick and coarser type I collagen fibres (old collagen) stain pink. At 14 days 
post-grafting there was little collagen formed. At 21 days post-grafting, more collagen 
was synthesized, predominantly type III collagen, with some collagen I at the reticular 
dermis. At 56 days post-grafting, a distinct layer of blue-staining fine collagen III 
fibres can be observed immediately underneath the epidermis, similar to the collagen 
architecture of normal skin. Collagen I can also be seen throughout the dermis. 
 K14 was stained throughout the human and mouse epidermis, and the 
proliferation marker Ki67 was mostly confined to the basal layer of the regenerated 
human epidermis (Figure 8.8). Figure 8.9 shows immunostaining of K16 and α-
smooth muscle actin (SMA) on the regenerated human skin. K16 is induced by stress 
in hyperproliferative “activated” keratinocytes, such as by wounding. K16 was 
present in the epidermis of the regenerated skin at 7 days and 14 days post-grafting, 





but appear to be confined to the upper layers of the epidermis at 56 days post-grafting. 
α-smooth muscle actin (SMA) was expressed in the dermis of the regenerated skin at 
7 days and 14 days post-grafting, indicating the presence of myofibroblasts containing 
contractile fibres. At 56 days post-grafting, α-SMA marked the presence of blood 
vessels in the regenerated skin, but the myofibroblasts had disappeared by that time.  





Fig. 8.5   Human-specific keratin 10 (K10) and involucrin (INV) immunostaining at 
the junction of regenerated human skin. Antibodies staining showed normal 
stratification in grafted skin 8 weeks post-grafting. 
 






Fig. 8.6   Human specific epidermal markers. (A, B, C) Human leukocyte antigen 
(HLA) markers on grafted skin 8 weeks post-grafting. (D) Vimentin (Vim) staining at the 
junction of regenerated skin 8 weeks post-grafting. 
 






  Fig. 8.7   Herovici’s staining of culture-generated human foetal skin on back of 
SCID mouse. 
 
Fig. 8.8   Immunostaining of K14 and proliferation marker Ki67 on the regenerated 
human skin (8 weeks post-grafting). 
 



































































This chapter reports the successful engraftment and stable skin regeneration using 
cultured foetal keratinocytes as bioengineered skin constructs in vivo. Experimental 
transplantation of human foetal keratinocytes seeded on an optimized engineered 
plasma scaffold yielded excellent epidermal architecture and phenotype, including the 
expression of structural intracellular proteins. 
The selection of fibrin prepared form blood plasma as a scaffold was chosen 
due to its superior properties to support keratinocyte and fibroblast growth in vivo, as 
well as in vitro, and its ability to enhance cellular motility in the wound (Currie et al., 
2001). Fibrin glue can be used as a delivery system for cultured keratinocytes and 
fibroblasts, to provide similar advantages to those of conventional skin grafts Besides 
acting as a scaffold for cells, fibrin matrix has also been shown to be a suitable 
delivery vehicle for exogenous growth factors that can be incorporated into the matrix 
or sprayed to accelerate wound healing (Gwak et al., 2005). In contrast to other 
dermal substitute materials such as bovine collagen or human donor dermis, plasma 
can easily be obtained autologously. 
The severe combined immunodeficient (SCID) mouse was chosen as the 
animal model in this xenotransplantation study. Mouse models have been used 
extensively for wound healing studies as they are fairly easy to handle and small in 
size. It should be noted that rodent wounds heal primarily by contraction and not by 
granulation tissue formation as human wounds (Gross, 1996; Stark et al., 2004). Pigs 
are also used for engraftment studies because of the similar dermal structure to human 
skin, and pig wounds tend to heal by a combination of granulation tissue formation 





and contraction (Gallant et al., 2004). However, this requires expertise for appropriate 
husbandry and handling.  
Due to lack of host immunity, immunodeficient mice are usually used as 
recipients for human cells or tissues. Immunodeficient mouse models available 
include the nude mouse, the SCID mouse, NOD scid mouse and NOD scid gamma 
(NSG) mouse, in increasing degree of immunodeficiency (Nonoyama et al., 1993; 
Shultz et al., 1995; Ishikawa et al., 2005; Shultz et al., 2005; Ito et al., 2002). SCID 
mice have impaired T and B cell lymphocyte development, but have an intact innate 
immunity including natural killer cell activity. Skin rejection has been demonstrated 
to be mediated primarily by T cells (see section 2.6), and SCID mice have been 
demonstrated to successfully engraft primary keratinocytes (Levy et al., 1998; Wang 
et al., 2000; Li et al., 2011), therefore SCID mice still remains a reliable model for 
skin engraftment studies. Furthermore, SCID mice can be sourced locally from the 
Biological Resource Centre, A*STAR, and cost less than NSG mice. Female mice 
were preferable in this study, because they can be housed in groups without fighting 
which may obliterate the grafted skin construct. Nevertheless, they were housed in 
pairs as a precaution. 
The humanized skin mouse model developed here using cultured foetal cells, 
as described for the first time in this chapter, can now be used to further study on 
wound healing and human diseases. Further studies on allograft rejection in vivo can 
be analyzed by using a human peripheral blood mononuclear cell reconstituted SCID 


















9.1 SUMMARY AND SIGNIFICANCE OF FINDINGS 
This thesis presents some new findings in foetal skin biology and some improved 
methods that will help in the generation of tissue engineered skin constructs fot 
clinical applications. The experiments in this thesis were designed to address the 
specific aims given in Chapter 1, i.e. the hypothesis that foetal keratinocytes have the 
potential to act as a better donor source for cultured skin grafts, a technology that has 
so far not received widespread adoption in the clinic nor much commercial success, 
mainly because it is too expensive. Although autografts remain the gold standard for 
full-thickness wound grafting, cultured foetal skin cells could provide a better 
alternative. The main findings of this thesis drawn from the experimental results are 
as follows. 
1. The principle tissue source of foetal keratinocytes was skin from second trimester 
foetuses. Therefore second trimester foetal dorsal skin was characterized prior to 
cell extraction, and compared and contrasted to adult skin. The expression of 
keratin structural proteins K18, K17, K19 were all seen in foetal but not in adult 
skin, confirming the immaturity of foetal epidermis by known robust biomarkers 
(Chapter 4). 
2. The dermis of maturing foetal skin was analysed using Herovici’s stain, which 
gives a qualitative readout of relative amounts of different major collagen types. 
This is the first report of the use of this technique on human foetal skin, and it 





demonstrated a different collagen composition to be present in foetal skin (i.e. 
more type III collagen and less type I than adult dermis) (Chapter 4). 
3. Primary cells are well known to age in tissue culture, with an accumulation of 
chromosomal damage over time and repeated passaging. This could limit the 
usefulness of foetal keratinocytes for clinical applications. However it was 
demonstrated that culture ageing was not observed and foetal keratinocytes could 
be stably and successfully cultured in vitro whilst maintaining their normal 
phenotype and karyotype, using an isolation and culture method optimized here 
for second trimester foetal keratinocytes. This culture protocol supports the 
possibility of cell-based therapy development for wound repair and regeneration, 
and permits a more detailed and convenient analysis of foetal keratinocytes 
(Chapter 5). 
4. If foetal cells are ultimately to be used for clinical applications, then quality 
control measures will need to be able to ascertain that the cells being propagated 
retain their desired defined state. Thus it is significant that retention of the foetal 
phenotype could be seen by the retained foetal keratin expression pattern, so that 
the foetal keratinocytes can still be distinguished in tissue culture from their adult 
counterparts by expression of K18, K7, and K19 (all low or absent in 
interfollicular adult epidermis), as well as by their significantly smaller size 
(Chapter 5). 
5. The prohibitive cost of generating cultured autografts is largely due to the time 
taken to amplify sufficient cell numbers to graft the patient, especially when 
starting from small biopsies. The speed of amplification depends greatly on how 
fast the cells grow, and what proportion of the cells have stem cell-like clonogenic 





potential. Foetal keratinocytes were shown to demonstrate higher proliferative 
potential than adult keratinocytes as seen by (1) their higher proliferative index (PI) 
in the epidermis in vivo, (2) their shorter doubling times and faster expansion 
times in vitro, and (3) their ability to generate more colonies at low cell. They 
were also confirmed to have, on average, longer telomeres than adult human 
keratinocytes (Chapter 6). This supports the use of foetal cells as a cheaper, 
expandable, long-lived cell source for regeneration of tissue. Thus, when starting 
with foetal skin cells, it may not be necessary to introduce additional preparative 
steps to enrich for stem cells in the starting population. This removal of a 
disruptive handling step would also further increase the cell viability and thus the 
yield. 
6. Having established that foetal keratinocytes have many desirable properties, it was 
possible that they would be unable to demonstrate an adult differentiation pattern 
upon stratification, which would also have restricted their value. However when 
experiments were carried out to evaluate this parameter, it was confirmed that 
second trimester foetal keratinocytes are capable of fundamentally normal adult-
type differentiation in vitro, as they can form a stratified epidermal structure that 
is morphologically similar to, and expresses major structural proteins of, adult 
epidermis. This further reinforces the possibility of using foetal skin cells to 
generate bioengineered skin (Chapter 6). 
7. The biggest obstacle to skin grafting using anything other than the pateint’s own 
cells is of course immune rejection. Expression of the major histocompatibility 
antigens by second trimester keratinocytes was therefore of great interest. The 
work presented here is the first to analyse the expression of MHC determinants on 





human foetal keratinocytes. Foetal keratinocytes were shown to express low MHC 
I and show no MHC II expression. The cells were also shown to elicit no 
proliferative response in naïve T cells. Following experimental T cell stimulation, 
the response could be induced with high foetal keratinocyte numbers (Chapter 7).  
8. An improved method of preparing fibrin gels directly from whole plasma is 
reported, which will be useful for the construction of bioengineered skin 
equivalents to provide a more cost-effective and clinically suitable product. 
9. Finally, a long-term ability to differentiate and maintain skin structure was clearly 
essential if the foetal cells are ever to be used for adult grafting. A humanized skin 
model using cultured human foetal skin cells on immune-deficient mice was 
therefore developed, which does not appear to have been done before. The 
successful engraftment and stable skin regeneration using cultured foetal skin cells 
shows that second trimester human foetal keratinocytes can be used to generate 
mature, differentiated epidermis in vivo. Some technology development was 
required to optimize this, including an improved method of preparing fibrin gels 
directly from whole plasma, which will be useful for the construction of 
bioengineered skin equivalents to provide a more cost-effective and clinically 
suitable product. 
Collectively, the hypothesis that foetal skin has the potential to act as a universal 
donor for skin grafts is supported by the work presented in this thesis. 
 
  





9.2 IMPLICATIONS AND FUTURE STUDIES 
Cues for developing the next-generation of cost effective, user-friendly, 
bioengineered skin constructs based on non-animal products, should be taken from 
embryogenesis, morphogenesis, and the acute wound healing process. The work 
presented in this thesis has implications for the future of cultured keratinocyte grafting 
of patients, particularly where time is of the essence.   
The possibility of off-the-shelf availability is important to the clinical and 
commercial success of the product. Off-the-shelf availability is essential in cases 
where treatment must be carried out early and at very short notice, such as massive 
burn wounds. In addition, preparation of products in large batches rather than as need-
based production is a more viable option as this results in less consumption of product 
for quality testing. Although allogeneic cells (Figure 9.1) can be used to achieve off 
the-shelf availability, the issue of immunogenicity is a major limitation. However, the 
work presented here suggests that second trimester foetal keratinocytes might indeed 
be a useful alternative source of cells. Much more follow-up work is now needed to 
confirm this, starting for example with foetal keratinocyte grafting onto immune-
competent mice. 
There is much discussion about the potential of using induced pluripotent cells, 
equivalent in many ways to embryonic stem cells, as an autologous cell source for 
generating large numbers of tissue cells for therapeutic applications. However, use of 
proliferative skin cells is likely to be faster and cheaper. Compared to embryonic or 
mesenchymal stem cells, cell culture requirements of foetal skin cells are technically 
less demanding. The expansion and maintenance of stem cells in an undifferentiated 
state require the addition of many specific growth factors, which presents a limiting 





factor for the up-scaling of stem cell cultures for clinical applications. Unlike stem 
cells, foetal keratinocytes are differentiated cells with high expansion, regeneration, 
low immunogenicity properties, and capable of epidermal differentiation. As the cells 
are already differentiated, they do not need to be directed or altered. Therefore, 
additional growth factors for differentiation are not needed for cell culture and 
expansion.  
Other studies have demonstrated that foetal cells, unlike neonatal or adult cells, 
also adapt particularly well to biomaterials, allowing efficient integration into various 
biomaterials with higher survival rates (De Buys Roessingh et al., 2006; Montjovent 
et al., 2005). Foetal fibroblasts have been shown to be highly resistant to oxidative 
and physical stress, and can survive at lower oxygen tensions than adult cells, making 
them highly suitable for hostile wound environments (De Buys Roessingh et al., 
2006). They are also more resistant to refrigeration and cryopreservation techniques 
than adult cells (De Buys Roessingh et al., 2006; Applegate et al., 2009). Further 
studies can be performed to confirm whether foetal keratinocytes could provide an 
additional advantage over adult keratinocytes, which will be useful for up-scaling for 
therapeutic use. Because foetal keratinocytes have been characterized, it is possible to 
use a pool of multiple donors for a batch of cells. Further studies on cell banking 
capabilities can be considered to ensure quality control, storage, expansion and 
distribution of foetal skin cells. 






Another possible benefit of using immature cells such as these for grafting is 
that it may be possible to re-initiate appendage formation from foetal cells. Absence 
of appendages such as hair follicles and sweat glands is one of the most difficult 
consequences of large-scale grafting. Holbrook et al. reported that skin tissue from a 
foetus during a critical window of time (9 – 12 weeks gestation) initiated follicle 
morphogenesis in vitro. Follicle germs continued to develop to the hair peg stage 
before arresting this process (Holbrook et al., 1993; Holbrook & Minami, 1991). In 
addition, primary cultures of mouse foetal and neonatal skin cells, containing both 
epidermal and dermal cells, will reform skin, complete with hair follicles, if 
transplanted to subcutaneous sites in the mouse (Yuspa et al., 1970; Worst et al., 
1982). It will be interesting if human foetal skin cells could recapitulate the data. 
Various factors can also be tested in foetal keratinocytes and foetal fibroblasts culture 
to determine how they may influence the process. The factors controlling sweat gland 
development are even less understood, but as sweat glands develop slightly later than 
hair follicles, it would be expected that this too might be possible. Recent publications 
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Figure 9.1   Possible sources of allogeneic cells employed for reconstruction of human skin 
and their associated challenges. 
 
 





have now begun to unravel the nature of sweat gland stem cells (Lu et al., 2012) and 
the interaction between progenitor cells and the extracellular matrix in generating 
sebaceous glands (Horsley et al., 2006). Future studies will need to focus on the foetal 
fibroblasts as well as the keratinocytes in generating appendage-competent grafts. 
It is clear that the processes associated with adult tissue repair and 
regeneration are not like those in foetal development. Identifying differences in gene 
or protein expression between foetal and adult skin cells could provide important 
information in inducing efficient tissue repair and growth factors for wound healing, 
which could be useful in burns and chronic wounds. 
The future of foetal cell therapy is likely to beset with numerous ethical issues, 
not least a reluctance of some patients to receive grafts from foetal cells. This issue 
will likely be less acute in emergency life-saving situations such as extensive burns, 
which would probably be the first context in which foetal grafts would be tested, but 
will have to be dealt with sensitively. All human tissue is precious. As we begin to 
understand much more about the mechanisms behind skin regeneration, a new 
approach to grafting is timely, and this may well be the most significant phase in the 
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